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Abstract 
 
Malaysia is ranked the 12th richest country for its biological diversity of plant 
species by the Convention on Biological Diversity and this project aims to 
contribute to existing knowledge of Malaysian rainforest plants, Acalypha 
wilkesiana, Duabanga grandiflora, Archidendron ellipticum and Pseuduvaria 
macrophylla, for the treatment of cancer.  
 
A. wilkesiana (Euphorbiaceae) whole plant EtOH and EtOAc extracts inhibited 
growth of breast cancer MDA-MB-468 cells (GI50: 22.7 and 15.9 ȝJPO and 
revealed preference over non-transformed MRC5 fibroblasts (GI50: 46.6 and 
53.3 ȝJPO, respectively).  EtOH and HEX extracts were able to impair cell 
survival and colony-forming abilities in MDA-MB-468 cells after 24 h.  
Detection of increased MDA-MB-468 sub-G1 cell populations after 48 h 
treatment to EtOH and HEX extracts, suggest that cells may be undergoing 
apoptosis. 
 
A. ellipticum (Leguminosae) crude polar bark and leaf extracts inhibited MDA-
MB-468 cell growth (GI50 of bark EtOH, EtOAc extracts: 1.7 and 40.4 ȝJPO, 
respectively and leaf EtOH and EtOAc extracts: 9.3 and 9.3 ȝJPO, 
respectively).  However, MDA-MB-468 cell growth was unaffected by HEX 
extracts (> ȝJPO  Separation of crude extracts revealed sub-fractions of 
greater activity, in particular a 50-fold enhanced potency in sub-fractions of 
HEX extract thus overcoming masking or antagonistic activity in the crude 
mixture.  Following 24 h, bark and leaf extracts impaired MDA-MB-468 cells¶ 
proliferative and colony-forming abilities at 1X and 2X GI50 values suggesting 
significant damage was induced leading to observed cellular senescence and 
inhibition of cell proliferation.  After 48 h exposure to EtOH and HEX extracts, 
MDA-MB-468 cells accumulated cellular damage, possibly affecting 
microtubule functions resulted in activation of apoptosis as shown by increased 
of sub-G1 and G2/M MDA-MB-468 cell populations and presence of 
phosphatidyl serine on the outer membrane of cells.  Modest levels of 
flavonoid and phenolic compounds were found in bark and leaf extracts, which 
correlated to moderate level of free radical scavenging activity observed.  
II 
 
D. grandiflora (Lythraceae) bark and leaf extracts revealed growth inhibitory 
effects against colorectal cancer HCT116 cells (GI50 of bark Water, EtOH, 
EtOAc and HEX extracts: 42.4, 37.5, 21.69 and 28.9 ȝJPO, respectively; leaf 
Water, EtOH, EtOAc and HEX extracts GI50: 38.0, 40.9, 24.7 and > 200 ȝJPO, 
respectively).  Separation of crude bark extracts resulted in fractions of greater 
activity, whereas separation of leaf extracts revealed reduced activity 
suggesting synergistic activity in the mixture.  Following 24 h, bark and leaf 
extracts impaired HCT116 cells¶ proliferative and colony-forming abilities at 
1X and 2X GI50 values indicating significant damage incurred leading to 
observed cellular senescence and cell proliferation inhibition.  After 48 h 
exposure to D. grandiflora extracts, increased sub-G1 HCT116 cell population 
and a G1/0 cell cycle block accompanied by decreased S and G2/M cell 
populations were measured.  Detection of phosphatidyl seULQH RQ FHOOV¶ outer 
membrane and activated apoptotic caspase 3 protein confirmed D. grandiflora 
extracts induced apoptosis.  Highest levels of flavonoid and phenolic 
compounds were found in polar bark and leaf D. grandiflora extracts, which 
may correlate to the highest free radical scavenging activity measured. 
 
P. macrophylla (Annonaceae) extracts collectively displayed greatest HCT116 
cell growth inhibition (EtOH, EtOAc and HEX extracts GI50: 5.2, 1.6 and 5.4 
ȝJPO DQG VHSDUDWLRQ RI (W2+ DQG (W2$F extracts revealed even greater 
activity in sub-fractions.  After 24 h, polar extracts at 2X GI50 completely 
impaired HCT116 cells¶ proliferative and colony-forming abilities suggesting 
extract-induced significant damage led to inability of cells to proliferate.  
Analysis of cell cycle distribution revealed increased sub-G1 HCT116 cell 
population and high levels of early apoptotic HCT116 cells following 48 h 
exposure to P. macrophylla extracts coupled with detection of caspase 3 
activation confirming execution of apoptosis.  Modest levels of flavonoid and 
phenolic compounds were detected in EtOH, EtOAc and HEX extracts, which 
correlated to modest free radical scavenging activity.  
 
The findings in this project should justify further separation and in vitro 
investigations.  
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1                 
Introduction 
 
1.1 The history of the application of medicinal plants in 
treatment of diseases 
Prehistoric evidence has revealed mankind¶Vapplication of natural products to 
treat various symptoms as well as benign and malignant diseases.1-3  Ancient 
accounts, dated approximately 2,600 BC, originating from the Sumerians and 
Akkaidians describe uses for approximately 1,000 plants and their derived 
substances such as oil, resin and juice.3, 4  Our ancestors chewed on particular 
herbs to relieve pain, used plants as tinctures or dressings to heal wounds and 
also used plants as poisons.3-5  Several surviving ancient recipes of plant-based 
treatment of diseases are still in use, for example the Egyptian Ebers Papyrus 
dated around 1550 to 2900 B.C, which includes over 700 drugs and 800 
formulae consisting of plants, animal organs and some minerals.  The Chinese 
Materia Medica dated from circa 1100 B.C describes the use of over 600 
plants in treating diseases.6, 7  Natural products used traditionally for treatment 
could incorporate entire or parts of organisms such as plants (flower, stems or 
roots), animal products (glands or organs), microorganisms or inorganic salts 
without extensive processing.5, 8  The selection and application of natural 
products for human well-being have prospered and evolved over the centuries 
through a process of trial and error.9  Indigenous knowledge and practices (or 
systems) are passed down generations worldwide for example, Traditional 
Chinese Medicine (TCM; China), Japanese Chinese Medicine or Kampo 
(Japan), Korean Chinese Medicine (KCM; Korea), Jamu (Indonesia), 
Ayurvedic Medicine (India), and more recently Phytotherapy (Europe).2  The 
World Health Organisation (WHO) defines traditional medicine (TM) as 
LQGLJHQRXVSUDFWLFHZKLFK³incorporates plant, animal, and/or mineral based 
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medicines, spiritual therapies, manual techniques and exercises applied 
singularly or in combination to maintain well-being, as well as to treat, 
diagnose or prevent illness´8  70 LV DOVR NQRZQ DV µFRPSOHPHQWDU\ DQG
DOWHUQDWLYH¶&$0RUµQRQ-FRQYHQWLRQDO¶PHGLFLQHLQFRXQWULHVZKHUH70 LV
QRW D SDUW RI WKH FRXQWU\¶V QDWLRQDO KHDOWK FDUH V\VWHP10, 11  At present, an 
HVWLPDWHGRI WKHZRUOG¶VSRSXODWLRQSULPDULO\LQXQGHYHORSHGFRXQWULHV
is reported to use TM as their primary healthcare.8  Whereas the other 20% of 
WKH ZRUOG¶V SRSXODWLRQ SULPDULO\ LQ GHYHORSHG FRXQWULHV LV EHLQJ SUHVFULEHG
drugs that are derived directly from natural products or designed from semi-
synthetic natural product pharmacophores.12  Since there is an extended record 
of using natural products for human consumption and treatment of diseases, it 
deems rational to investigate plant materials as a source for biologically active 
therapeutic compounds.13  
1HYHUWKHOHVVPDQNLQG¶VGHVLUHWRSXUVXHDEHWWHUOLIH-style has led to increased 
commercial pressure for habitable areas, food sources and employment (e.g. 
farming).  As a result, there is an ever-growing concern over the effect of the 
deforestation and industrialisation of the planet on the natural habitat of 
wildlife and plant species.  The decline and potential extinction of species 
could result in the loss of interesting novel therapeutic compounds as well as 
the gradual loss of indigenous traditions and ethnobotanical knowledge.14, 15  
Therefore the race to identify useful natural compounds could ease commercial 
pressures and preserve natural habitats if governments and authority bodies 
enforce stricter regulations on deforestation.  
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1.2 Advances in traditional medicine: Ethnopharmacology and 
Molecular Pharmacognosy  
+HUEDOUHPHG\UHFLSHVDUHULFKVRXUFHVRISK\WRFKHPLFDOVWKHWHUPµSK\WR-¶LV
derived from the Greek word for plant) and thus provide guidance for potential 
drug-leads.16, 17  The observation of natural products¶XVH by indigenous groups 
accompanied by the scientific investigation of herbal recipes to identify active 
phytochemicals is an area of drug research termed ethnopharmacology.3  
Ethnopharmacology is enhanced by multicultural exposure and global 
communication enabling methodological collection and validation of medicinal 
valuable ethnobotanical evidence.18  In the 18th century when medicines were 
mainly limited to natural products, Johann Adam Schmidt (1759±1809) 
DGRSWHGWKHWHUPµSKDUPDFRJQRV\¶ WRLQFRUSRUDWHWKHDUHDRIGUXJNQRZOHGJH
DQG µHWKQRERWDQLF PHGLFLQH¶3, 11, 14  Consequently, pharmacognosy has 
advanced to incorporating various disciplines such as ethnobotany, 
phytochemistry, biochemistry, organic chemistry, taxonomy and pharmacology.  
Each discipline contributes to the accurate identification of plant species (plant 
selection), extraction of plant materials, verification of biological activity and 
the isolation and structure elucidation of novel active compounds or of already 
known active compounds by validating on compound databases (de-
replication); this is termed µPROHFXODU SKDUPDFRJQRV\¶ ZKLFK ³explores 
naturally occurring structure-activity relationships (SAR) with a  drug potential´
to increase chances of finding new structures, biological activity and targets 
(Figure 1-1).19   
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Figure 1-1: Explanatory model for molecular pharmacognosy. 
 
At the beginning of the 19th century, approximately 80% of all medicines were 
derived from different plant sections e.g. root, leaf and/or bark.20  For instance, 
Solanum dulcamara bark extract is used in TCM for its analgesic properties to 
relieve pain.21  By the late 19th century, aspirin (or acetylsalicylic acid) (1), 
from the bark of Salix alba was developed.  Aspirin is the first synthetic 
pharmaceutical drug for the relief of minor pains, which highlights the 
significance of nature in drug development.5, 22, 23  Upon tissue damage, 
algogenic chemicals such as prostaglandins are released to cause hyperalgesia, 
and aspirin acts to inhibit the biosynthesis of such molecules.23-25  Later, 
morphine was isolated from opium poppy, Papaver somniferum, and the search 
and isolation for new drug leads continues today with approximately 75% of 
drugs for infectious and parasitic diseases consisting of natural products or 
natural product derivatives.11, 20    
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Figure 1-2: The chemical structure of acetylsalicylic acid (1). 
 
Between 1981 and 2002, 52% of the 868 new chemical entities (NCEs) were 
natural products, natural product derivatives or compounds containing a 
pharmacophore from natural products.26  In 2004, 70 natural product-related 
compounds were in clinical trials.5  Recently, approved drugs based on natural 
products include artemether (isolated from Artemisia annua L. (Asteraceae) 
used in TCM), galantamine (isolated from Galanthus woronowii Losinsk 
(Amaryllidaceae)), calanolide A (isolated from Calophyllum lanigerum var. 
austrocoriaceum (Whitmore) (Clusiaceae)) and nitisinone (modified from 
mesotrione, from Callistemon citrinus Stapf. (Myrtaceae)), which are available 
in the United States (U.S.) for indications VXFK DV PDODULD $O]KHLPHU¶V
HIV/AIDS and tyrosinaemia, respectively.11  Patients commonly acquire 
resistance to their treatment e.g. malaria patients develop resistance to 
chloroquine (2) over prolonged use, therefore drug development is a continual 
process to ensure new leads such as cryptolepine (3), an alkaloid from the 
African Cryptolepis sanguiolenta, with an alternative mechanism of action will 
be available as another treatment option.27 
 
 
Figure 1-3: The chemical structures of chloroquine (2) and cryptolepine (3). 
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Fabricant and Farnsworth (2001) outlined several key objectives of 
investigating plants for therapeutic compounds, including the use of isolated 
bioactive compounds as direct drugs, structural templates for semisynthesis, 
pharmacologic tools and/or using the crude plant as a herbal remedy.14, 28  The 
number of unexplored higher plant species, angiosperms and gymnosperms, in 
the world is estimated between 215,000 to 500,000.2, 29  Of these, only 6% have 
been screened for their biological activity and < 20% have been subjected to 
laboratory investigation for potential therapeutic use.13, 30  Sneader (2005) 
suggested that < 3,200 (1%) plant species are used in TM, highlighting that 
there are many unexplored areas in drug discovery from plant species.2  
Interestingly, Farnsworth et al. (1985) identified that of the 122 active 
compounds found in 94 different ethnomedicinal plant species, 80% of the 
active compounds have been used to treat identical or related indications to 
their ethnomedicinal use.  Consequently, attesting H[WUDFWV¶ traditional 
application could provide direction and selection of more specific assays for 
the plant species.28  
 
1.2.1 Approaches to Natural Product Drug Discovery 
Many different approaches are available to identify biologically active 
phytochemicals.  Random collection and screening of phytochemicals is 
perhaps one of the most economical and popular approaches to isolate 
phytochemicals such as flavonoids, alkaloids, isothiocyanates, triterpenes etc.1, 
7, 12, 27
  In vivo and in vitro bioassays could be employed to determine the 
activity of crude plant extracts prior to committing to extensive extraction, 
isolation and characterisation procedures for active fractions.1, 31  Alternatively, 
guidance from archived literature documenting traditional medicinal systems 
could assist in identification of  plants (extracts) with interesting bioactivity 
followed by isolation and characterisation of compounds present to enable 
investigation of their potential application in disease.32  Collection and 
organisation of ethnomedicinal information should facilitate the identification 
of possible positive hits.14 
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Between the period of 1970 and 1990, the emergence of high-throughput 
screening (HTS) and generation of chemical compound libraries via 
combinatorial chemistry enabled identification of defined molecular targets 
and NCEs, respectively.33-36  These technologies have the potential to produce 
and screen numerous drug candidates where typically a small team of 
researchers can screen over a million of samples annually.  This is appealing 
compared to natural product drug discovery and development (NPDD), which 
often demand high expenditures, long discovery timelines, high possibility of 
re-discovery and sourcing of natural products as well as the fierce competition 
between big pharmaceutical companies to deliver first-in-class drugs with well-
defined mechanism of actions.35, 37  HTS enabled vast numbers of plant species 
to be validated, and companies with such facilities have the ability to screen 
WKRXVDQGV RISODQW H[WUDFWVSHU ZHHN +HQFH /LSLQVNL¶V µUule-of-ILYH¶ 52
criteria were established to rationalise and respond to numerous chemical 
compound libraries and to assess the relationship between a compound¶s 
FKHPLFDO VWUXFWXUH DQG ELRORJLFDO SURSHUWLHV  /LSLQVNL¶V 52 SUHGLFWs and 
selects for orally active compounds by fulfilling the criteria shown in Table 1-
1.38   
 
Table 1-1: /LSLQVNL¶V5XOHRI)LYH52FULWHULD IRUSUHGLFWLQg orally active 
compounds.38   
/LSLQVNL¶V5XOHV Criterion 
Molecular weight (MWT)  
Log P  
Hydrogen bond donors  
Hydrogen bond acceptors  
 
In 2004, Lipinski suggested other factors for example the number of aromatic 
rings, number of rotational bonds and topological polar surface area (TPSA) 
should be included.  Collectively, physicochemical features affecting drug 
absorption, distribution, metabolism, excretion (ADME) and interaction with 
target receptor will impact the quality of lead-like compounds used in 
screening libraries such as small molecule fragment and chemical libraries.38, 39  
However, applying the RO5 on a single combinational chemical core will 
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restrict the structural diversity of combinatorial libraries and satisfying the 
RO5 does not guarantee a drug-like compound.38  Zhang et al. (2007) reported 
that just over 50% of the 1,204 US Food and Drug Administration (FDA)-
approved orally administered small-molecule drugs obey the RO5, therefore 
the RO5 should be followed with caution and its compatibility in rational drug 
design and development should be re-evaluated.  It has already been stated that 
natural products do not comply with /LSLQVNL¶V5226  Kumar and Soni (2010) 
revealed statistical results from their data collection suggesting medicinally 
useful natural products tend to contain physicochemical features violating the 
/LSLQVNL¶V52FULWHULDTable 1-2).   
 
Table 1-2: Physicochemical properties of medicinally useful natural 
products.34 
/LSLQVNL¶V5XOHV Criterion 
Molecular weight (MWT) 0:7 
Log P -ORJP  
Hydrogen bond donors (HBD) +%' 
Hydrogen bond acceptors (HBA) +%$ 
Nitrogen atoms QLWURJHQDWRPV 
Oxygen atoms R[\JHQDWRPV 
Topological polar surface area (TPSA) 736$ 
Aromatic rings DURPDWLFULQJV 
Rotatable bonds 0 URWDWDEOHERQGV 
 
Lee and Schneider (2000) have cross-analysed 1,748 and 807 different ring 
systems from natural products (in the BioscreenNP collection) and from trade 
drugs (in the Derwent World Drug Index (WDI)), respectively.  Interestingly, 
results emphasised the diversity of natural product structures revealing that 
approximately 35% of trade drugs contained a ring system also present in the 
natural product collection whereas only 17% of natural products share the same 
ring system present in trade drugs.13  Natural products have significantly higher 
numbers of chiral centres and greater steric complexity.40  Therefore, 
information gained from the structure of natural products will introduce 
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diversity and increase opportunities for strong drug candidates not necessarily 
complying with the RO5, hence encouraging new drugs with novel 
mechanisms of action.41, 42  This revived interest could be due to the low 
success rate of chemical libraries over the last two decades, with only one de 
novo compound approved by the FDA in 2005.  Sorafenib (BAY43-9006; 
Nexavar®) is an oral multiple kinase inhibitor for the treatment of advanced 
renal cell carcinoma from Bayer Pharmaceuticals.  Despite the short discovery 
timeline of 11 years, more systematic approaches should be employed to 
maintain the progression of drug discovery.43  This could be achieved by 
changing from large libraries to using smaller focused libraries (termed 
Diversity Oriented Synthesis (DOS)) with approximately 100 to 3,000 
compounds, and most of which are structurally related to natural products.44 
Additionally, natural product skeletons could act as templates in combinatorial 
chemistry to generate compound libraries of novel natural product scaffolds for 
screening.13, 35  The extended history of phytochemicals used in medicine and 
evidence of their structural complexity could be deemed unsurprising since the 
co-evolution between plants and animals has resulted in compatibility between 
the building blocks present in both species (Figure 1-13).33  Natural products 
have structural homogeneity across many plant species hence sharing 
comparable structural domains to biological targets.5, 20 Therefore, 
phytochemicals PD\ ILWEHWWHU LQWRWKHµFKHPLFDO VSDFH¶RI WDUJHWSURWHLQVHJ 
interaction with targets in human signal transduction pathways.16  
 
1.2.2 Purposes and classes of phytochemicals 
Plants produce phytochemicals to serve different purposes including self-
protection from destructive toxins and predators e.g. carcinogens or mutagens.  
Several tree species produce tannins as their defense mechanism in response to 
damaged leaves caused by predators or for communication with neighbouring 
plants to increase their survival chances.2, 45, 46  As previously mentioned, 
exploring phytochemicals can offer advantages such as uncovering new drug 
leads or additional sources for currently available compounds.11  Nonetheless, 
undesired side effects are also associated with phytochemicals because their 
purpose is to enhance survival and competitiveness of plants by defending 
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against possible threats and not for treating human diseases.2, 20 Many natural 
products possess structures that are beyond the imaginative designs of 
VFLHQWLVWV DQG RIWHQ FRQWDLQ PXOWLSOH VWHUHRFHQWUHV µchiral centres, aromatic 
rings, complex ring systems, degree of molecule saturation, and number and 
UDWLRRIKHWHURDWRPV¶11  Phytochemicals can be grouped in different ways such 
as by their chemical structures, physiological effects, or by their biosynthesis 
mechanisms.3   
 
1.2.2.1 Shikimic acid derivatives 
Shikimic acid (4) is a common precursor of aromatic amino acids 
(phenylalanine, tryptophan and tyrosine) as well as other proteins and peptides, 
alkaloids, phenols, coumarins, chromones, xanthones, stilbenes, flavonoids, 
lignans and gallic acid.47  Gallic acid is the precursor for many types of tannin, 
which is abundant in all plants, and forms insoluble compounds with proteins.  
Tannins can be obtained from galls produced on various plants and used to 
treat diarrhoea and bleeding gums. 
 
 
4 
Figure 1-4: The common chemical structures of Shikimic acid (4). 
 
1.2.2.2 Carbohydrates 
Carbohydrates, Cn(H2O)n, are the main constituents of living organisms and are 
present in abundance on cell surfaces with diverse fundamental functions 
including molecular recognition and signal transduction.48  In plants, 
carbohydrates are one type of photosynthetic products, whose functions 
include providing structural support (e.g. cellulose), and energy storage (e.g. 
starch).  Carbohydrates can be grouped into monosaccharides (3 to 9 carbons), 
disaccharides, oligosaccharides (2 to 10 monosaccharide molecules) and 
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polysaccharides (over 10 monosaccharide molecules).  One example of 
medicinal use of mucilage (polysaccharide) from Linseed, (flax; Linum 
usitatissimum L. (Linaeceae)), is use as a laxative.47   
 
1.2.2.3 Acetate derivatives 
Acetate (5) is a common precursor for fatty acids (saturated and unsaturated 
triglycerides), fats and waxes, phospholipids, polyketides, monoterpenes, 
sesquiterpenes, diterpenes, triterpenes and steroids.  Synthetic steroids are used 
for cancer treatments and to reduce adverse reactions to chemotherapy.  Low 
doses of glucocorticoids can treat adverse reactions such as chemotherapy-
induced emesis and dyspnoea in cancer patients via interaction with 
intracellular glucocorticoid (steroid) receptors (GR) to trigger signaling 
pathways and down-regulation of GR.49 
 
 
5 
Figure 1-5: The chemical structure of the acetate group (5). 
 
1.2.2.4 Alkaloids 
Alkaloids are derived from amino acids and there are over 3,000 known 
alkaloids such as cocaine, vincristine and vinblastine.  Alkaloids are naturally 
occurring organic compounds that have nitrogen as part of a heterocyclic ring 
system.  Only present in some plant families, the types of alkaloids range from 
pyridine and piperidine, tropane, isoquinoline, indole, quinolone and imidazole.  
Common alkaloids include caffeine and nicotine.  
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1.2.3 Common procedures in Natural Products Drug Discovery 
Application of modern technologies such as analytical, structural chemistry 
DQGYDULRXVµ-omLFV¶WHFKQLTXHVKDVHQDEOHGWKRURXJKVWXGLHV to be conducted 
LQWR FRPSRXQGV¶ 6$5VDQG WKHLU ELRORJLFDO HIIHFWV &ROOHFWLQJDQGYHULI\LQJ
such information has resulted in comprehensive databases such as the 
Dictionary of Natural Products (DNP), which has > 214,000 entries of natural 
compounds and their derivatives.50  Rational design of chemical compounds 
could offer a secondary role for natural products in drug discovery and 
development by providing a template for combinatorial chemistry and 
molecular biology.  Only by addressing the challenges would the enormous 
potential to discover novel compounds from natural sources be unlocked.2  
Bruhn and Bohlin (1997) mentioned four possible relationships of a bioactive 
compound: known activity and known structure, known activity and new 
structure, new activity and known structure or new activity and new structure; 
the last being of greatest interest.19   
There are thousands of reports of antiviral, antibacterial and antifungal drugs 
derived from plants that are used to treat various indications.  Newman and 
Cragg (2012) published a comprehensive list of NCEs with accompanying 
plants source and treatment indication(s).51  Interestingly, several plants 
containing anticancer compounds were also used traditionally as anticancer 
agents.   Diseases such as cancer where resistance is common will require 
continuous efforts to find novel compounds.  Table 1-3 illustrates a 
compilation of the anticancer agents that are either directly from nature or 
natural products-derived in clinical use between the periods of 1981 to 2010.   
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Table 1-3: A list of drugs derived from plants with their corresponding uses and source discovered between the years 1981 and 2010.  
Drug Plant Source of Natural Product-derivatives 
Phytochemical 
compound class Main Target(s) 
Ethno-medical 
correlation/ 
Reference 
Andrographolide 
 
 
Andrographis paniculata Diterpenoid Caspase-3 and -8, p16, p21, p27 Yes  
52
 
Arglabin 
 
 
Artemisia glabella Sesquiterpene Raf kinase cascade No 53 
Belotecan hydrochloride 
 
 
Camptotheca acuminate Decne Alkaloid Topoisomerase I No  54 
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Cabazitaxel 
 
Taxol derivative Diterpene 7XEXOLQĮ-DQGȕ-1 chains No  55 
Camptothecin 
 
Camptotheca acuminate Decne Alkaloid DNA Topoisomerase I No 56, 57 
Docetaxel 
 
Taxol derivative Diterpene 7XEXOLQȕ-1 chain, VEGF No  58 
Demecolcine 
 
Colchicum autumnale L. Alkaloid 
30S ribosomal protein S9 
and 30S ribosomal protein 
S4 
Yes  59 
15 
 
Elliptinium acetate 
 
 
Bleekeria vitensis Alkaloid DNA Topoisomerase II-Į No  60 
Etoposide  
Etoposide phosphatec 
 
 
Podophyllotoxin derivative Alkaloid DNA Topoisomerase II-Į  Yes  61 
Glaucine 
 
 
Glaucium flavum Crantz Alkaloid DNA No  62, 63 
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Homoharringtonine 
 Omacetaxine mepesuccinate 
 
Cephalotaxus harringtonia var. 
drupacea Alkaloid 80S ribosome (eukaryotes) No   
64
 
Irinotecan (prodrug) 
Irinotecan hydrochloride 
 
Camptothecin derivative Alkaloid DNA Topoisomerase I  No   65, 66 
Masoprocol 
Nordihydroguaiarectic acid  
 
Larrea divaricata Cav. Phenolic Arachidonate 5-lipoxygenase No  
67, 68
 
Monocrotaline 
 
Crotolaria sessiliflora L Alkaloid Microtubules Yes  69 
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Paclitaxel  
Paclitaxel nanoparticles 
 
 
Taxus brevifolia Nutt  
Taxol derivative Diterpene 7XEXOLQȕ-1 chain and Bcl-2 No  
70, 71
 
Podophyllotoxin 
 
 
Podophyllum peltatum L. Alkaloid Structure used for derivatives Yes  
72, 73
 
Solamargines 
 
Solanum incanum Alkaloid TNFR and Bcl-2 No  74 
Talaporfin Chlorophyll Aspartyl chlorin Tumour tissues o 75, 76 
18 
 
Talaporfin sodium 
 
Chlorophyll Aspartyl chlorin Tumour tissues No  75, 76 
Teniposide
 
Podophyllotoxin derivative Alkaloid DNA Topoisomerase II-Į Yes  77 
Topotecan hydrochloride 
 
Camptothecin derivative Alkaloid DNA Topoisomerase I No  78 
19 
 
Vinblastine 
 
Cantharanthus roseus (L.) G. Don Alkaloid 
Tubulin -Į-3, -ȕ-į-%? and 
-İFKDLQVDQG7UDQVFULSWLRQ
factor AP-1 
No  79 
Vincristine 
 
Cantharanthus roseus (L.) G. Don Alkaloid 7XEXOLQĮ-DQGȕFKDLQV No  80 
20 
 
The listed anticancer compounds are either isolated directly from plants or are a plant derivative from the period of 1981 to 2010.  The 
ethnomedical correlation is noted for each plant and its active compound(s).  Information regarding the mechanism of action of each drug was 
obtained from DrugBank, the NCI and/or the given references.78, 83, 84 
Vinflunine 
 
Vinca alkaloids derivative Alkaloid Tubulin No  81 
Vinorelbine (di-)tartrate 
 
Vinca alkaloids derivative Alkaloid Tubulin-ȕFKDLQ No 82 
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1.2.4 Selection of plant materials 
The selection of plants (or specific plant sections) for investigation could begin 
with searching random collections, literature and/or ethnopharmacology 
systems.18, 85  The accuracy of documentation and authentication of the plant 
specimen should be verified by experts prior to standardised methodical 
processes.  Specimen selection based on ethnopharmacological evidence 
should acknowledge the intellectual property (IP) of the traditional healers.  A 
record of collection including harvest time (day or evening), season (month, 
weather and soil condition), age of the plant and location (specific area) should 
be kept because inconsistency will lead to differences in phytochemical 
compositions between samples.  Furthermore, the endemic status of the plant 
DQG GHIRUHVWDWLRQ VWDWXV DUH IDFWRUV DIIHFWLQJ WKH FROOHFWRU¶V judgment to 
investigating certain plants for their therapeutic properties.85  The order of 
procedures from selection to identification of active plant extracts using bio-
guided fractionation and subsequent structure elucidation of the active 
compound(s) has been extensively described.85-87  The following procedures in 
this chapter were adapted from Houghton and Raman (1998), Samuelsson 
(1999) and Arnason et al. (1995).18, 47, 87  
 
1.2.5 Preparation of crude extracts 
In general, the starting plant material must be reduced in size through processes 
such as grinding and pulverisation prior to extraction.  There are three types of 
extracts: dry i.e. prepared without solvent (extracta sicca), soft (extracta 
spissa) and fluid (extracta fluida) which are prepared with solvents of varying 
polarity (Table 1-4).3  The choice of solvent determines which type of 
phytochemicals are eluted from the crude extract and the polarity provides 
LQGLFDWLRQRIWKHHOHFWURQGLVWULEXWLRQDFURVV WKHPROHFXOH VXFKDVʌHOHFWURQV
(aromatic rings, carbon-carbon double bonds and carbonyl groups) and lone-
pair electrons (electronegative atoms).18  Other pressures on solvent selection 
include boiling temperature, reactivity, viscosity, vapour pressure, safety, cost 
and recovery.  Plant extracts should be checked for contamination e.g. 
microorganisms, prior to preservation of samples.  The samples could be dried 
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either by leaving in a warm, dry atmosphere or by freeze-drying then stored in 
the dark and at a sub-zero temperature.  
 
Table 1-4: Polarity of solvent molecules used for UNMC extraction process. 
Solvent Structure Polarity Chemical class 
extracted 
Hexane 
 
Non-polar 
waxes, fats and 
fixed oils 
(volatile oils) 
Ethylacetate 
 
Moderate polarity; 
HOHFWURQVʌDQG
lone-pair) on oxygen 
alkaloids, 
aglycones, 
glycosides 
Ethanol 
 
Polar glycosides 
Water 
 
Polar, no lipophilic 
non-polar areas 
sugars, amino 
acids, glycosides 
  
1.2.6 Extraction methods 
The selection of a suitable extraction method is essential as this will impact on 
(active) phytochemicals present in the crude plant mixture for validation in 
bioassays.  Many extraction methods are available to extract chemicals from 
plant extracts (see Table 1-5).  Description of general extraction procedures are 
adapted from Houghton and Raman 1998, Gunnar and Samuelsson 1999 and 
Arnason et al.1995 and will be briefly described.3, 18, 87  
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Table 1-5: Common methods employed for extracting chemicals from crude 
plant extracts. 
Extraction method Procedure 
Maceration 
Coarsely powdered extract is soaked in a solvent 
contained in a sealed container at room temperature 
for at least three days. Material should be stirred until 
soluble matter has dissolved before straining; it is then 
pressed and filtered with liquid. 
Infusion 
Like maceration, plant materials undergo intermittent 
exposure to cold and boiling water and soluble matter 
should be contained in the solution. 
Digestion Like maceration, plant material is subjected to gentle heating during the whole extraction process. 
Decoction 
The material is boiled in a specified volume of 
menstruum for a set period at a fixed ratio. The 
macerated material is then cooled and strained. 
Percolation 
The material is placed in a sealed container with a 
specified volume of menstruum and incubated for 4 h; 
then packed into a percolator with added menstruum to 
macerate overnight. The liquid is allowed to drip 
slowly.   
Soxhlet 
The material is placed in folded filter paper then in 
apparatus where heat is applied to small volume of 
menstruum so the vapours condense and the 
condensed extractant drips into another chamber for 
collection.  
Fermentation The sample is soaked for a specified time to enable fermentation, hence alcohol is formed. 
Counter-current 
The material is processed into a slurry and fine sample 
prior to being placed with a solvent in a cylindrical 
extractor and moved in a unidirectional manner.  
Sonication 
The ultrasound frequency used ranges from 20 kHz to 
2000 kHz to extract chemicals from material following 
disruption of permealising cell walls. 
Supercritical Fluid 
The use of CO2 or argon as the extracting fluid means 
a low temperature can be used as well as recycling the 
solvents.  
Phytonics Process 
A technology using fluorocarbon (1,1,2,2-
tetrafluoroethane) solvent for the extraction of plant 
materials.  
Description of extraction processes are adapted from Handa 2008.85  The term 
material refers to the crude plant material and menstrum refers to the extraction 
solvent. Some of the techniques are used in the Ayurveda system. 
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A series of other procedures will follow extraction such as filtering the extract 
obtained from the residues following extraction (marc) and spray drying to 
obtain a dry powder.85  Extracts should be stored correctly at low temperatures 
(< -20°C) and away from light to minimise deterioration, decomposition and 
formation of artefacts to allow identification of constituent compound(s).   
 
1.2.7 Activity-guided fractionation 
Extract fractions should be tested in the appropriate in vitro systems so any 
extract fractions that are more active than the crude extract can be further 
separated and re-tested until the active substance(s) is isolated and identified.  
With respect to anticancer drug discovery, many cell-based assays intend to 
PHDVXUHFDQFHUFHOOV¶YLDELOLW\DIWHUH[SRVXUHWRDQ LQYHVWLJDWLRQDO FRPSRXQG
since cancer cells are commonly associated with dysregulated cell proliferation 
and death; results could be indicative of an effective anticancer candidate.88  
Alternatively, mechanism-of-action-based bioassays can be used where the 
agent is directed to a molecular target of interest e.g. proteasome inhibition 
assay.11, 86, 89   
It is of interest to determine the characteristics of any observed cytotoxic 
effects induced by the extracts such as those consistent with the hallmarks of 
cell death e.g. the loss of plasma membrane integrity, fragmentation of cells 
into apoptotic bodies or the fragments taken up by neighbouring cells.  Several 
assays can indirectly test for induced cytotoxicity by measuring biochemical 
processes of viability markers since a reduction in metabolism is expected in 
dying cells.88   A common approach to assessing in vitro cell viability is to 
measure its ability to inhibit vital dyes from crossing the intact plasma 
membrane.  Vital dyes are used in a variety of techniques such as those that 
only label dead cells (e.g. trypan blue, propidium iodidHDQG¶-diamidino-2-
phenylindole (DAPI)) by entering the cell via  a compromised plasma 
membrane. These dyes are widely adopted in flow cytometric techniques.  In 
contrast, fluorogenic esterase substrates (e.g. calcein acetoxymethylester 
(calcein-AM)) are taken up by viable cells and hydrolysed by intracellular 
esterases to its active fluorescent form to be captured by microscopy.90, 91   
Alternatively, the loss of plasma membrane integrity resulting in the release of 
     
25 
intracellular protein such as glucose-6-phosphate dehydrogenase (G6PD) and 
lactate dehydrogenase (LDH) or intracellular ATP concentrations could be 
measured using conventional assay kits to assess cell viability.  Furthermore, 
several colorimetric assays such as sulforhodamine B (SRB) and tetrazolium 
salts are dependent on the binding between the cationic aminoxanthine (pink 
dye) to basic amino acids in the cells or viable cells reducing tetrazolium salts 
to formazan compounds, respectively, and the absorbance intensity measured is 
proportionate to the cell numbers (indicating cell growth, viability or death).92-
94
  Since the abovementioned cell death detection methods could be subjected 
to interference from other intracellular processes, it is important that the results 
are validated in a subsequent assay, which measure bona fide cell death 
markers such as phosphatidylserine or (cleaved) poly(ADP-ribose) polymerase 
(PARP)  protein.94   
 
Assays that are simple, effective and economical should be considered for 
initial screening.  The choice of cytotoxicity assay is also of importance to 
avoid false negatives since active compounds may be present in trace amounts 
or their activity may be masked by other toxins in the crude extract.2, 95  Since 
1990, the NCI has been screening for potential active compounds using in vitro 
screening methods comprising a panel of 60 different human tumour cell-lines 
from nine organ sites, (including leukemia, melanoma and cancers of the lung, 
colon, brain, ovary, breast, prostate and kidney) and a simple cell 
viability/cytotoxicity assay (e.g. SRB and tetrazolium salt assay).96, 97  Since 
1990, this programme has allowed the screening of > 80,000 compounds.93, 98 
 
1.2.8 Isolation, structure elucidation and de-replication of 
active compounds 
Analysis of active compounds can be assisted by techniques such as solid 
phase chromatography, nuclear magnetic resonance (NMR), high performance 
liquid chromatography (HPLC or LC) linked to ultraviolet (UV) absorption 
detector and mass spectroscopy (MS).5  These well-established technologies 
FDQ EH µOLQNHG¶ WRJHWKHU RWKHUZLVH NQRZQ DV µK\SKHQDWHG¶ PHWKRGV IRU
facilitating the separation, isolation and identification of phytochemicals in 
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mixtures.  The combined, hence hyphenated, use of HPLC, NMR, gas 
chromatography (GC) and MS systems (e.g. LC-NMR, LC-MS, LC-NMR-
MS) are becoming increasingly common in facilitating the drug discovery 
process.  These systems provide information on the molecular mass, carbon 
skeleton and proton distribution and characteristics (e.g. polarity) of 
compounds, which enable accurate determination of compound structures.37   
Furthermore, hyphenated techniques minimise wasted efforts by supporting the 
process of de-replication (e.g. avoiding re-discovery) via reconciliation with 
established databases of already known compounds thus prioritising unknown 
or novel compounds for further testing.2, 11, 35  A thorough investigation 
concluded that approximately 80% of several global database entries regarding 
plant information, genome, phytochemical composition, taxonomy, 
ethnomedicinal uses and authentication information are inaccurate.99  For 
instance, approximately 75% of the GenBank plant records are incorrect.99, 100  
At present, lack of reliable genomic data for the metabolomes of medicinal 
plants proves unaccommodating to creating authenticated libraries of 
µPHWDEROLWH ILQJHUSULQWV¶ RI SODQWV100  Metabolomic analysis is a very useful 
tool to avoid de-replication, misidentification and SAR determination of 
metabolomes from medicinal plants, the latter can improve estimation of the 
efficacy and toxicity of investigational compounds before commercial 
development.101  Employment opportunities are promising if medicinal plants 
are to be grown on a larger scale for pharmaceutical use and may persuade 
JURZHUV RI µLOOHJDO SODQWV¶ WR FXOWLYDWH WKHVH SURILWDEOe crops instead.20  
Nevertheless, the issue of inaccurate and insufficient plant records is 
acknowledged and considerable efforts are being invested into creating 
accessible international databanks of information such as The Plant List for 
validated entries of information.102  
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1.2.9 Synergism in phytomedicine 
Crude plant extracts contain a mixture of secondary metabolites, which are 
biologically active.  Whole plant extracts represent some of the most 
therapeutic drugs in the market and may rely on the synergistic effect of these 
bioactive compounds including their by-products.16, 46, 103  Synergy is an 
overall greater effect caused by using a combination of drugs than the total 
effect of using a single compound.104, 105  Williamson (2001) presented several 
examples whereby volunteers given ginseng and gingko together have 
improved cognitive function compared to those who were only given one of 
the extracts.105, 106  There are two broad types of synergy described by Spinella 
(2002), which are pharmacodynamic or pharmacokinetic.109   
Pharmacodynamic synergy occurs when two compounds are targeting a similar 
receptor target or physiological system.  Pharmacokinetic refers to absorption, 
distribution, biotransformation, or elimination of the drug e.g. some 
polyphenols can facilitate absorption of agents.16, 103, 107 Interaction between 
phytochemicals can also evoke antagonism, where the overall effect is less 
than that of a single compound or potentiation whereby an inactive compound 
can further increase the activity of an active compound.  Another possible 
RXWFRPHLVµPDVNLQJ¶ZKHUHWZRFRPSRXQGVZLWKRSSRVLQJHIIHFWVFDQFHOHDFK
other out therefore, resulting in no net effect.16  %HUHQEDXP¶VLVREROPHWKRGLV
XVHGWR³differentiate between real synergy and additional effects of a mixture 
of two plant constituents or extracts´16, 104  Recently, a multidrug approach is 
preferred over monodrug therapy in conventional medicine.  This could be due 
to activation or inhibition of multiple targets in signaling pathways giving rise 
to synergistic effects.103, 104, 108 Hence, perturbation of multiple modes of action 
could increase therapeutic efficacy allowing use of lower dosage.109  Also 
using a lower dose of multiple agents acting via distinct mechanisms of action 
could reduce toxicities as well as minimise emergence of acquired drug 
resistance.  However, this approach (common in standard cytotoxic 
chemotherapy use) raises concerns in natural product medicinal use as it is 
difficult to rationalise and standardise treatment without identifying the 
mechanisms that generate the synergistic effects.103, 105  
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1.3 Cancer 
1.3.1 Cancer: a global problem 
Cancer is a group of fatal diseases with more than 200 cancer types and each 
are quite distinct to each other (e.g. secretion, expression and or mutation of 
different proteins), of which the most common are breast, colorectal, lung, 
prostate and stomach cancers, however the highest incidence of mortality rates 
occurs within lung, breast, stomach, liver and colorectal cancers.110-114  In 2011, 
WHO published a Global Status Report, which revealed cancer accounts for 
approximately 7.6 million (13%) world deaths in 2008.115, 116  There are 
approximately 6 million new cancer incidences worldwide per year, those 
figures are predicted to increase to 27 million new cancer cases and 17.5 
million cancer deaths by 2050.117  Around 325,000 people are diagnosed with 
cancer annually in the United Kingdom (UK) and it is the second leading cause 
of death in the U.S.118, 119    
 
1.3.2 Molecular biology of cancer and possible targets 
The process of carcinogenesis is a multistep process requiring initiation, 
promotion and progression and metastasis.  Cells undergoing unregulated 
growth within a specific tissue of any organ could, over time, usually decades, 
accumulate further mutations.  As a result, acquiring the ability to invade 
surrounding areas and metastasise to distant sites by hijacking vessels formed 
by tumour angiogenesis.120-122  This process presents various opportunities to 
intervene at the different stages.112, 123 Cancers arising from epithelial cells 
(carcinoma)  are the most common (85%) compared to those from mesoderm 
layer (sarcoma) or glandular tissue (adenocarcinomas).112  During treatment 
tumour cells may progress into a more aggressive phenotype and become 
resistant to conventional anticancer drugs, therefore anticancer drugs with 
original modes of action e.g. that molecular targeted, are desired and so 
constant efforts to discover novel agents are needed.  The biology of cancer is 
very complex and its surrounding microenvironment is equally as important in 
tumourigenesis.  Different types of cancers acquire different genetic mutations 
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and phenotypes, however there are several essential capabilities shared by most, 
if not all, cancers enabling neoplastic cells to progress in multistep 
carcinogenesis.124  The hallmarks of cancer described by Hanahan and 
Weinberg (2011 and 2000), unveil promising pathways as targets for 
therapeutic anti-cancer intervention.122, 124  These hallmarks include self-
sufficiency in growth signals, insensitivity to anti-growth signals, apoptosis 
evasion, sustained angiogenesis, tissue invasion and metastasis, limitless 
replicative potential, evasion of immune destruction and reprogramming of 
energy metabolism (Figure 1-6).124  
 
 
Figure 1-6: Depiction RI +DQDKDQ DQG :HLQEHUJ¶V KDOOPDUNV RI FDQFHU 
illustration.  The diagram illustrates the cancer hallmarks as representative of 
drug targets and thH H[DPSOHV RI FRPSRXQGV WKDW LQWHUIHUH ZLWK WKH WDUJHWV¶
functions.  Many drugs under development are found to be both intentionally 
and unintentionally directed to interfere with these hallmarks.124 
 
Self-sufficiency in growth signals: Transformed cells, unlike normal cells, are 
self-sufficient in mitogenic growth signals, which sustain continuous cell 
proliferation.  Cancer cells may produce growth factor ligands, which act 
autonomously on their own receptors or by increasing the level of protein 
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receptors on the cell membrane enabling capture of minute/normal levels of 
growth factors, translating into an exaggerated response.  An example is the 
mutation of the ras gene, which is present in 30% of all human cancers.  The 
Ras proteins are membrane-associated guanine nucleotide-binding proteins, 
and its activation requires the transient binding of an extrinsic ligand e.g. 
growth factors, resulting in cell proliferation.  However, mutated Ras is 
permanently in its activated conformation and is independent of GTP binding 
resulting in constitutive activation of downstream signaling cascade (Ras-Raf-
MEK-ERK) and cell proliferation.125 
 
Insensitivity to anti-growth signals: Transformed cells are unresponsive to 
antigrowth signals e.g. soluble growth inhibitors and immobilised inhibitors, 
that are found on the surface of neighbouring cells hence disregarding such 
anti-growth signals will maintain the transformed cells in a permanently active 
state.122  An example is the loss of the retinoblastoma protein (pRb) function 
where pRb is a mediator of anti-proliferative signals.  In a hypophosphorylated 
state, pRB is bound to E2F (transcription factor) thus altering its function and 
inhibiting cell cycle progression from G1 phase.  Mutations in the pRB gene 
caused by the human papillomavirus (HPV) E7 oncoprotein liberate E2F 
allowing transcription hence cell c\FOHSURJUHVVLRQWKURXJKWKHUHVWULFWLRQ µ5¶
point into S phase.126  
 
Evading apoptosis: Homeostasis is maintained by a balanced level of cell 
proliferation and cell attrition (e.g. apoptosis).  Cancer cells acquire various 
mechanisms, which overcome cell death such as through the loss of tumour 
suppressor proteins (TSPs) and overexpression of survival proteins.  For 
instance, the wild-type p53 protein is a DNA damage sensor and a component 
of the apoptotic signaling pathway.  Loss of p53 protein (a consequence of 
point mutation in p53 gene) is found to occur in over 50% of human cancers 
and 75-80% of colon carcinomas are without both p53 alleles.127  One of the 
roles of p53 act as a regulator of cell cycle by making necessary cell cycle 
arrests at G1/S phase and binding to any damaged DNA, repair can be initiated 
before commitment to the entire cycle upon passing the R point.  If the damage 
is irreparable then p53 can initiate apoptosis.128  Over-expressions of certain 
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anti-apoptotic Bcl-2 family members e.g. Bcl-2, Bcl-XL and Mcl-1, are 
essential in inhibiting apoptosis, hence supporting deregulated oncogene 
expressions.    
 
Sustained angiogenesis: Cancer cells can initiate angiogenesis and generate 
blood vessels from the existing capillary network; WKLV µDnJLRJHQLF VZLWFK¶ LV
vital for tumour growth and metastasis.  The tumour can modulate its own 
supply of angiogenic factors, classed into activators (e.g. vascular endothelial 
growth factor (VEGF) and angiogenin) and inhibitors (e.g. thrombospondin 
and angiostatin); production levels are increased and decreased by the tumour 
cells, respectively.129  However, the tumour vasculature formed under the 
influence of VEGF is of poor quality and highly disorganised leading to 
hypoxia and additional VEGF production hence leading to a more aggressive 
phenotype.130 
 
Tissue invasion and metastasis: Transformed epithelial cells can invade local 
WLVVXHV DQG PHWDVWDVLVH YLD YDULRXV SURFHVVHV VXFK DV WKH µHSLWKHOLDO-
PHVHQFK\PDO WUDQVLWLRQ¶ (07 SURFHVV  $OWKRXJK OHVV WKDQ  RI
metastatic cells are successful in colonisation at the distant site, metastases 
confer a highly unfavourable patient prognosis, and are responsible for >90% 
of cancer deaths.131  A tumour cell can acquire the ability to remodel the host 
tissue extracellular matrix (ECM) and secrete proteases such as matrix 
metalloproteinases (MMPs).  Increased MMPs levels e.g. MMP-2, MMP-9 and 
MMP-13, in cancer cells can facilitate the detachment of tumour cells from the 
primary site, cell migration towards the lymph and/blood vessels, degradation 
of the vascular basement membrane and penetration of the vascular lumen to 
invade a distant site.132 
 
Limitless replicative potential (immortalisation): Normal cells are 
constricted to undergo a finite number of replications (Hayflick number) and 
enter senescence due to the degradation of the protective cap of DNA, 
telomeres (a repeating DNA sequence TTAGGG), found at the end of 
chromosome arms.  Eventually, the shortened chromosome ends will be 
exposed resulting in chromosomal fusion and apoptosis.133  Approximately 85-
90% of cancerous cells become immortalised by upregulating telomerases 
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(DNA polymerase) to replenish telomeres on the chromosomes, hence cells 
become capable of unlimited cycles of replications.122 
 
Evading immune destruction: The immune system offers several 
mechanisms to prevent or detect and eliminate tumour cells by infiltrating 
tumour masses e.g. eliminating virus-induced tumours, which account for 20% 
of tumours.  Secondly, during inflammation many growth factors, survival 
factors, pro-angiogenic factors and enzymes facilitating EMT and ROS are 
released into the tumour microenvironment contributing to tumourigenesis and 
progression.124  Also, immune immunoediting, which is based on the concept 
of detection and elimination of tumour cells expressing tumour-specific 
antigens or stress-induced antigens, consists of three phases: designated 
elimination, equilibrium and escape.134  Firstly the immune system will 
eliminate the detected tumour cells, however elimination may only be partial 
therefore the remaining tumour cells may exist in an equilibrium state.  
However, the immune system will continue to eliminate any tumour clones that 
continue to grow and accumulate further alterations translating to antigen 
expression.  Any tumour clones that escape elimination are more resistant and 
surpass immune surveillance.134 
 
Reprogramming energy metabolism: The rate of cancer cell metabolism 
should support the rate of rapid neoplastic cell proliferation, resulting in further 
accumulation of genetic alterations and instability, which may translate to 
additional cancerous traits.  A subpopulation of cancer cells can reprogramme 
µVZLWFK¶WKHLUPHWDEROLVPWRJO\FRO\VLVHYHQLQWKHSUHVHQFHRIR[\JHQDQGLW
has been shown to be associated with activated oncogenes Ras, Myc, P13K 
(phosphatidylinositol-3-kinase) and mutated TSPs, p53, PTEN (Phosphatase 
and tensin homolog) and NF-1 (neurofibromatosis type I).135, 136  Adoption of  
glycolysis may present several advantages for cancer cells such as providing 
macromolecules and organelles for new cells formation as a result of the 
upregulation of glucose transporters and enzymes of the glycolytic pathway as 
well as providing various glycolytic intermediates for various biosynthetic 
pathways.124, 137  
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1.3.3 The role of medicinal plants in treating cancer 
A series of publications by Dr J. Hartwell has described the traditional 
application of over 3,000 plant species in cancer treatment.30, 32 The task of 
cancer diagnosis is not straightforward therefore evaluation of historical 
evidence of plants in cancer treatment should be validated using appropriate 
techniques.  During the peak of NP drug discovery between 1960 and 1982, the 
NCI collected and tested over 114,000 plant-derived extracts for their 
cytotoxicity.  Introduction of new screening technologies in the following years 
(1986 to 2004) led to the establishment of the Natural Products Branch of the 
Developmental Therapeutics Program (DTP) by the NCI.  The DTP has 
collected approximately 60,000 higher plant samples worldwide for screening 
in a cell-line panel consisting of 60-tumour cell lines and further in vivo 
evaluation.  More recently extensive reviews by Newman and Cragg (2007 and 
2012) classified all the therapeutic compounds marketed between 1981 and 
2010 into to their treatment category and origin.44, 51  NCEs approved between 
1940 to mid-2006, have been subdivided into the following categories 
biological (B), natural product (N), natural product derivative (ND), totally 
synthetic drug (S), synthetic drug with a natural product pharmacophore (S*), 
natural product mimic (NM) and vaccine (V).  Of the 1,184 NCEs, 174 are 
anticancer agents related to natural products (52%; 10% S/NM, 4% S*, 10% 
S*/NM, 5% N, 23% ND), and the majority are inspired by natural products 
(48%; 4% V, 14% B, and 30% S).26  There have been reviews highlighting that 
the compounds in the synthetic category are essentially isosteres of peptide 
substrates and therefore act as NMs.44, 138  Chemotherapy for many common 
solid tumours has limited anti-solid tumour activity without significant effects 
on SDWLHQWV¶ survival rates; moreover, many tumours will acquire resistance to 
currently available antineoplastic treatments.45  Therefore a continuous effort 
to search for novel active compounds from nature to create a library for high 
throughput screening is vital in order to impede carcinogenesis.  Such a goal 
has inspired this project combined with a long history of successful anticancer 
drug candidates from nature.5, 139   
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1.3.4 Classes of anticancer compounds  
6LQFHWKH¶V> 60% of all the available anticancer drugs introduced into 
the clinic are related to natural products and > 70% of compounds in clinical 
trial in 2004 were related to natural products.140-142  The sources of these active 
natural products is not limited just to plants but also include microorganisms 
and marine organisms as well since many marine compounds possess antibiotic 
and anti-inflammatory properties and as such could play a role in cancer 
treatment.5  The current plant-based anticancer drugs used in the clinic can be 
categorised into four main classes of compounds: vinca (or Catharanthus) 
alkaloids, epipodophyllotoxins, taxanes, and camptothecins (shown in Table 1-
3).11, 86, 140 The success of natural compounds is reflected by their worth in the 
global anti-cancer marker of over $2.75 billion US dollars in 2002.11 
 
1.3.4.1 Vinca alkaloids 
Vinca alkaloids isolated from the Madagascan periwinkle, Catharanthus 
roseus G. Don. (Apocynaceae), were the first natural product-based anticancer 
agents to be used clinically.11  Vinca alkaloids such as vinblastine (7) and 
vincristine (8) were found to be active against murine lymphocytic leukaemia.  
This discovery led to development of semi-synthetic analogues of these active 
agents vinflunine, vinorelbine and vindesine, which are used in multidrug 
therapy to treat various cancers including leukaemias, lymphomas, advanced 
WHVWLFXODU FDQFHU EUHDVW DQG OXQJ FDQFHUV DQG .DSRVL¶V VDUFRPD143  Vinca 
alkaloids and their derivatives bind to tubulin leading to microtubule 
depolymerisation in metaphase therefore they act as anti-microtubule, anti-
mitotic agents.11, 26, 140 
 
 
7; R= CH3 8; R= CHO 
Figure 1-7: The chemical structure of vinblastine (7) and vincristine (8). 
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1.3.4.2 Taxanes 
Paclitaxel (taxol®) isolated from the bark of the Pacific Yew, Taxus brevifolia 
Nutt (Taxaceae), is used to treat several cancers of the breast, ovary and non-
small cell lung cancer (NSCLC).140  Paclitaxel (9) was discovered during the 
1&,¶VVFUHHQLQJSURJUDPDQGVHUYHVDVDSUHFXUVRUIRU23 analogues, which are 
currently in pre-clinical development for various cancers indications.  The 
taxanes bind to and stabilise microtubules to halt cell division at the G2-M 
phase of cell cycle.5  
 
   
9     10 
Figure 1-8: The chemical structure of taxol (9) and docetaxel (10).  
 
1.3.4.3 Epipodophyllotoxins 
Podophyllotoxin and other closely related lignans isolated from the 
Podophyllum species (Podophyllaceae) revealed antitumour activity 
accompanied by serious toxicity.  This observation resulted in development of 
safer semi-synthetic analogues such as etoposide and teniposide.  These 
analogues exert cytotoxicity against lymphomas, bronchial and testicular 
cancers via DNA strand breaks, induced by permanently binding to DNA 
topoisomerase II in the G2 phase of the cell cycle.140  
 
    
11         12     13 
Figure 1-9: The chemical structure of podophyllotoxin (11), etoposide (12) 
and teniposide (13). 
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1.3.4.4 Camptothecins 
Camptothecin is isolated from the Chinese Camptotheca acuminata Decne 
(Nyssaceae), which contains an D-hydroxylactone system and an unsaturated 
conjugated pyridine moiety.144  Initial studies demonstrated severe bladder 
toxicity and therefore more water soluble and potent derivatives topotecan and 
irinotecan were developed for treating advanced ovarian and small cell lung 
cancers and metastatic colorectal cancers, respectively.140  The mechanism of 
action involves selectively inhibiting topoisomerase I, which interferes with the 
cleavage and reassembly of DNA.   
 
   
14     15 
 
16 
Figure 1-10: The chemical structure of camptothecin (14), topotecan (15) and 
irinotecan (16). 
 
Many other compounds from plants with antitumour activity have already been 
used traditionally such as homoharringtonine (Cephalotaxus harringtonia var. 
drupaecea), an active alkaloid administered to chronic myeloid leukemia 
(CML) patients.  Homoharringtonine and its analogues with reduced methyl 
groups can inhibit DNA topoisomerase II.89  It also inhibits CDK9 and protein 
translation, downregulating the survival protein Mcl-1. It is thought that CDK9 
inhibition contributes to anticancer activity.  Salvia species roots and rhizome 
extracts have shown to inhibit proliferation of cancer cell lines of the liver, 
colon (colon-205), cervical (HeLa), nasopharynx (KB) and larynx (Hep-2).89  
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Extracts from several other plant species including Brucea, Euphorbia, Rubia, 
Cocculus trilobus, Curcuma (turmeric) and Maytenus are also used in therapy.  
Many analogues of existing anticancer drugs isolated from plants are in clinical 
trials and many are found to affect the cell cycle (Figure 1-11).   
 
 
 
Figure 1-11: A simple representation of the cell cycle phrases, G1, S, G2, M, 
and the corresponding anticancer compounds that targets those specific phases.  
 
A totally synthetic flavone, flavopiridol (17), was synthesised based on the 
structure of the natural product rohitukine, which was initially found to induce 
cell-cycle arrest and apoptosis in murine ovarian cancer cells, OCA-I.140, 145 
Flavopiridol is the first cyclin-dependent kinase inhibitor in clinical trial.146-148  
Flavopiridol is currently being investigated in eighteen Phase I and Phase II 
clinical trials either alone or in combination with other chemotherapy agents.89 
 
17 
Figure 1-12: The chemical structure of the cyclin-dependent kinase inhibitor, 
flavopiridol (17).149 
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1.3.5 Chemoprevention 
Besides importance as drugs, natural products can be a vital source of 
FRPSRXQGV WR ³suppress, arrest or reverse carcinogenesis, in its early 
stages´17, 110  A balance between oxidants and antioxidants (phytochemicals) 
obtained from diets rich in fruits and vegetables are essential for an optimal 
physiological state.150, 151  Many epidemiologic studies support the proposed 
inverse correlation between increased consumption of fruits and vegetables in 
the diet and cancer risk.110, 152, 153  Several phytochemicals possess 
chemopreventive properties that act on various pathways (apoptosis, 
angiogenesis and metastasis) and targets (oncogenes, tumour suppressor genes 
(TSG) etc.) to maintain cellular health and homeostasis.  Certain 
phytochemicals act on normal cellular processes such as cell division, and 
hence inhibit proliferation of (cancer) cells. Further considerations to facilitate 
drug discovery from plants include improved sourcing and advances in 
combinatorial biosynthesis, microbial genomics and synthetic biology by 
addressing issues of complex structural synthesis.41  
 
 
Figure 1-13: Diagram displaying some relevant targets for anti-cancer activity 
and examples of phytochemicals which interact with these targets, adapted 
from Williamson (2010).16  
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Phytochemicals have the ability to modulate certain molecules in key signal 
transduction pathways relating to cancer such as the nuclear factor±NB (NF±
NB), receptor tyrosine kinases, mitogen-activated protein kinase (MAPK) and 
cyclooxygenases (COX).46  Additionally, phytochemicals may modulate the 
immune system and possess antimicrobial, anti-inflammatory, anti-asthmatic 
and anti-anaphylactic activity.154, 155 Exogenous antioxidants found only in 
plants can be classed as water-soluble or lipid-soluble e.g. vitamin C and E-
carotene respectively.156  Sufficient amounts of antioxidants are required to 
counteract endogenous free radicals otherwise the resulting oxidative stress 
could lead to oxidative damage to macromolecules, lipids, proteins and DNA.16, 
140, 141 Data from in vitro measurements and cell-free models suggest that 
compared to other cellular processes such as methylation, deamination and 
depurination, oxidation from normal metabolism causes the highest levels of 
DNA bases (around 26,000) loss daily subsequently leading to an increased 
risk of developing chronic diseases such as cancer.157, 158  Many research 
projects such as that of the National Cooperative Drug Discovery Group 
(NCDDG) are characterising potential anticancer compounds from plants of 
the tropical rainforest to isolate compounds from edible plant species and 
dietary supplements.11  Several clinical trials are being conducted by the NCI 
on potential cancer chemopreventive agents including curcumin (phenolic acid; 
Phase I colon), genistein (flavonoid; Phase I breast and endometrial), soy 
isoflavones (isoflavonoid; Phase II prostate), epigallocatechin gallate 
(flavonoids; Phase II breast, Phase I unspecified cancer, Phase II bladder 
recurrence) and resveratrol (alkaloid; Phase I unspecified cancer).11 
 
Phytochemicals can be classified into the categories of terpenes, carotenoids, 
phenolics e.g. flavonoids, alkaloids, nitrogen-containing compounds and 
organosulfur compounds, which may be sub-divided into further categories 
(Figure 1.15).17   
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Figure 1-14: A flow chart listing some sub-families of phytochemicals: 
carotenoids, phenolics, alkaloids, nitrogen-containing compounds and 
organosulphur compounds.17 
 
1.3.5.1 Terpenes 
There are over 600 different caroteniods identified, of which there are two 
main classes: xanthophylls (oxygen containing) and carotenes (non-oxygen 
containing).159  This predominant pigment possesses provitamin and 
antioxidant activities.  The basic structure usually contains a 40-carbon 
skeleton structure of isoprene units and often occur in the all-trans form.17  The 
number of double bonds determines the shape, chemical reactivity and light-
absorbing properties of carotenoids.159  Carotenoids have the ability to quench 
and inactivate reactive oxygen species (ROS) preventing genomic instability 
and carcinogenesis.118, 160, 161 Diets rich in carotenoid pigments (vitamin A 
(retinol)) e.g. eggs and carrots can prevent the development and progression of 
epithelial cancers.11, 110, 162  However, studies have suggested that in the long-
term high levels of retinol are associated with an increased risk of osteoporotic 
hip fracture in women due to  reducing bone mineral density.163 
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Figure 1-15: The chemical structures of carotenoids such as D-carotene (18), 
ȕ-FDURWHQHȕ-cryptoxanthin (20), lutein (21), zeaxanthin (22), astaxanthin 
(23) and lycopene (24).17 
 
1.3.5.2 Phenolics 
Phenolics are protective secondary metabolites produced by plants.  Their 
structure consists of t 1 aromatic ring(s) with t 1 hydroxyl group.17  The 
phenolic ring can exist in an oxidised or reduced states giving rise to a quinone 
or phenol, respectively.156  Phenolics can be grouped into phenolic acids 
(hydroxybenzoic acids and hydroxycinnamic acids), flavonoids (flavanols, 
flavones, flavonols, flavonones, anthocyanidins and isoflavonoids), stibenes, 
coumarins and tannins, as shown in Figure 1-16:  and Figure 1-17.  It is 
estimated that 2/3 of the phenolics consumed in our diet (in foods such as nuts, 
fruits, vegetables, red wine, coffee and tea) consist of mainly flavonoids and 
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1/3 phenolic acids.17  Flavonoids may also have a role in chemotherapy to 
induce or inhibit the metabolism of drugs by interfering with the function of 
cytochrome P450 (CYP) enzymes.105, 164  
 
 
Figure 1-16: The chemical structures of phenolic acids such as caffeic acid 
(25), ferulic acid (26), sinapic acid (27), syringic acid (28), protocatechuic acid 
(29), 3,4-dihydroxyphenylacetic acid (30).156 
 
However, tannins may act adversely on health by forming complexes with 
proteins, starch and digestive enzymes, thus lowering nutritional values.  
Tannins may also have an adverse effect on the absorption of amino acids and 
alkaloids.105, 154, 165  7KH QHW HIIHFW PD\ LQFOXGH ³a decrease in food intake, 
JURZWK UDWH«QHW PHWDEROLVDEOH HQHUJ\ SURWHLQ GLJHVWLELOLW\«GDPDJH RI WKH
mucosal lining of gastrointestinal tract and alteration of excretion of certain 
cations, and increased excretion of proteins and essential amino acids´ 165  
Paradoxically, certain tannins also appear to possess chemopreventive 
properties and together with the above mentioned adverse activities make 
tannins a concern for use.  
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Figure 1-17:  The chemical structures of flavonoids such as flavonols (31), 
flavones (32), flavanols (catechins) (33), flavanones (34), anthocyanidins (35) 
and isoflavonoids (36).17  
 
1.3.5.3 Alkaloids 
Alkaloids are nitrogen-containing compounds and thousands have been 
identified, and many have been used for their medicinal value for centuries.154  
Examples of alkaloids used medicinally include atropine, cocaine, hyoscine, 
morphine, emetine and ergometrine.166  As discussed, vinca alkaloids are used 
in treatment of cancers such as leukaemias and lymphomas.  Currently under 
Phase II/III clinical trial for chronic myeloid leukemia (CML) is the plant 
alkaloid homoharringtonine (6), which functions by inhibiting protein synthesis 
at the ribosome level.30, 143  
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1.4 A megadiverse country: Malaysia 
Malaysia has been ranked the 12th richest country for its biological diversity of 
plant species according to the National Biodiversity Index (NBI), which is 
evaluated by the World Conservation Monitoring Centre (WCMC).167, 168  In 
Malaysia, the estimated 40,000 plant species can be sub-divided into 
approximately 12,500 flowering plants, 15,000 higher plants and over 1,100 
ferns and related species.167, 169  
MalD\VLD¶V IDYRXUDEOH FOLPDWH offers a variety of habitats to suit diverse life 
forms.  The majority of the total land area (57.5% - 59.9%) is forest area of 
which large proportions (57%) are tropical rainforests on the hills and 
mountains.168  Areas in Pasoh, Peninsular Malaysia, Lambir, Sabah, and 
Sarawak contain particularly dense forests with hundreds of tree species.170  
The lowlands have been largely converted to agricultural land, mainly for 
growth of cash crops, oil palm and rubber.  Apart from other crops such as 
coconut, rice and sugar cane, the agricultural lowlands support pineapple, 
cocoa, tapioca, maize and coffee plant growth.  The main economic product of 
0DOD\VLD¶V forest is timber and the most important timber producing families 
are the Dipterocarpaceae and Leguminosae.169 
 
1.4.1 Plant profiles 
Colleagues from the University of Nottingham Malaysia Campus (UNMC) 
collected various plants in Malaysia, and the following have been selected for 
investigation. 
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1.4.1.1 Acalypha wilkesiana Müll, Arg. (Euphorbiaceae) 
 
Latin name: Acalypha wilkesiana Müll, Arg. 
Synonymous name: A. amentacea f. circinata (Müll, Arg.) Fosberg, A. 
Wilkesiana (Müll, Arg.) Fosberg, A. compacta Guilf. ex C.T. White, A. 
godseffiana Mast, A. godseffiana var. heterophylla L.H. Bailey, A. 
hamiltoniana Briant, A. macafeeana Veitch,  A. musaica auct, A. tr icolor Seem, 
A. triumphans. Linden & Rodigas, A. wilkesiana f. appendiculata J.W. Moore, 
A. wilkesiana f. circinata (Müll, Arg.), A. wilkesiana f. illustris J.J. Sm, A. 
wilkesiana f. macrophylla J.J.Sm, A. 
wilkesiana var. marginata E. Morren, A. 
wilkesiana f. monstrosa J. J. Sm, A. 
wilkesiana f. triumphans (Linden & 
Rodigas) J. J. Sm, Ricinocarpus 
wilkesianus (Müll, Arg.) Kuntze.171 
 
Vernacular name: Beef steak plant, 
copper plant (leaf), fire dragon and 
-DFRE¶VFRDW 171 
Order:  Malpighiales 171 
Family:  Euphorbiaceae 171 
Genus:  Acalypha 171 
Species:  Acalypha  171 
 
Description: Tropical bush of up to 1.5 m high with red spiral leaves.  Flowers 
are apetalous and without a nectary disc.  The male inflorescences are spikes 
found at the top whilst the female are found at the base. Fruits are three-lobed 
capsules splitting into 3 valves.172  
 
Distribution: Asia-Pacific 173 
 
Uses: ,Q0DOD\VLDWKLVSODQWLVERLOHG LQJRDW¶VPLONand the milk is drank to 
lower blood pressure, treat fever and pimples and relieve coughs or it is boiled 
in sugar to treat thrombocytopaenic purpura and allergic purpura.  In Nigeria, 
the leaves are boiled in water and given to those with gastrointestinal disorders 
or suffering from skin infections such as Impetigo contagiosa, Candida 
intetrigo, Pityriasis versicolor, Tinea corporis, Tinea pedis and Tinea 
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versicolor.174  It is also recognized as an abortifacient herb in Nigeria besides 
its common use to treat headache, common cold and swelling.175 
 
Constituents: Anthraquinone, corilagin, gallic acid,  geraniin, kaempferol- and 
quercetin-3-0-rutinoside.176   
 
Pharmaceutical Interest: It has shown antibacterial and antifungal properties 
in the aqueous and ethanolic extracts by inhibiting the growth of bacteria 
(Staphylococcus aureus) and fungus (Candida albicans, Trichophyton rubrum, 
Trichophyton mentagrophytes and Aspergillus flavus).177  It has been shown to 
cause apoptosis in lymphocytes and stimulate the release of tumour necrosis 
IDFWRUĮ71)-ĮLQWHUOHXNLQ,/-5 and -6 and interferon-Ȗ175 
The collection took place in May 2007 at Broga forest, Malaysia. The whole 
plant was extracted in increasing polarity solvents: hexane (HEX), ethyl acetate 
(EtOAc) and ethanol (EtOH). 
 
1.4.1.2 Archidendron ellipticum (Blume) Hassk. (Leguminosae) 
Latin name: Archidendron ellipticum 
(Blanco)  
Synonymous name: Abarema elliptica 
(Blanco) Kosterm, Abarema elliptica 
(Blume) Kosterm, Albizia asciculate 
(Benth.) Kurz, Inga elliptica Blume, 
Pithecellobium ellipticum (Blanco) Hassk, 
Pithecellobium ellipticum (Blume) Hassk, 
Pithecellobium fasciculatum Benth, 
Pithecellobium waitzii Kosterm.102, 178, 179 
 
Vernacular name: Langir (antu), Borneo 
Indelebah, Jaring, Jering-jering.180 
 
 
Order:   Fabales 171 
Family:  Fabaceae 173 
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Genus:   Archidendron 178, 179, 181 
Species:   Ellipticum 181 
 
Description:  A small flowering tree which can grow up to 20 m in height and 
50 cm in diameter.178  The leaves are flat and the rachis can be between 4 and 
15 cm bearing yellow and yellowish-green flowers (0.3 cm in diameter). The 
fruits are orange-red (13.8 cm) containing black seeds.178, 180 
 
Habitat:  It is found in lowland primary and secondary rain forest, along 
rivers, on hillsides with sandy soils and in areas of limestone.181, 182  
 
Distribution:  Widespread in Malaysian states: Johor, Kedah, Kelantan, 
Melaka, Megeri Sembilan, Pahang, Perak, Penang, Perlis, Selangor, Singapore, 
Terengganu and Langkawi. Also found in Nicobar Islands, Peninsular Thailand, 
Sumatra, Java, Borneo and Philippines.178  
 
Uses:   The fruits of this plant can be consumed for food flavouring, the leaves 
are used for lice problems and the roots are use as piscicide.178, 180, 183  
 
Constituents:  Possibly djenkol acid, rotenoids, coumarins, lignans, terpenoids, 
polyacetylenes, alkaloids, saponins, toxalbumins, which are present in other 
piscicidal plants.178, 184  
 
Pharmaceutical Interest: Traditional healers often employ many piscicidal 
plants in their practice.  Previously, active antitumour compounds have been 
isolated from several piscicidal plants.184  Kunitz proteinase inhibitors were 
identified in the seeds and are commonly used to inhibit the digestive 
proteinases of insects leading to possible starvation.185  Whereas, trypsin 
inhibitors of Glycine max inhibited 50% of MCF-7 breast cancer cell 
SUROLIHUDWLRQDWDORZFRQFHQWUDWLRQRIȝ0186  
 
Plant material was collected on 21st April 2008 in Sg. Congkak forest, 
Malaysia.  The bark and leaf specimens were extracted in solvents of 
increasing polarity: HEX, EtOAc and EtOH. 
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1.4.1.3 Duabanga grandiflora Walp. (Lythraceae) 
 
Latin name: Duabanga grandiflora (DC.) Walp 
 
Synonymous name:  Duabanga sonneratioides 
Buch.-Ham, Lagerstroemia grandiflora Roxb. Ex 
DC and Leptospartion grandiflorum (Roxb. ex 
DC.) Griff.181, 187 
 
Vernacular name:  Khykan, Hokol, Lomatia, 
Magasawih, Bondraphulla 
Order:   Myrtales 181 
Family:  Lythraceae 170, 187 
Genus:   Duabanga 181 
Species:   Grandiflora 181 
Description:  A fast-growing flowering tree of 
30 - 40 m in height with straight trunks, light 
brown branches with leaves of 25 cm in length 
and 10 cm broad.  The flowers are 5-7cm in size 
and are white in colour with a strong unpleasant 
smell.  The calyx is bell-shaped and separated 
into six segments with many stamens.  The fruit 
contains many seeds in a leathery capsule and 
can be collected in April.188-191 
 
Habitat:  They live in mixed evergreen and deciduous forests at an altitude 
range of 650 ± 1450 M, also commonly found in stream valleys.190, 192 
 
Distribution:  Eastern Himalayas (riverbanks of sub-Himalayan valleys), 
southwards through Assam to Burma, Andaman Island, India, Malaysia and 
Bangladesh, the Philippines, Japan, Thailand, Nepal, Bhutan, Cambodia, 
Eastern India, Laos, Myanmar, Northern Thailand and Vietnam.188, 189, 193 
 
Traditional value:   In Nepal, the bark of D. grandiflora has been used as a 
piscicide.194  The leaf extracts are used traditionally in Thai medicine for their 
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skin whitening, anti-aging and anti-inflammatary properties.195  Additional 
dermatological properties include improving sagging, burns, liver spots and 
dullness.  In Northern Thailand, the seeds of D. grandiflora are used 
traditionally for abdominal pain, food poisoning and peptic ulcer.196  The 
timber is used for furniture.191 
 
Constituents:   Eugeniin (ellagitannin), ellagic acid, hentriacontane, 
hentriacontanol, hentriacontanone, b-sitosterol, a-amyrin, epioleanolic acid, 
epifriedelinol, lignoceryl ferulate, betulinic acid, acacetin, tetramethylellagic 
acid, quercetin 3-glucoside and 3-galactoside, genkwanin and gentianin 40-
galactoside.195-197  Furthermore,duabanganals, latifolinal, 3b-hydroxyursane-
9(11),12-diene, 3b-hydroxy-12-oleanen-11-one, oleanolic acid,  3-O-(E)-
coumaroyloleanolic acid, 3b-hydroxyolean-9(11),12-diene, hyptatic acid, 
betulenic acid 12, divergioic acid, (E)-5-(2-form-ylvinyl)-7-methoxy-2(3,4-
methylenedioxyphenyl)benzofuran, 3,4-O-methylenedioxy-30,40,50-tri-O-
methylellagic acid, vanillin, b-sitosterol, b-sitosterol glucoside, 3-hydroxy-4-
methoxycinnamaldehyde and 5-formyl- furfurol.193  Eugeniin (37) has also 
been isolated from Geum japonicum and Syzygium aromaticum.198   
 
 
37 
Figure 1-18: The chemical structure of eugeniin (37). 
 
Pharmaceutical Interest:  The extracts contain antioxidants and can inhibit 
collagenase activity, fat accumulation and melanin formation.  Eugeniin has 
been shown to stimulate strong dose dependent type III collagen production.196  
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Eugeniin is also found in the bud of Syzygium aromatica and possesses 
virucidal effects against herpes simplex virus (HSV) (GI50: ȝJPODQGW\SH
A influenza virus.199  Antiviral activity is achieved by hindering RNA and 
DNA replication.198, 200  Further investigations on the antiviral properties of 
Eugeniin have been published.198-204  Antimicrobial activity was seen in a 
range of Gram-negative and Gram-positive bacteria e.g. E. coli and S. aureus, 
respectively.205  Cytotoxicity in Walker Carcinosarcoma 256 has also 
reported.197 Recently, crude methanolic extracts of D. grandiflora have been 
shown to act as a repellent for rice weevil, Sitophilus oryzae.206   
 
The plant material was collected on 21st April 2008 at Semenyih Dam, 
Malaysia.  HEX, EtOAc, EtOH and water bark and leaf extracts were prepared. 
 
1.4.1.4 Pseuduvaria macrophylla (Oliv.) Merr (Annonaceae) 
 
Latin name:  Pseuduvaria macrophylla 
(Oliv.) Merr 207, 208 
Synonymous name:  Mitrephora 
macrophylla Oliv 207, 208 
 
Vernacular name:  Unknown 
Order:   Magnoliales 170 
Family:  Annonaceae 200  
Genus:   Pseuduvaria 201 
Species:   Macrophylla 170, 207, 208  
 
 
 
Description:   A small tree with a wide spread growing up to 20-30 ft.173  
Pseuduvaria genus could be informally classed into: basal grade, long branch 
clade (47 genera and 1,500 species) and short branch clade (50 genera and 700 
species) based on the differing rates of molecular divergence recorded.  The 
flowers appearance resembles three sepals and two whorls of three petals, 
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usually unisexual.  The inner petals are differentiated into a blade and basal 
claw and usually longer than the outer petals.209  
 
Distribution: Malaysia hosts 12 species of the short branch clade, of which, 
eight are endemic.  Found in the lowland and hill forest of Pulau Tioman, 
Peninsular Malaysia, Sungai Air Besar and southern Thailand.173, 210, 211 
 
Traditional value: P. macrophylla has been reported to treat coughs, fever, 
nausea and vomiting.211, 212 
 
Constituents:  Dioxoaporphine alkaloid: 1,2,3-trimethoxy-4,5-dioxo-6a,7-
dehydroaporphine and O-methylmoschatoline.213  1,2,3-trimethoxy-4,5-dioxo-
6a,7-dehydroaporphine (yellow colour, melting point 199-201 °C) was also 
isolated from Peperomia sui and Pseuduvaria setsoa.214 
 
 
38    39 
Figure 1-19: The chemical structures of 1,2,3-trimethoxy-4,5-dioxo-6a,7-
dehydroaporphine (38) and O-methylmoschatoline (39). 
 
Pharmaceutical Interest: Antimicrobial activity was seen in a range of 
Gram-negative and Gram-positive bacteria such as Escherichia coli and 
Staphylococcus aureus, respectively.205  Due to the decreasing endemic status 
of this species, not many reports have been published on this species.209  Other 
dioxoaporphines such as cepharadione and artabotrine have shown 
antimicrobial activies as well as anticancer activity against P-388 leukaemia 
cell lines, respectively.215  
 
The collection took place on 8th August 2007 at Sg. Congkak forest in 
Malaysia.  Extracts from whole plant were prepared in HEX, EtOAc and EtOH. 
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1.5 Research aims and objectives 
Mankind has a long history of using natural products to prevent and treat 
diseases such as cancers.  The biology and chemistry of natural products and 
their associated mechanisms of action are becoming better understood as 
research methods and technologies progress.  Previously, limited reports 
described antitumour activities of A. ellipticum and D. grandiflora extracts 
whereas P. macrophylla has never before been examined for its biological 
DFWLYLW\WKHUHIRUHWKHVHSODQWV¶ H[WUDFWVDUHZRUWK\RILQYHVWLJDWLRQ WRYDOLGDWH
their use(s), to build on existing knowledge and explore the potential of these 
traditional medicinal plants for treatment of cancer and/or other diseases.  
 
The aims of this project were to investigate selected Malaysian Rainforest 
plants for their potential antitumour properties and possible mechanism(s) of 
action.  The rationale for selecting the aforementioned plants for investigation 
is based on the lack of available data on the biological activities of the species 
in general or the lack of scientific evidence for it as a potential anticancer 
activity specifically.  Plant specimens were selected to coincide with studies 
being conducted by University of Nottingham, Malaysia Campus (UNMC) 
colleagues.  A systematic approach was taken to study these plant extracts.  It 
is the major goal of this project to determine whether UNMC plant extracts 
contain active phytochemicals, which may affect the survival of cancer cells.  
This project is in its infancy and will require interdisciplinary skills and 
techniques to evaluate the in vitro biological activities of UNMC plant extracts.  
This will support mechanistic studies of the UNMC plant extracts in order to 
justify the use of these plants to treat malignant disease.   
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The objectives of this thesis are: 
1. To evaluate the in vitro growth inhibitory activities of crude extracts in 
a panel of cancer cell lines by measuring the cell viability and analysing 
cell cycle distribution.  The assays employed to achieve the objectives 
are: 
i. MTT assay 
ii. Clonogenic assay  
iii. Flow cytometric techniques using fluorescent staining of DNA 
with propidium iodide (PI) 
 
2. To investigate whether the UNMC plant extracts induce apoptosis and 
to confirm any positive findings in a sensitive cell line.  
i. Using flow cytometric analysis to measure dual Annexin V and 
PI florescent staining 
ii. Confirmation of apoptosis by Western blotting techniques by 
employing specific antibodies to detect caspases and survival 
proteins. 
 
3. To evaluate additional putative anticancer properties of extracts 
including the ability to  
i. Inhibit cancer cell migration adopting the wound-healing 
(scratch) assay. 
ii. Induce cellular senescence, an irreversible process leading to 
cell death.  The assay employed to achieve this objective is 
LQWUDFHOOXODUGHWHFWLRQWKHVHQHVFHQFHPDUNHUȕ-galactosidase. 
  
4. To evaluate potential chemopreventive properties of UNMC plant 
extracts by determining extract chemical contents as well as measuring 
the in vitro free radical scavenging activity.  The following methods 
were employed: 
a. Aluminium chloride method to determine the total flavonoid 
content 
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b. Folin Cioulteau methods to determine the total phenolic content 
c. DPPH assay to measure the free radical scavenging activity.  
 
5. To conduct initial activity-guided fractionation of crude extracts to 
enable identification of fraction(s) containing possible active 
components, if any.  The following methods were employed: 
i. Crude fractionation of UNMC extracts using extraction 
cartridge then analysing the collected material via HPLC 
techniques. 
ii. To determine growth inhibitory properties of the crude extract 
fractions in selected cell lines using the MTT assay.  
 
A literature search was performed on the medicinal uses and chemical 
constituents of A. wilkesiana, P. macrophylla, A. ellipticum and D. grandiflora.  
For instance D. grandiflora extracts have been used to treat stomach pain and 
for skin whitening through traditional practice in Thailand and its activity has 
been verified by identifying eugeniin, the active compound responsible.196  
There is a lack of evidence of P. macrophylla's biological activity, however it 
was found to possess high levels of compounds possessing alkaloid 
functionality.213, 214  A range of phytochemicals such as alkaloids found in 
plants possess therapeutic properties, thus suggesting the aforementioned 
plants are worthy of further investigation into their potential anticancer 
properties (refer to Plant profiles 1.4.1).28, 32, 89, 216 
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2  
The influence of Acalypha wilkesiana, Duabanga grandiflora, 
Archidendron ellipticum and Pseuduvaria macrophylla crude 
extracts on cell viability 
Approaches to select natural compounds as sources of potential anticancer drug 
leads include evaluating evidence of medicinal plants used in traditional 
systems or through random screening of natural compounds.  Either approach 
would require validation via  rapid, inexpensive and robust methods.  Assays 
assessing cell viability are widely adopted in the preliminarily selection  to 
identify those extracts with good activity. For instance the sulforhodamine B 
(SRB) assay is currently employed by the NCI in vitro anticancer-drug 
discovery program.217  Other popular cell viability assays used in small-scale 
assessment of cancer cell viability after exposure to investigational compounds 
include tetrazolium salt-based assays such as 2,3-bis-(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) and 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (thaizolyl blue; 
MTT).93, 218  Identification of µactive¶ extracts in primary screening would 
IDFLOLWDWHVHOHFWLRQRIµDFWLYH¶crude extracts to undergo further investigations.  
 
2.1 Selection of UNMC plant extracts for investigation 
Following the literature search, it was proposed that a primary screen 
investigating the anticancer activity of the plant extracts would enable 
preliminary selection of UNMC plant extracts.  A range of bioassays has been 
considered and the robust and inexpensive, MTT and clonogenic assays were 
employed to examine in vitro growth inhibitory and cytotoxicity effects of the 
extracts in human-derived cancer cell lines.  A cell panel was employed 
consisting of two breast adenocarcinoma cell lines, two ovarian carcinoma cell 
lines, two renal carcinoma cell lines, two colon carcinoma cell lines and a non-
transformed lung fibroblast cell line.  Non-transformed MRC-5 fibroblasts 
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were employed as a preliminary control to assess the putative selectivity of the 
in vitro growth inhibitory and cytotoxicity effects of UNMC plant extracts to 
cancer cells.  A cervical cell line, SiHa, containing human papilloma virus 
(HPV) was included in the cell line panel to test D. grandiflora extracts due to 
previous reports of anti-viral activity by eugeniin.202  Subsequently, sensitive 
cell lines were selected to conduct further in vitro examination to assess 
potential anticancer effects of UNMC plant extracts.   The details of each type 
of cancer cell line and the specific cell lines utilised are shown in Table 2-1. 
 
 Table 2-1: Mammalian cell lines used for primary selection. 
Cell 
type Cell line Characteristics Reference 
B
re
as
t a
de
n
o
ca
rc
in
o
m
a 
MCF-7 
Er+; p53+; express WNT7B 
oncogene. Growth is inhibited 
TNF-Į 
Cellular products: insulin-like 
growth factor binding proteins 
BP-2, BP-4 and BP-5. Isolated 
from adult Caucasian female. 
$7&&QR¶+7%-
22; Brooks et al. 
1973219 
MDA-MB-
468 
Er- ; PR- ; Her 2-; expression of 
EGF and TNF-Į ,VRODWHG IURP
African female. 
$7&&QR¶+7%-
132; Cailleau et 
al. 1978220 
O
v
ar
ia
n
 
ad
en
o
ca
rc
in
o
m
a IGROV1 Isolated from adult female. Bénard et al. 1985221 
SK-OV-3 
Blood type B (Rh+). Isolated 
from adult Caucasian female. 
Resistant to TNF-Į DQG VHYHUDO
cytotoxic drugs including 
diphtheria toxin, cis-platinum 
and adriamycin. 
$7&&QR¶+7%-
77; Frogh et al. 
1975222 
R
en
al
 
ce
ll 
ca
rc
in
o
m
a 
Caki-1 
Blood type O (Rh-). Contains 
many microvilli, few filaments, 
many small mitochondria, well-
developed Golgi and ER, lipid 
droplets and multilaminate 
bodies, secondary lysosomes. 
Isolated from adult Caucasian 
male. 
$7&&QR¶+7%-
46; Frogh et al. 
1975222 
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TK-10 Human spindle cell carcinoma isolated from adult male. Bear et al. 1987
223
 
Co
lo
re
ct
al
 
ca
rc
in
o
m
a 
HCT116 
7*)ȕ-1+; P53 (wild-type) and 
mutation in codon 13 of ras 
protooncogene. Cellular 
products: keratin and 
carcinoembryonic antigen.   
Isolated from adult male. 
$7&&QR¶&&/-
247; Brattain et 
al. 1981224 
HCC2998 P53 (mutated) and K-ras (wild-
type) 
Goldwasser et al. 
1995225 and 
Kobayashi et al. 
1999226 
Ce
rv
ic
al
 
sq
u
am
o
u
s 
ce
ll 
ca
rc
in
o
m
a 
SiHa 
P53+; pRB+; HPV-16 (1 to 2 
copies per cell). Grade II 
squamous cell carcinoma with 
an abundance of tonofilaments 
in the cytoplasm. Isolated from 
adult Asian female. 
AT&&QR¶+7%-
35; Durst et al. 
1992227 
N
o
rm
al
 
hu
m
an
 
fo
et
al
 
lu
n
g 
fib
ro
bl
as
t 
MRC-5 
Isolated from 14 weeks gestation 
Caucasian male.  Onset of 
senescence occurs after 42 to 46 
population doublings. 
$7&&QR¶&&/-
171; Jacobs et al. 
1970228 
Information on the human cell lines used can be obtained from American Type 
Cell Culture (www.atcc.org) and National Cancer Institute 
(http://dtp.nci.nih.gov).  
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2.1.1 In vitro growth inhibitory and cytotoxicity effects of 
UNMC plant extracts in a cell line panel  
An established method to observe the cell viability of a cell line after exposure 
to a compound of interest is the MTT assay.229, 230  The method is mediated by 
substrates of mitochondrial dehydrogenases such as succinate, NADH and 
NADPH in viable cells to reduce soluble MTT dye into insoluble formazan 
with adsorption range between 510 and 570 nm.231, 232  Therefore, the MTT 
assay can be used to investigate the effect of plant extracts on cell viability and 
proliferation in a panel of cancer cell lines.  The mean absorbances were used 
to construct a dose-response curve, from which the estimated extract 
concentration inducing 50% growth inhibition (GI50 value) was calculated.  
The selection criteria for µDFWLYH¶crude extracts are GI50 values of 2ȝg/ml 
from in vitro assays.95   
The cell lines were exposed to serial dilution of UNMC extracts for 72 h, 
followed by the addition of MTT.  The cells were then incubated for 4 h at 
37 °C before absorbance at 555 nm was read according to the MTT assay 
protocol outlined in Section 9.2.3.  The absorbance of formazan for the cells at 
time of treatment (T0) was also measured to determine basal level formazan 
produced by the viable cells.  The T0 value then allowed the calculation of the 
concentration of plant extract required to inhibit cell proliferation by 50% 
(GI50).  Furthermore, the anti-carcinogenic flavonoid, quercetin, was used as a 
positive control.233  Quercetin was used to ensure that any activity seen for the 
extracts was not due to experimental error.  Therefore, quercetin was tested 
against the cell line panel (n = 4) in at least three independent experiments. 
 
2.1.1.1 In vitro growth inhibitory and cytotoxicity effects of Acalypha 
wilkesiana extracts in a cell line panel  
A. wilkesiana (whole plant) EtOH and EtOAc extracts have demonstrated 
growth inhibitory effects across the cell line panel as shown in Table 2-2 (see 
appendix 1 for dose-response curves).  Interestingly, both breast MCF-7 and 
MDA-MB-468, ovarian SK-OV-3 and CRC HCT116 cell lines appear to be 
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amongst the most sensitive to the growth inhibitory effects of the EtOH and 
EtOAc extracts.  
 
Table 2-2: In vitro growth inhibitory effects of A. wilkesiana extracts in a cell 
line panel revealed by the MTT assay. 
  Mean GI50 YDOXHVȝJPO 
A.
 
w
ilk
es
ia
n
a
 
ex
tr
ac
ts
 
M
CF
-
7 
M
D
A
-
M
B
-
46
8 
IG
R
O
V
1 
SK
-
O
V-
3 
Ca
ki
-
1 
T
K
-
10
 
H
CT
11
6 
H
CC
29
98
 
M
R
C-
5 
Et
O
H
 43.41 
± 
9.85 
22.67 
± 
3.66 
44.66 
± 
1.47 
41.80 
± 
7.29 
64.23 
 ± 
4.51 
77.99 
± 
7.18 
35.98 
± 
1.53 
88.74 
± 
3.71 
46.60 
± 
8.03 
Et
O
A
c 35.96 
± 
1.27 
15.88 
± 
4.28 
60.32 
± 
8.13 
46.23 
± 
8.52 
120.99 
± 
20.34 
52.23 
± 
5.96 
39.14 
± 
0.84 
79.86 
± 
3.42 
53.26 
± 
9.23 
H
EX
 
>200 >200 >200 >200 >200 >200 >200 >200 >200 
Qu
er
ce
tin
 
5.33 
± 
6.31 
22.88
± 
8.08 
9.66 
± 
0.24 
4.49 
± 
1.37 
5.03 
± 
0.48 
14.53
± 
1.24 
21.47 
± 
9.26 
20.76
± 
12.61 
18.56 
± 
9.25 
Extract concentration ȝJPODWZKLFKFHOOJURZWK LVLQKLELWHGE\*,50) 
after 72 h exposure.  Mean GI50 YDOXHVȝJPO6(0ZHUHREWDLQHGIURP
(n = 4) individual experiments where active crude extracts (GI50 YDOXHV0 
ȝJPODUHKLJKOLJKWHGLQ bold, extracts ± SEM values that could be considered 
active are highlighted in italics; the lowest GI50 values are underlined. 
 
Fingerprint graphs (Figure 2-1) highlight MDA-MB-468 as the most sensitive 
cell line to EtOH and EtOAc extracts, with mean GI50 values of ȝJPO 
and 15.88 ȝJPO, respectively.  However EtOH and EtOAc extracts did not 
demonstrate selectivity between cancer cell lines and MRC-5 fibroblasts.  
EtOH and EtOAc extract-treated MDA-MB-468 cells produced GI50 values of 
ȝJPODQGȝJPl, respectively, which are near or lower than the 
selection criteria set (~ 20 ȝJPO).  
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Figure 2-1: NCI-style mean fingerprint graphs for A. wilkesiana extracts. 
EtOH, EtOAc and HEX extracts were screened against a cell line panel and the 
bars represent the individual mean GI50 value of the cell line.  The overall 
mean GI50 value of all the cell lines was set to the center (0.0); all values were 
to the function of log10.  Bars to the left indicate cell lines that are less sensitive 
than the mean and bars to the right indicate cell lines that are more sensitive 
than the mean to the extract. 
-0.50 -0.25 0.00 0.25 0.50
MCF-7
MDA-MB-468
IGROV-1
SKOV-3
Caki-1
TK-10
HCT116
HCC2998
MRC-5
 Log10 
C
el
l 
li
n
es
Mean cell line panel GI50: 51.79 g/ml
EtOH
-0.50 -0.25 0.00 0.25 0.50
MCF-7
MDA-MB-468
IGROV-1
SKOV-3
Caki-1
TK-10
HCT116
HCC2998
MRC-5
 Log
10
 
C
el
l 
li
n
es
Mean cell line panel GI50:  55.99 g/ml
EtOAc
-0.50 -0.25 0.00 0.25 0.50
MCF-7
MDA-MB-468
IGROV-1
SKOV-3
Caki-1
TK-10
HCT116
HCC2998
MRC-5
C
el
l 
li
n
es
 Log
10
 
Mean cell line panel GI50:  > 200 g/ml
HEX
     
61 
In addition, HCT116 cells revealed modest sensitivity towards EtOH and 
EtOAc extracts with GI50 values of 35.98 and 39.14 ȝJPO, respectively.  The 
difference between EtOH and EtOAc extract-treated mean cell line panel 
(GI50) is 4.20 ȝJPO, suggesting growth inhibitory and cytotoxic effects of both 
extracts are similar.  There was no difference between the mean GI50 values for 
cell lines exposed to HEX extracts (> ȝJPO since no growth inhibitory 
effects were demonstrated at the concentrations used.  
 
2.1.1.2 In vitro growth inhibitory and cytotoxicity effects of Archidendron 
ellipticum extracts in a cell line panel  
GI50 values for A. ellipticum extracts were determined using the MTT assay 
and are summarised in Table 2-3 (see Appendix 1 for dose-response curves). 
EtOH bark and leaf extracts inhibited the growth of cancer cell lines at low 
concentrations, MDA-MB-468 (1.73 and 9.32 ȝJPO), Caki-1 (21.71 and 5.07 
ȝJPO), HCT116 (11.65 and 3.51 ȝJPO) and HCC2998 DQGȝJPO 
cells, respectively.  To a lesser extent, growth of ovarian SK-OV-3 cells 
responded to EtOH bark extract (10.00 ȝJPO), whereas renal TK-10 cells only 
responded to EtOH leaf extract (28.77 ȝJPO).  
In comparison, growth inhibitory effect of EtOH extracts appeared to be 
greater than EtOAc extracts as represented by mean cell line panel GI50 (EtOH 
bark: 45.28 and EtOH leaf: 45.73; EtOAc bark: 54.47 and EtOAc leaf: 138.82 
ȝJPO).  Whereas, > 2-fold observed difference between the mean cell line 
panel GI50 YDOXHVRI(W2$FEDUNȝJPODQG(W2$FOHDIȝJPO
extracts.  Data from Table 2-3 revealed EtOH bark and leaf extracts 
demonstrated comparable activity (GI50 values) in MDA-MB-468, SK-OV-3, 
Caki-1, TK-10, HCT116, HCC2998 and MRC-5 cells  (Figure 2-2).   
Overall, EtOH extracts induced the greatest growth inhibitory effects across the 
cell line panel, particularly, in renal and CRC cell lines.  It is interesting to note 
comparable mean GI50 values was observed across the cell line panel in bark 
and leaf extracts of the same solvents, e.g. EtOH bark = ȝJPODQG leaf = 
ȝJPO; HEX EDUN ȝJPODQG leaf  = > ȝJPOH[WUDFWV In 
general, cell growth remained unaffected by HEX extracts even at high 
FRQFHQWUDWLRQ RI  ȝJPO ZKLFK LV ; JUHDWHU WKDQ WKH 1&,¶V VHOHFWLRQ
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criteria for crude extract activity.   Furthermore, MRC-5 fibroblasts responded 
to EtOH and EtOAc bark and EtOH leaf extracts at low GI50 values: 3.82, 
18.80 and 3.29 ȝJPO, respectively.   
 
Table 2-3: In vitro growth inhibitory effects of A. ellipticum extracts in a cell 
line panel revealed by the MTT assay. 
  Mean GI50 YDOXHVȝJPO 
A.
 
el
lip
tic
u
m
 
ex
tr
ac
ts
 
M
CF
-
7 
M
D
A
-
M
B
-
46
8 
IG
R
O
V
1 
SK
-
O
V
-
3 
Ca
ki
-
1 
T
K
-
10
 
H
CT
11
6 
H
CC
29
98
 
M
R
C
-
5 
B
A
R
K
 
Et
O
H
 151.85 
±  
5.82 
1.73  
± 
 1.52 
174.2
1± 
19.37 
10.00 
±  
4.01 
21.71 
±  
6.78 
28.77 
±  
3.29 
11.65  
± 
 2.43 
3.74 
 ± 
 0.26 
3.82  
± 
 1.78 
Et
O
A
c 82.35  
± 
 4.07 
40.43 
± 
 7.13 
53.78 
± 
12.80 
62.26 
± 
11.17 
75.22 
±  
7.38 
32.45 
±  
2.98 
72.24  
± 
 2.21 
52.68 
 ±  
4.26 
18.80 
±  
5.90 
2.
1.
1.
3 
H
EX
 
>200 >200 
166.93  
± 
 10.46 
>200 >200 >200 
141.36 
± 
10.07 
>200 >200 
L
E
A
F 
Et
O
H
 97.64 
 ±  
2.67 
9.32 
 ±  
5.98 
242.05 
±  
4.97 
42.51 
± 
 4.49 
5.07  
±  
0.59 
5.24 
 ± 
0.50 
3.51 
±  
0.16 
2.94  
± 
 0.51 
3.29  
± 
 0.42 
Et
O
A
c 
>200 
9.28  
± 
 1.16 
198.50 
±  
 26.67 
108.12 
± 
 7.10 
>200 >200 
122.22 
 ±  
5.89 
19.97 
 ± 
 9.66 
69.73 
± 
 0.95 
H
EX
 193.42 
 ±  
14.52 
>200 >200 >200 >200 >200 >200 >200 >200 
Qu
er
ce
tin
 
5.33  
± 
6.31 
22.88 
± 
8.08 
9.66 
± 
0.24 
4.49 
± 
1.37 
5.03 
± 
0.48 
14.53
± 
1.24 
21.47 
± 
9.26 
20.76
± 
12.61 
18.56 
± 
9.25 
([WUDFW FRQFHQWUDWLRQȝJPODWZKLFh cell growth is inhibited by 50% (GI50) 
after 72 h exposure.  Mean GI50 YDOXHVȝJPO6(0ZHUHREWDLQHGIURP
(n = 4) individual experiments where active crude extracts (GI50 YDOXHV0 
ȝJPODUHKLJKOLJKWHGLQ bold, extracts ± SEM values that could be considered 
active are highlighted in italics; the lowest GI50 values are underlined. 
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Figure 2-2: NCI-style mean fingerprint graphs for A. ellipticum extracts. 
EtOH, EtOAc and HEX extracts were screened against a cell line panel and the 
bars represent the individual mean GI50 value of the cell line.  The overall 
mean GI50 value of all the cell lines was set to the center (0.0); all values were 
to the function of log10.  Bars to the left indicate cell lines that are less sensitive 
than the mean and bars to the right indicate cell lines that are more sensitive 
than the mean to the extract. 
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2.1.1.4 In vitro growth inhibitory and cytotoxicity effects of Duabanga 
grandiflora extracts in a cell line panel  
The in vitro growth inhibitory and cytotoxicity activities of D. grandiflora bark 
and leaf extracts across the cell line panel are summarised in Table 2-4 (see 
Appendix 1 for dose-response curves).  Interestingly, polar Water bark extracts 
induced growth inhibition only in breast cancer MCF-7 cells at concentrations 
within 1&,¶V selection criteria ( ȝJPO.  Growth inhibition of renal 
cancer Caki-1 and CRC HCT116 cells was observed at a lesser extent when 
exposed to EtOH bark extract (GI50 values: 34.40 and 37.54 ȝJPO, 
respectively).  EtOAc bark extract demonstrated greatest growth inhibitory 
effects across the cell panel, in particular, MCF-  ȝJPO +&7
 ȝJPO DQG +&&  ȝJPO cell lines.  The cell lines most 
susceptible to growth inhibitory effects of HEX bark extracts were breast 
cancer MCF-7 ȝJPODQG&5&+&7ȝJPOFHOOV 
Overall, EtOAc and HEX extracts appeared to induce growth inhibitory effects 
in the greatest number of cell lines amongst the bark extracts.  In comparison, 
EtOAc leaf extract emerged as effective in inhibiting the growth of CRC 
HCT116 (24.73 ȝJPODQGEUHDVWFDQFHU0'$-MB-ȝJPOFHOOVDW
similar concentrations to bark extracts.  However, this trend was not seen in 
cells under the influence of Water leaf extract treated e.g. MDA-MB-468 (GI50 
 ȝJPO DQG +&7 GI50  ȝJPO cells and EtOH leaf extracts-
treated breast cancer MCF- ȝJPO and +&7 ȝJPOFHOOV.  
A lack of cellular response to HEX leaf extract was observed at the highest 
concentration tested (> 200 ȝJPO).  In general, bark extracts presented the 
most number of active extracts against the cell line panel with mean cell line 
panel GI50 values of 65.04, 105.54, 31.58 and 36.3 DQG ȝJPO IRU Water, 
EtOH, EtOAc and HEX extracts respectively, as compared to 79.80, 61.41, 
43.78 and > 200 ȝJPO for Water, EtOH, EtOAc and HEX leaf extracts, 
respectively.  D. grandiflora  bark extracts demonstrated broader growth 
inhibitory properties against the cell line panel compared to leaf extracts, 
suggesting different components are embedded in the extracts.  MDA-MB-468, 
MCF-7 Caki-1, HCT116 and HCC2998 cells have shown broad sensitivity 
towards D. grandiflora extracts; contrarily IGROV1, SK-OV-3 and TK-10 
cells were less sensitive to D. grandiflora extracts (Figure 2-3).  Undesirably, 
     
65 
low GI50 ȝJPOYDOXHVRIDQGin MRC-5 fibroblasts were obtained 
in both EtOAc and HEX bark extracts, respectively.   
 
Table 2-4: In vitro growth inhibitory effects of D. grandiflora extracts in a cell 
line panel revealed by the MTT assay. 
 
Mean GI50 YDOXHVȝJPO  
D
.
 
gr
a
n
di
flo
ra
 
ex
tr
ac
ts
 
M
CF
-
7 
M
D
A
-
M
B
-
46
8 
IG
R
O
V
1 
SK
-
O
V-
3 
Ca
ki
-
1 
T
K
-
10
 
H
CT
11
6 
H
CC
29
98
 
Si
H
a 
M
R
C-
5 
 
B
A
R
K
 
W
at
er
 19.53 
± 
3.97 
47.28 
± 
7.34 
69.98 
± 
7.83 
63.93 
± 
6.12 
46.69 
± 
3.38 
113.6
5 ± 
11.03 
42.44  
± 
3.28 
106.94 
±  
11.07 
- 
74.9
1 ± 
12.8
2 
 
Et
O
H
 146.0
9 ± 
9.35 
40.04 
± 
3.32 
194.1
5 ± 
15.77 
135.6
9 ± 
8.00 
34.40 
± 
12.25 
153.3
6 ± 
22.06 
37.54 
± 
5.68 
141.46 
 ± 
18.31 
64.
76 
± 
9.4
1 
67.1
2 ± 
3.60 
 
Et
O
A
c 19.87 
± 
1.43 
36.24 
± 
4.10 
29.49 
± 
3.00 
71.60 
± 
8.00 
31.53 
± 
10.66 
61.78 
± 
0.56 
21.69 
± 
0.64 
4.65 
± 
2.13 
69.01 
± 
3.54 
7.37 
± 
1.32 
 
H
EX
 29.70 
± 
0.53 
34.95 
± 
1.79 
31.47 
± 
2.57 
56.59 
± 
7.63 
52.93 
± 
4.97 
36.65 
± 
5.79 
28.88 
± 
1.55 
35.22 
± 
3.27 
67.06 
± 
3.28 
20.8
8 ± 
1.34 
 
L
E
A
F 
W
at
er
 57.85 
± 
6.40 
37.40 
± 
5.45 
79.9 
± 
3.78 
66.58 
± 
3.64 
88.52 
± 
2.71 
150.1
7 ± 
2.96 
38.02 
± 
3.25 
111.34 
± 
20.11 
- 
88.3
8 ± 
15.7
9 
 
Et
O
H
 34.47 
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33.24 
± 
7.37 
49.36 
± 
3.94 
36.13 
± 
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± 
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2.32 
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± 
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3.05 
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4.83 
 
H
EX
 
>200 >200 >200 >200 >200 >200 >200 >200 >200 >200 
 
([WUDFW FRQFHQWUDWLRQȝJPODWZKLFKFHOOJURZWK LVLQKLELWHGE\*,50) 
after 72 h exposure.  Mean GI50 YDOXHVȝJPO6(0ZHUHREWDLQHGIURP
(n = 4) individual experiments where active crude extracts (GI50 YDOXHV20 
ȝJPODUHKLJKOLJKWHGLQ bold, extracts ± SEM values that could be considered 
active are highlighted in italics; the lowest GI50 values are underlined. 
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Figure 2-3: NCI-style mean fingerprint graphs for D. grandiflora extracts. 
Water, EtOH, EtOAc and HEX extracts were screened against a cell line panel 
and the bars represent the individual mean GI50 value of the cell line.  The 
overall mean GI50 value of all the cell lines was set to the center (0.0); all 
values were to the function of log10.  Bars to the left indicate cell lines that are 
less sensitive than the mean and bars to the right indicate cell lines that are 
more sensitive than the mean to the extract. 
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2.1.1.5 In vitro growth inhibitory and cytotoxicity effects of Pseuduvaria 
marcophylla extracts in a cell line panel  
The MTT assay demonstrated P. macrophylla extracts exerted in vitro growth 
inhibitory activity in all the cell line panel: potency EtOAc > EtOH > HEX 
(summarised in Table 2-5 and dose-response curves are shown in Appendix 1).  
 
Table 2-5: In vitro growth inhibitory effects of P. macrophylla extracts in a 
cell line panel revealed by the MTT assay. 
 Mean GI50 YDOXHVȝJPO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± 
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± 
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± 
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4.49 
± 
1.37 
5.03 
± 
0.48 
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± 
1.24 
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± 
9.26 
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± 
12.61 
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± 
9.25 
([WUDFW FRQFHQWUDWLRQȝJPODWZKLFKFHOOJURZWK LVLQKLELWHGE\*,50) 
after 72 h exposure.  Mean GI50 YDOXHVȝJPO6(0ZDVREWDLQHGIURP
(n = 4) individual experiments where active crude extracts (GI50 YDOXHV0 
ȝJPODUHKLJKOLJKWHd in bold, extracts ± SEM values that could be considered 
active are highlighted in italics; the lowest GI50 values are underlined.  
 
EtOAc extract yielded GI50 YDOXHVȝJPOLQ0&)-7, MDA-MB-468, SK-
OV-3, Caki-1, HCC2998 and HCT116 cancer cells as well as in MRC-5 
fibroblasts.  The activity between the EtOH and HEX extracts showed 
comparable growth inhibitory effects.  HEX extracts revealed moderate 
selectivity (~ 5-fold) towards cancer cell lines MDA-MB-468, SK-OV-3 and 
HCT116 (GI50 values of 6.49, 5.88 DQGȝJPO UHVSHFWLYHO\), over non-
transformed MRC-5 fibroblasts (GI50 values: ȝJPO  However, EtOAc 
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and EtOH extracts did not demonstrate selectivity towards cancer cells 
compared with MRC-5 fibroblasts (Figure 2-4).  Subtle differences in cell 
panel GI50 values were observed in cell line panel GI50 values following 
treatment with EtOH (GI50 value: 5.05 ȝJPO) and EtOAc (GI50 value: 2.02 
ȝJPO) extracts whereas cancer cellV¶ sensitivity towards HEX extract varied 
(GI50 values: 5.41 to 18.72 ȝJPO).   
 
 
Figure 2-4: NCI-style mean fingerprint graphs for P. macrophylla extracts. 
EtOH, EtOAc and HEX extracts were screened against a cell line panel and the 
bars represent the individual mean GI50 value of the cell line.  The overall 
mean GI50 value of all the cell lines was set to the center (0.0); all values were 
to the function of log10.  Bars to the left indicate cell lines that are less sensitive 
than the mean whereas bars to the right indicate cell lines that are more 
sensitive than the mean to the extract. 
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2.1.1.6 Summary of the in vitro growth inhibitory and cytotoxicity effects 
of UNMC extracts in a cell line panel 
 The MTT assay was used to examine in vitro growth inhibition and 
cytotoxicity of UNMC plant extractV¶ effects in human-derived cancer cells; 
H[WUDFWV¶ VHOHFWLYLW\against cancer cell line was compared in non-transformed 
fibroblasts.   
 
Acalypha wilkesiana: Extracts of A. wilkesiana primarily affected breast 
cancer cell line, MDA-MB-468 (GI50 values: EtOH: 22.67 and EtOAc: 15.88 
ȝJPO, respectively) and MCF-7 breast cancer (EtOH: 43.41 and EtOAc: 35.96 
ȝJPOUHVSHFWLYHO\.  In support of this finding, Büssing et al. (1999) reported 
the verification of ethnopharmacological use of A. wilkesiana seeds to treat 
breast tumours and inflammation owing to their cytotoxic and 
immunomodulatory effects via generation of reactive oxygen intermediates 
(ROI), release of pro-inflammatory cytokines TNF-Į DQG ,/-6, T-cell-
associated cytokines IL-5 and IL-Ȗ.175  This could be due to the presence of 
amphiphilic saponins in the extracts, which has ability to permeabilise cell 
membranes.  
Another study has reported mean GI50 values of 28.03 and 89.63 ȝJPO for 
U87MG (grade IV human gliobastoma) and A549 (human lung carcinoma) 
cells following 72 h exposure to A. wilkesiana EtOAc extracts.  U87MG cells 
required almost two times greater concentration of EtOAc extracts to induce 
growth inhibitory effects when compared to MDA-MB-468 cells treated with 
EtOAc extracts (GI50 15.88 ȝJPO).234  Both U87MG and A549 cells were 
insensitive to EtOH and HEX extracts (GI50 values between 166.30 to > 300 
ȝJPOwhich corresponded to the trend observed for HEX extracts (see Table 
2-2), suggesting unseparated components in crude HEX extract to be least 
effective in inducing growth inhibition.  
There was minimal selectivity between MDA-MB-468 and MRC-5 cells.  No 
evidence of growth inhibition was seen in HEX-treated cell lines.  The absence 
of oestrogen (ER) and progesterone (PR) receptors on MDA-MB-468 cells 
may not to be a factor to FHOOV¶ sensitivity towards these extracts, suggesting 
the active constituents may not be in the phytochemical class of isoflavonoids 
(phyto-oestrogens) or flavonoids (anti-oestrogens).  Results from MTT assays 
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revealed MDA-MB-468 cells to be among the most sensitive to the growth 
inhibitory properties of A. wilkesiana extracts; therefore MDA-MB-468 cells 
were selected for further study with this plant.   
 
Archidendron ellipticum: EtOH extracts from A. ellipticum demonstrated good 
activity across the cell line panel.  With the exception of ovarian carcinoma 
SK-OV-3 cells, the same cell lines responded to growth inhibitory effects of 
EtOH bark and leaf extract (MDA-MB-468 > HCC2998 > MRC-5 > HCT116 
> TK-10 > Caki-1, in order of sensitivity), suggesting similar compounds are 
embedded.  MDA-MB-468 cells were sensitive to EtOH and EtOAc extracts at 
low concentrations between 1.73 - 9.32 ȝJPO.  Only MCF-7 and IGROV1 
cells revealed less sensitivity towards growth inhibitory effects of the extracts.   
Comparable GI50 values suggest that similar phytochemicals might be present 
in the EtOH bark and leaf extracts based on the similar sensitivity observed in 
MDA-MB-468, SK-OV-3, Caki-1, TK-10, HCT116, HCC2998 and MRC-5 
cells.   
Beutler et al (1997) stated that in vitro cytotoxicity of several crude legume 
extracts from the NCI natural product repository were comparable to that of A. 
ellipticum, such as Albizia zygia and Albizia altissima, sharing similar mean 
fingerprint patterns with saponins from A. ellipticum.235  Many leguminous 
plant seeds contain biologically active compounds that could inhibit proteases 
and amylases.  Kunitz (serine) proteinase inhibitor, which is present in 
germinative tissues of A. ellipticum and many Mimosoideae species possesses 
dual functions as storage protein DQGDSDUWRIWKHSODQW¶VGHIHQVLYHPHFKDQLVP
against seed predators.236, 237  Inagaki et al. (2012) identified Kunitz-type 
protease inhibitors may affect ion channels (K+, Na+ and Ca2+) and inhibit 
MMP2 activity hence may have a role in cancer metastasis inhibition.238  
Results from MTT assays revealed MDA-MB-468 cells to be among the most 
sensitive to growth inhibitory properties of A. ellipticum extracts; therefore 
MDA-MB-468 was selected for further study with this plant.   
 
Duabanga grandiflora: EtOAc bark extract of D. grandiflora exerted greatest 
activity across the cell line panel with growth inhibition in 70% of the cell line 
panel at near 20 ȝJPO 1&,¶V VHOHFWLRQ FULWHULD, in the order of sensitivity: 
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HCC2998 > MRC-5 > MCF-7 > HCT116 > IGROV-1 > Caki-1 > MDA-MB-
468.  Overall, HCT116 cells were most sensitive to D. grandiflora extracts 
EtOAc (bark) > EtOAc (leaf) > HEX (bark) > EtOH (bark) > Water (leaf) 
extracts with GI50 between 21.69 - ȝJPO.  Interestingly, HEX extracts 
appeared to induce broad activity against MRC5 > HCT116 > MCF-7 > 
IGROV-1 > MDA-MB-468 > HCC2998 > TK-10 cells (in order of sensitivity) 
with GI50 values between 20.88 to  ȝJPO.  In contrast no growth 
inhibition was observed in cells exposed to HEX leaf extracts even at 200 
ȝJPO7he unresponsiveness of cells to HEX leaf extract (> ȝJPO could 
either indicate a lack of potent compounds present in the extract or the masking 
of activity by other compounds present.   
It is noted that the cervical cell line, SiHa, containing copies of HPV-16 (DNA) 
virus was included in the cell line panel due to reports identifying an anti-viral 
compound, eugeniin, present in D. grandiflora extracts.  Eugeniin interferes 
with HSV DNA polymerase therefore it is also a reason to test if these 
conserved DNA reading proteins are also affected in HPV.34 Traditional uses 
e.g. for anti-aging and anti-whitening, were supported by Tsukiyama et al. 
(2010) as the active hydrolysable tannin, eugeniin could stimulate type III 
collagen production.196, 198 It was found that 2.74 ȝJPO of eugeniin was 
effective at inducing cytotoxic effects against 50% of melanoma cells (RPMI-
7951).239  Another study revealed EtOH bark extract of D. grandiflora from 
India to be active in Walker carcinosarcoma 256 in rats.197  Conversely, 
eugeniin extracted from leaf extracts using MeOH induced growth of human 
skin cells, normal human fibroblast (NHF) cells at concentration range between 
31 ± 125 ȝJPO196  The constituents, oleanane triterpene (pentacyclic 
triterpenes) and lupine triterpene (betulinic acid) revealed cytotoxic activity 
against an acute lymphoblastic leukaemia cell line, MOLT-3, (GI50: 9.5 and 
14.1 ȝ0DQGDKHSDWRFDUFLQRPD+HS* *,50DQGȝ0FHOO OLQH
These constituents were found to be inactive against (GI50 > ȝ0+X&&$-1 
(human chlolangiocarcinoma), A549 (human lung cancer), HeLa (human 
cervical carcinoma), and MDA-MB-231 (hormone independent breast cancer) 
cell lines.193   
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However, MTT results did not reveal any extract potency against or ability to 
promote proliferation of SiHa cells ZKLFK PD\ EH GXH WR WKH µPDVNLQJ¶ RU
DQWDJRQLVPRIHXJHQLLQ¶VDFWLYLW\E\RWKHUFRPSRXQGVLQWKHPL[WXUH.  
Results from MTT assays revealed HCT116 cells to be among the most 
sensitive to growth inhibitory properties of D. grandiflora extracts, therefore 
this cell line was selected for further study with this plant.   
 
Pseuduvaria macrophylla: The order of P. macrophylla extracts potency can 
be ranked as follow EtOAc > EtOH > HEX based on mean cell line panel GI50 
values   DQG  ȝJPO UHVSHFWLYHO\  Remarkably, P. 
macrophylla extracts were able to inhibit growth across the cell line panel at 
concentrations lower than those observed for A. wilkesiana, D. grandiflora and 
A. ellipticum hence the most active plant in this collection.  Good selectivity 
was observed between cancer cells and MRC5 fibroblasts treated with HEX 
extract.  P. macrophylla plant extracts are the most active against cancer cell 
lines and exhibited GI50 effects < 10 ȝJPOZKLFKLV lower (i.e. more potent) 
than selection requirement.  There are no previous studies on the biological 
activity of P. macrophylla.214  Aporphinoid (38) isolated from aerial parts of 
Pseuduvaria setosa has reveal cytotoxicity in small cell lung cancer cells, NCI-
H187 at IC50 YDOXH RIȝg/ml.  Whereas reduced activity was observed in 
KB (epidermoid carcinoma) and BC (breast cancer) cells (IC50!ȝJPO.214  
CRC HCT116 cells were amongst the most sensitive to growth inhibitory 
properties of P. macrophylla extracts, in particular to HEX extract; therefore 
this cell line was selected for further study of P. macrophylla in vitro 
anticancer properties. 
 
Further examination of in vitro activity of plant extracts were explored using 
other comparable cell-based assays.  Growth inhibition was seen in most 
cancer lines treated with the above mentioned UNMC plant extracts; HCT116 
and MDA-MB-468 cell lines were amongst the most sensitive cell lines hence 
chosen for further investigations into in vitro activity of UNMC extracts.  
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2.1.2 Influence of UNMC plant extracts on cell survival and 
clonogenicity 
The clonogenic assay is another established method to examine the abilities of 
cancer cells to survive, proliferate and form colonies.  Cytotoxic agents may 
exert their effects via various mechanisms including induction of cell cycle 
arrest or apoptosis leading to a loss of proliferative potential and protein 
degradation, respectively.240, 241  This bioassay determines survival and 
subsequent proliferative and colony formation capacity of single cells 
following brief exposure (~ 24 h) to extracts of interest.145, 242  The end-point is 
considered when the control populations contain  50 cells per colony.  
Subsequently, cell colony(ies) are fixed with methanol then stained with 
methylene blue dye then quantified by counting.243, 244  Plumb et al. (1987) and 
Carmichael et al. (1987) have reported the positive correlation between the 
clonogenic and the MTT assay.243, 245  Hence both assays were used in 
conjunction to compare the cytotoxic effects of the aforementioned plant 
extracts on the cell survival and proliferation of a panel of cancer cell lines.  
The cell lines and treatment concentrations (0.5X, 1X and 2X GI50 values) 
chosen to examine the sensitivity to the UNMC extracts were guided by results 
of MTT assays.  DuQQHWW¶VPXOWLSOHFRPSDULVRQ2QH-way ANOVA) analysis 
was used to compare each extract-treated group to the control group.  Any 
statistically significant values are denoted: * = 0.01< p < 0.05.   
 
2.1.3 Influence of Acalypha wilkesiana extracts on MDA-MB-
468 cellV¶VXUYLYDODQGFORQRJHQLFLW\ 
Due to the unavailability of EtOAc extract only the clonogenicity of A. 
wilkesiana EtOH and HEX extracts were assessed.  Results from clonogenic 
assay illustrated decreasing colony formation capacity of MDA-MB-468 cells 
with increasing extract concentration shown in Figure 2-5.  Significant 
inhibition of colony formation was observed with EtOH extract at 36 and 72 
ȝJPO;DQG;*,50) where < 40% of the cells formed colonies when at 1X 
GI50 EtOH and > 50% colony formation inhibition at 2X GI50.  Likewise, 
inhibition of colony formation following exposure to 1X and 2X GI50 of HEX 
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extracts was determined to be significant when compared to the control (p < 
0.05).  Although HEX extracts were able to inhibit colony formation, the 
treatment concentrations used DQGȝJPO) were 5-fold greater 
than EtOH extract concentrations used.   
 
  
Figure 2-5: Effects of A. wilkesiana extracts to MDA-MB-468 cells¶
survival and clonogenicity.  Bars (error bar = SEM) denote the mean % of 
HCT116 colonies formed after 24 h exposure to whole H[WUDFWVIURPQ 
 LQGLYLGXDO H[SHULPHQWV SODWLQJ HIILFLHQFLHV ZHUH   SHU H[SHULPHQW
'XQQHWW¶V PXOWLSOH FRPSDULVRQ 2QH-way ANOVA) analysis was used to 
compare each extract-treated group to the control group.  Any statistically 
significant values are denoted: * = 0.01< p < 0.05 and *** = 0.001 < p < 0.01.   
 
2.1.4 Influence of Archichendron ellipticum extracts to MDA-
MB-468 FHOOV¶VXUYLYDODQGFORQRJHQLFLW\ 
Dose-dependent inhibition of MDA-MB-468 colony formation was determined 
after 24 h exposure to A. ellipticum extracts (Figure 2-6).  Constituents from 
bark EtOAc extractions appeared to be most active against breast cancer MDA-
MB-468 cells with only 24% of treated cells retaining colony forming ability at 
0.5X GI50, which is significant compared to the control.  Whereas EtOAc leaf 
extracts at ~ 5-fold less concentration than EtOAc bark extracts significantly 
inhibited colony formation.  MDA-MB-468 celOV¶ FRORQ\ IRUPDWLRQ LQKLELWLRQ
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ability was comparable at the same treatment range of EtOH and EtOAc leaf 
extracts (4.5, 9 and 18 ȝJPO).  Conversely, no significant difference in colony 
formation was observed when cells were exposed to EtOH and HEX bark 
extracts at 0.5X GI50 (77% and 88% control respectively; p > 0.05).  
Comparable numbers of MDA-MB-468 colonies (%) were counted after 
treatment with HEX extracts.  Colony formation was affected by HEX leaf 
extract at high treatment concentrations (100, 200 DQGȝJPO, which were 
up to 100-fold higher than other extracts used.   
 
 
 
Figure 2-6: Effects of A. ellipticum extracts on MDA-MB-468 cells¶ 
survival and clonogenicity.  Bars (error bar = SEM) denote the mean % of 
HCT116 colonies formed after 24 h exposure to bark and leaf H[WUDFWVIURP
(n = 4) individual experiments; plating efficiencies were SHUH[SHULPHQW
'XQQHWW¶V PXOWLSOH FRPSDULVRQ 2QH-way ANOVA) analysis was used to 
compare each extract-treated group to the control group.  Any statistically 
significant values are denoted: * = 0.01< p < 0.05, ** = 0.001 < p < 0.01 and 
*** = p < 0.001.   
 
Overall, bark and leaf EtOH and EtOAc extracts were most effective in 
inhibition of MDA-MB-468 colony formation with consideration of the low 
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ȝJPO (W2$F OHDI   DQG  ȝJPO DQG YHULILHG WR EH VWDWLVWLFDOO\
different from colony-forming ability of DMSO-treated control cells (p < 0.05).  
Again, a general dose-dependent trend of decreased colony formation with 
increasing extract concentration was observed.  All treatments of A. ellipticum 
EtOAc extracts affected MDA-MB-FHOOV¶DELOLW\WRSUROLIHUDWHS 0.05). 
 
2.1.5 Influence of Duabanga grandiflora extracts on HCT116 
FHOOV¶VXUYLYDODQGFORQRJHQLFLW\ 
The effect of D. grandiflora extracts on HCT116 colony formation is shown in 
Figure 2-7.  Polar Water and EtOH extractions appeared to be the most 
effective in inhibiting HCT116 cell survival and clonogenicity in comparison 
to EtOAc and HEX extracts.   
Significant inhibition of colony formation was noted with 1X and 2X GI50 
treatments of polar bark and leaf extracts, revealing > 90% colony formation 
inhibition.  Overall, greatest cell response was noticed with D. grandiflora 
EtOH extracts at all concentrations tested and verified to be statistically 
different to the DMSO control cells (p < 0.001).  HCT116 cells responded in 
similarly to both HEX extracts in regards to the number of colonies formed, 
however concentrations of HEX bark extract (14.5, 29 and 58 ȝJPO) used 
were almost 7-fold lower than that of HEX leaf extract (100, 200 and 400 
ȝJPO  Therefore, polar extracts demonstrated greatest colony formation 
inhibitory effects on HCT116 cells. 
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Figure 2-7: Effects of D. grandiflora extracts to HCT116 cells¶ survival and 
clonogenicity.  Bars (error bar = SEM) denote the mean % of HCT116 
colonies formed after 24 h exposure to bark and leaf H[WUDFWVIURPQ 
LQGLYLGXDO H[SHULPHQWV SODWLQJ HIILFLHQFLHV ZHUH   SHU experiment.  
'XQQHWW¶V PXOWLSOH FRPSDULVRQ 2QH-way ANOVA) analysis was used to 
compare each extract-treated group to the control group.  Any statistically 
significant values are denoted: * = 0.01< p < 0.05, ** = 0.001 < p < 0.01 and 
*** = p < 0.001.   
 
2.1.6 Influence of Pseuduvaria macrophylla extracts to HCT116 
FHOOV¶VXUYLYDODQGFORQRJHQLFLW\ 
The effects of P. macrophylla extracts on HCT116 colony formation after 24 h 
exposure are summarised in Figure 2-8.  Both P. macrophylla EtOH and 
EtOAc extracts significantly inhibited HCT116 colony formation (P < 0.001) 
at 0.5X GI50 (47.35% and 42.87% colony counted, respectively), 1X GI50 
(2.75% and 3.33% counted, respectively) and 2X GI50 (0.75% and 0.50% 
counted, respectively). Contrastingly, there was no evidence to suggest HEX 
extract induced significant inhibition of HCT116 colony formation at the 
concentrations tested at ȝJPO(IIHFWVRI+(;H[WUDFWDW1X and 2X GI50 
(DQGȝJPO) revealed only a ~ 5% difference in the number of colonies 
formed.  Whereas a greater ~ 40% difference in colony formation inhibition 
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was observed between EtOH and EtOAc extracts treated cells at 1X and 2X 
GI50.    
 
  
Figure 2-8: Effects of P. macrophylla extracts on HCT116 cells¶ VXUYLYDO
and clonogenicity.  Bars (error bar = SEM) denote the mean % of HCT116 
colonies formed after 24 h exposure to whole extraFWV IURP   Q   
LQGLYLGXDO H[SHULPHQWV SODWLQJ HIILFLHQFLHV ZHUH   SHU H[SHULPHQW
'XQQHWW¶V PXOWLSOH FRPSDULVRQ 2QH-way ANOVA) analysis was used to 
compare each extract-treated group to the control group.  Any statistically 
significant values are denoted: * = 0.01< p < 0.05, ** = 0.001 < p < 0.01 and 
*** = p < 0.001.   
 
2.1.6.1 Summary of the effects of UNMC extracts on cancer cell colony 
formation 
The clonogenic assay examined the in vitro anti-proliferative and clonogenicity 
of human-derived cancer cells post exposure to UNMC extracts, hence reveals 
the ability of individual cancer cells to survive UNMC extract challenge (24 h) 
and form colonies post-treatment, hence repopulate a tumour.  HCT116 cells 
were exposed to D. grandiflora and P. macrophylla extracts, whereas MDA-
MB-468 cells were treated with A. wilkesiana and A. ellipticum extracts for 
reasons stated earlier.  Although significant inhibition of colony formation was 
observed in several extracts, further experiments are necessary to conclude 
whether the growth inhibition is a consequence of cytostasis or cytotoxicity.   
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Acalypha wilkesiana: EtOH and HEX extracts at 1X and 2X GI50 significantly 
inhibited > 50% MDA-MB-468 colonies, however, HEX extract required 
concentrations of > 5-fold higher than that of EtOH used to achieve similar 
colony formation inhibitory effects.  Significant colony formation inhibitory 
effect following exposure of cells to EtOH extracts is consistent with 
irreversible cytotoxicity.  EtOH extract concentration inhibited MDA-MB-468 
colony formation by 50% (IC50 DWȝJPO WKHUHIRUHFRPSDUDEOH WR WKH
GI50 YDOXHȝJPOREWDLQHGLQWKH077DVVD\ 
 
Archidendron ellipticum: Remarkably, EtOH extracts induced good inhibitory 
effects in MDA-MB-468 cells at 20-fold and 100-fold less concentration than 
EtOAc and HEX extracts, respectively.  The presence of EtOAc extract 
resulted in fewest colonies formed (5.8 %) suggesting EtOAc possesses 
irreversible growth inhibitory (cytotoxic) effects (seen in MTT assay).  
Although, HEX extracts of A. ellipticum bark and leaf demonstrated modest 
anti-proliferative activity in MDA-MB-468 cells, the concentrations used were 
very high.  At higher concentrations (1X and 2X GI50), cells treated with bark 
and leaf polar extracts failed to recover suggesting irreversible cytotoxic 
effects; the cells may have died or failed to proliferate and remained as a single 
cell.  The IC50 ȝJPOYDOXHV IRU(W2+ EtOAc and HEX bark extracts were 
13.31, 18.93 and 69.78, respectively; EtOH, EtOAc and HEX leaf extracts IC50 
values were 2.71, 61.22 and > 200, respectively.  These values varied slightly 
from those obtained from the MTT assay.  The difference in IC50 values 
suggests that HEX bark extract of A. ellipticum may not affect cell viability 
HYHQ DW KLJK FRQFHQWUDWLRQV \HW FHOOV¶ DELOLW\ to proliferate and recover after 
treatment was affected, which could lead to senescence. 
 
Duabanga grandiflora: Inhibitory effects of D. grandiflora bark extracts in 
order of highest activity (lowest IC50) on HCT116 colony formation was Water 
>EtOH >EtOAc >HEX.  EtOH leaf extract showed the highest anti-
SUROLIHUDWLYHDFWLYLW\HYHQDWD ORZFRQFHQWUDWLRQȝJPO, 0.5X GI50) and 
colony forming ability was almost completely inhibited by EtOH extracts at 1X 
and 2X GI50.  The presence of significantly fewer colonies with surviving cells 
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and maintained proliferative capacity after initial insult with polar extracts may 
suggest extracts to contain compounds, which exerts irreversible cytotoxic 
effects.  Intriguingly, at 1X and 2X GI50 treatment of bark and leaf polar 
extracts, HCT116 cells failed to recover suggesting irreversible cytotoxic 
effects; cells may have died or remained as a single cell.  The IC50 values for 
Water, EtOH, EtOAc, and HEX bark extracts were 15.02, 25.49, 16.47 and 
 ȝJPO UHVSHFWLYHO\ WKHVH YDOXHV DUH FRPSDUDEOH WR 077 GI50 values: 
42.44, 37.54, 21.69 and 28.77 ȝJPOUHVSHFWLYHO\ The IC50 values for Water, 
EtOH, EtOAc and HEX leaf extracts were 40.69, 16.95, 16.48 and > 200 ȝJPO 
were also comparable to leaf GI50: 38.02, 40.92, 24.73 and > 200 ȝJPO 
 
Pseuduvaria macrophylla: Both in vitro assays revealed the same order of 
potency of P. macrophylla extracts against HCT116 cells (EtOAc > EtOH > 
HEX) based on GI50 DQGȝJPODQG ,&50 values (0.33, 2.24 
DQG  ȝJPO UHVSHFWLYHO\  /HVV WKDQ  RI FHOOV ZHUH DEOH WR IRUP
colonies after exposure to EtOH and EtOAc extracts at 1X and 2X GI50 and 
modest anti-proliferative activity was observed in HEX extract.  Results 
illustrated EtOH and EtOAc extracts induced significant inhibitory effects and 
the growth inhibitory effects of extracts observed in MTT assay were 
irreversible.  Comparable EtOH and EtOAc extracts-treated HCT116 cell 
proliferation profiles suggest that similar phytochemicals may be embedded in 
these extracts.  The anticancer activity of 1,2,3-trimethoxy-4,5-dioxo-6a,7-
dehydroaporphine (38) has been previously reported to be active against NCI-
H187 (GI50: 5.6 ȝJPO).  Interestingly, a similar dioxoaporphine with N-methyl 
substitution have shown increased activity against NCI-H187 cells (GI50: 0.8 
ȝJPO).214  Aristolochic acids and aristolactam share distinct similarity to the 
chemical skeleton of aporphinoids are known immunuostimulants and 
anticancer agents.214 
   
In summary, greatest anti-proliferative effects observed with low extract 
concentration used resides with D. grandiflora bark and leaf EtOH and Water, 
A. ellipticum bark EtOAc and P. macrophylla whole EtOH and EtOAc extracts.  
Extracts active in both MTT and cloQRJHQLFDVVD\V VXJJHVW FHOOV¶YLDELOLW\ LV
affected and therefore their ability to proliferate and recover after exposure.  
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Results illustrating modest activity in the MTT assay a  ȝJPO WR LQKLELW
50% of cell growth) yet high activity (almost complete colony formation 
inhibition) in the clonogenic assay could be GXH WR WKH H[WUDFWV¶ DELOLW\ WR
induce irreversible anti-SUROLIHUDWLYHSURSHUWLHVZLWKRXWDIIHFWLQJFHOOV¶YLDELOLWy 
e.g. A. wilkesiana EtOH, A. ellipticum bark EtOAc, D. grandiflora polar bark 
and leaf (Water and EtOH) extracts.  Therefore, single viable cells with 
inhibited proliferative abilities could be present but fail to be detected, which 
may be the effects of more polar D. grandiflora bark EtOH and Water extracts.  
Therefore, cytotoxic and cytostatic effects of the extracts could be 
distinguished by comparing results from MTT and clonogenic assays; 
furthermore, if MTT results reveal a lower cell density than the seeding density 
it could imply a cytotoxic effect.      
Overall, the IC50 values and GI50 values vary but are not too dissimilar and this 
may be due to low seeding densities, however the values still reveal anti-
proliferative effects of UNMC extracts and a trend of decreased colony 
formation ability with increasing extract concentration.   
 
Flow cytometric techniques were adopted to further investigate the 
observations of UNMC extracts on sensitive cell lines to determine whether 
embedded compounds halt cell cycle or exert cytotoxicity.   
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3  
The influence of UNMC crude extracts on cell cycle and 
apoptosis induction 
Flow cytometry is a widely used technique where single cell particles in sheath 
fluid are delivered rapidly to a focused light source (laser beam).  The 
fluorescence or photons scattered by particles (e.g. cells sorted by their DNA 
content) are deflected at different angles, then pass through a series of optical 
filters, are captured by photomultiplier detectors, converted to digital signals, 
(that are proportional to the strength of emitted or deflected light) and sent to 
the computer.91   
Agents that are effective modulators of cell cycle (checkpoints) can drive cells 
into apoptosis and potentially have a role on carcinogenesis.246  It is now 
evident that anticancer agents can exert their activity by interfering with cell 
cycle mechanisms; camptothecin, etoposide and doxorubicin are S-phase 
blockers and inhibit cyclin-dependent kinases (CDKs).247  One common 
application of flow cytometry is the measurement of DNA content to 
understand cell cycle distributions.  Fluorescent stains such as propidium 
iodide (PI) bind stoichiometrically to nucleic acids and emit enhanced signals 
that can be detected by the instrument.248  The detection of DNA-bound PI 
hence DNA content (hypodiploid, diploid, hyperdiploid and tetraploid 
compared to control cells) can reveal the cell cycle phase of the cell population 
i.e. sub-G1, G1/0, S and G2/M, respectively.  Any disruptions in the DNA 
histograms (representative of the cell cycle) can be indicative of investigative 
agents having an (cytotoxic or growth arresting) effect on the cell cycle.249   
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3.1 UNMC plant extracts effects¶ on cell cycle distribution 
The effect of UNMC plant extracts on cell cycle distribution was measured 
after 48 h exposure, using an Epics XL-MCL flow cytometer.  Cells and 
treatment concentrations chosen to examine effects of UNMC extracts on cell 
cycle distribution were guided by results from the selection assays, and were 
1X, 2X and 4X GI50 concentrations.  The samples were kept overnight in a 
solution containing buffer, detergent and ribonuclease A, prior to analysis.  The 
results were established from three or PRUHLQGLYLGXDO H[SHULPHQWV 15,000 
cells per sample, n = 2 per experiment).  Data are represented as histograms 
and processed using EXPO32 software.  Further analyses of cell cycle data 
were conducted using cell cycle analysis software, Cylchred.  'XQQHWW¶V
multiple comparison (One-way ANOVA) analysis was used to compare each 
extract-treated group to the control group.  Any statistically significant values 
are denoted: * = 0.01< p < 0.05.  Regretfully, the investigation of A. wilkesiana 
EtOAc extract could not be examined due to a lack of supply. 
 
3.1.1 Acalypha wilkesiana extracts¶ effects on MDA-MB-468 
cell cycle distribution 
MDA-MB-468 cell populations detected in sub-G1 phase increased with A. 
wilkesiana extracts concentrations, which is indicative of apoptotic cell death 
(Table 3-1).  Following 48 h exposure to EtOH and HEX extracts at 4X GI50, 
the cell population in sub-G1 population (2.7% and 2.3%, respectively) was at 
similar levels as control cells (2.4%) accompanied by a slight decrease in the 
G2/M population.   
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Table 3-1: Cell cycle distribution of MDA-MB-468 cells after exposure to A. 
wilkesiana extracts. 
A. wilkesiana 
extract 
concentration 
GI50 value >ȝJPO@ 
Cell cycle phase 
Sub-G1 G1/0 S G2/M 
DMSO 
control 
[0] 2.4 ± 0.3 45.1 ± 5.3 15.1 ± 1.6 36.9 ± 3.4 
EtOH 
1X [36] 1.6 ± 0.0 49.6 ± 1.0 15.8 ± 1.0 32.7 ± 1.3 
2X [72] 3.8 ± 1.2 48.2 ± 8.8 17.7 ± 7.05 30.3 ± 0.6 
4X [144] 2.7 ± 12.3 47.1 ± 5.5 15.4 ± 1.2 34.4 ± 5.8 
HEX 
1X [200] 
2X [400] 
4X [800] 
3.0 ± 1.0 45.4 ± 17.8 17.8 ± 1.50 33.2 ± 2.7 
4.9 ± 0.0 43.0 ± 0.0 18.4 ± 0.0 34.0 ± 0.0 
2.3 ± 1.3 42.1 ± 0.1 16.8 ± 0.8 39.4 ± 2.6 
Mean MDA-MB-468 cell population (%) in each cell cycle phase (± SEM) 
obtained from DNA content histograms analysis generated by flow cytometry. 
Control (DMSO treated) samples were compared with extract-treated groups 
using 'XQQHWW¶V PXOWLSOH FRPSDULVRQ 2QH-way ANOVA) analysis. Any 
statistically significant values (p < 0.05) are highlighted bold.  
 
Figure 3-1 illustrates that at lower concentrations (1X and 2X GI50: 36 and 72 
ȝJPO, respectively) of EtOH extracts, the % of cell population in sub-G1, 
G1/0, S and G2/M were comparable to the control cells.  The % of MDA-MB-
468 cell population in each of the cell cycle phases of control cells were 
comparable to HEX extract-treated cells at very high concentrations (200, 400 
DQGȝJPO, as shown in Figure 3-2.  There seem to no overall significant 
effects induced by extracts on MDA-MB-468 cells cycle.   
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Figure 3-1: MDA-MB-468 cell cycle distributions after 48-hour exposure 
to A. wilkesiana extracts. Bars (error bar = SEM) denote the mean cell 
population (%) in each cell cycle phase after exposure to EtOH (A) and HEX 
(B) extracts IURP   Q    Lndividual experiments. 'XQQHWW¶V PXOWLSOH
comparison (One-way ANOVA) analysis was used to compare each extract-
treated group to the control group.  Any statistically significant values are 
denoted: * = statistically significant (p < 0.05).  
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Figure 3-2: Detection of PI staining of MDA-MB-468 cellular DNA content 
after exposure to A. wilkesiana extracts at 4X GI50 concentration for 48 
hour.  Data is represented as histogram of cellular DNA content revealing % 
events in each cell cycle phase; images from a single representative experiment 
are shown.  The samples were kept chilled overnight in a solution containing 
buffer, detergent and ribonuclease A prior to analysis. The results were 
HVWDEOLVKHGIURPWKUHH 15,000 cells per sample and processed using EXPO32 
software.  Image is representative of cell cycle distribution of one sample 
following treatment with UNMC extract as described above. 
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3.1.2 Archidendron ellipticum extracts¶ effects on MDA-MB-
468 cell cycle distribution 
MDA-MB-468 cell cycle distribution after exposure to A. ellipticum extracts 
varied between extracts and concentrations used, shown in Table 3-2.  Flow 
cytometric analysis of cells exposed to EtOH bark extract revealed increased 
*0FHOOSRSXODWLRQ2-fold), which coincided with significant decrease in 
G1/0 cell populations (p < 0.05), while no comparable changes were noticed in 
sub-G1 and S phases (p > 0.05).  Exposure of MDA-MB-468 cells to high 
concentrations of EtOAc bark extract ( DQG  ȝJPO) caused increased 
sub-G1 events by 3.8% and 8.6%, respectively, accompanied by decreased 
G1/0 cell populations compared to control cells (Figure 3-3).  There is 
insufficient evidence to suggest changes in G1/0, S and G2/M cell cycle phases 
were influenced by EtOAc bark extract (p > 0.05).  Concentrations of HEX 
bark and leaf extracts used were very high and appeared unable to cause 
perturbation to the distribution of the cell cycle.   
Interestingly, EtOH bark and leaf extracts displayed similar trends where 
increased levels of sub-G1 and S phase cell populations were accompanied by 
a significant decrease in G1/0 and G2/M phase cell populations (p < 0.05).  
The slight changes in cell cycle distribution of EtOAc leaf extract were 
statistically insignificant when compared to the control cells.  Again, at very 
KLJKFRQFHQWUDWLRQVRI+(;OHDIH[WUDFWVWRȝJPOQRVLJQLILFDQWFHOO
cycle distribution perturbation was observed with HEX leaf treated cells 
(Figure 3-4).  Overall, comparable cell cycle distributions were observed 
following exposure to A. ellipticum extracts; therefore it is probable that 
similar extracts are present in the respective extracts. 
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Table 3-2: Cell cycle distribution of MDA-MB-468 cells after exposure to A. 
ellipticum extracts 
A. ellipticum extract 
concentration 
GI50 YDOXH>ȝJPO@ 
Cell cycle phase 
Sub-G1 G1/0 S G2/M 
Ba
rk
 
DMSO 
control 
[0] 2.2 ± 0.3 50.0 ± 1.7 32.1 ± 1.0 15.7 ± 1.4 
 
1X [2] 2.6 ± 0.4 35.6 ± 2.3 35.0 ± 2.4 26.8 ± 0.8 
EtOH 2X [4] 2.6 ± 0.5 33.1 ± 2.1 36.9 ± 3.1 27.4 ± 1.2 
 
4X [8] 3.5 ± 1.1 33.0 ± 3.0 36.1 ± 2.7 27.4 ± 2.4 
 
1X [40] 3.9 ± 0.8 47.5 ± 2.2 32.3 ± 1.2 16.3 ± 0.5 
EtOAc 2X [80] 6.0 ± 1.1 44.2 ± 2.6 32.5 ± 2.7 17.3 ± 1.0 
 
4X [160] 10.8 ± 1.2 43.3 ± 3.1 25.8 ± 3.3 20.1 ± 3.7 
 
1X [200] 3.1 ± 1.1 46.4 ± 4.2 31.7 ± 2.4 18.8 ± 1.7 
HEX 2X [400] 2.5 ± 0.4 48.7 ± 3.5 31.4 ± 2.4 17.6 ± 1.7 
 4X [800] 2.8 ± 1.2 44.1 ± 3.9 37.2 ± 3.0 15.9 ± 1.2 
Le
a
f 
DMSO 
control 
[0] 2.2 ± 0.3 50.0 ± 1.7 32.1 ± 1.0 15.7 ± 1.4 
 
1X [9] 3.2 ± 1.7 32.6 ± 2.7 34.9 ± 2.7 22.4 ± 3.6 
EtOH 2X [18] 3.7 ± 1.8 33.3 ± 1.4 35.9 ± 2.7 21.0 ± 3.4 
 
4X [36] 5.3 ± 1.7 29.4 ± 1.5 41.2 ± 0.8 24.1 ± 0.9 
 
1X [9] 4.0 ± 1.3 45.9 ± 4.5 33.9 ± 2.6 16.1 ± 1.1 
EtOAc 2X [18] 3.2 ± 0.4 50.6 ± 2.1 32.0 ± 1.7 14.3 ± 1.1 
 
4X [36] 3.0 ± 0.4 51.9 ± 2.0 31.0 ± 1.7 14.2 ± 0.4 
 
1X [193] 3.5 ± 1.2 51.6 ± 2.2 29.8 ± 2.4 15.0 ± 1.3 
HEX 2X [386] 3.8 ±0.9 50.6 ± 2.6 30.6 ± 3.2 15.0 ± 0.6 
 4X [772] 4.7 ± 1.4 52.8 ± 2.4 27.5 ± 2.5 15.0 ± 1.0 
Mean MDA-MB-468 cell population (%) in each cell cycle phase (± SEM) 
obtained from DNA content histograms analysis generated by flow cytometry.  
Control (DMSO treated) samples were compared with extract-treated groups 
using 'XQQHWW¶V PXOWLSOH FRPSDULVRQ 2QH-way ANOVA) analysis. Any 
statistically significant values (p < 0.05) are highlighted bold. 
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Figure 3-3: MDA-MB-468 cell cycle distributions after 48-hour exposure 
to A. ellipticum extracts. Bars (error bar = SEM) denote the mean cell 
population (%) in each cell cycle phase after exposure to EtOH, EtOAc and 
HEX extraFWV IURP   Q    LQGLYLGXDO H[SHULPHQWV 'XQQHWW¶V PXOWLSOH
comparison (One-way ANOVA) analysis was used to compare each extract-
treated group to the control group.  Any statistically significant values are 
denoted: * = statistically significant (p < 0.05). 
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Figure 3-4: Detection of PI staining of MDA-MB-468 cellular DNA content 
after exposure to A. ellipticum extracts at 4X GI50 concentration for 48 
hour. Data is represented as histogram of cellular DNA content revealing % 
events in each cell cycle phase; images from a single representative experiment 
are shown. The samples were kept chilled overnight in a solution containing 
buffer, detergent and ribonuclease A prior to analysis. Results were established 
IURP WKUHH 15,000 cells per sample and processed using EXPO32 software.  
Image is representative of cell cycle distribution of one sample following 
treatment with UNMC extract as described above. 
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3.1.3 Duabanga grandiflora extracts¶ effects on HCT116 cell 
cycle distribution  
HCT116 cell cycle distribution after exposure to D. grandiflora extracts varied 
between extracts and concentrations used shown in Table 3-3.  The % of cells 
measured in sub-G1 phase following exposure to bark extracts (Water, EtOH, 
EtOAc and HEX) was significantly higher than the control populations and 
accompanied by decreased cell populations in S-phase.  HCT116 cells treated 
with HEX bark extracts displayed cell cycle distribution that is statistically 
different to the control population, with at least 20%, of cells in sub-G1 (p < 
0.05) and S-phase populations accompanied by decreasing cell populations in 
G1/0 and G2/M phases (Figure 3-5).  EtOAc bark extract induced similar cell 
cycle response to HEX extracts in HCT116 cells.  
 
Overall, HCT116 cells exposed to D. grandiflora bark extracts displayed 
general trends, which includes emerging events in sub-G1 phase, accumulation 
of G1/0 events accompanied by decreased S and G2/M phase events.  Whereas, 
high HEX leaf extract concentrations   DQG  ȝJPO caused a 
decrease in G2/M cell populations (12.6, 12.6 and 8.8 %).  Cell cycle 
perturbation effects of D. grandiflora bark extracts were distinctly more 
prominent than leaf extracts in HCT116 cells.  There was insufficient evidence 
to suggest that cells treated with Water, EtOH and EtOAc leaf extracts induced 
any significant perturbations in cell cycle compared with the control population.  
Overall, D. grandiflora leaf extracts appeared to positively influence sub-G1 
and G1/0 populations accompanied by decreasing HCT116 cells in S and 
G2/M phases.   
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Table 3-3: Cell cycle distribution of HCT116 cells after exposure to D. 
grandiflora extracts. 
D. grandiflora extract 
concentration 
GI50 YDOXH>ȝJPO@ 
Cell cycle phase 
Sub-G1 G1/0 S G2/M 
B
ar
k 
DMSO 
control [0] 0.9 ± 0.1 37.9 ± 3.4 41.8 ± 2.31 19.3 ± 1.9 
 1X [42] 1.9 ± 0.4 51.4 ± 2.3 31.5 ± 2.1 15.2 ± 1.8 
Water 2X [82] 2.3 ± 0.5 47.8 ± 3.5 33.0 ± 1.8 16.9 ± 1.5 
 4X [168] 2.9 ± 1.0 43.1 ± 6.3 36.4 ± 4.4 17.6 ± 2.0 
 1X [38] 2.1 ± 0.4 47.2 ± 3.2 34.9 ± 1.8 15.8 ± 1.9 
EtOH 2X [76] 3.9 ± 1.3 40.7 ± 5.0 36.9 ± 1.9 18.5 ± 2.7 
 4X [152] 3.1 ± 0.8 39.5 ± 6.7 41.6 ± 6.1 15.8 ± 0.9 
 1X [22] 2.9 ± 0.7 46.1 ± 4.2 34.1 ± 3.0 16.9 ± 1.9 
EtOAc 2X [44] 4.8 ± 1.2 49.9 ± 4.5 31.9 ± 5.0 13.4 ± 1.1 
 4X [88] 5.4 ± 1.9 60.7 ± 2.3 22.3 ± 2.9 11.1 ± 2.1 
 1X [29] 4.1 ± 0.9 57.7 ± 3.5 27.3 ± 3.4 10.9 ± 1.0 
HEX 2X [58] 9.0 ± 1.6 57.8 ± 4.3 23.4 ± 4.1 9.7 ± 0.6 
 4X [116] 8.5 ± 1.9 60.1 ± 3.4 23.1 ± 3.0 8.2 ± 0.9 
Le
a
f 
DMSO 
control [0] 1.1 ± 0.3 43.7 ± 2.3 35.6 ± 2.6 19.6 ± 1.6 
 1X [38] 1.3 ± 0.2 50.7 ± 1.5 33.1 ± 2.5 15.0 ± 2.1 
Water 2X [76] 1.6 ± 0.4 49.1 ± 1.9 33.1 ± 2.5 16.0 ± 2.1 
 4X [152] 1.7 ± 0.3 47.6 ± 3.8 33.5 ± 2.6 17.2 ± 2.6 
 1X [41] 2.7 ± 0.9 48.0 ± 1.9 31.0 ± 1.0 18.4 ± 1.8 
EtOH 2X [82] 3.6 ± 1.2 36.0 ± 4.5 42.6 ± 5.8 17.8 ± 2.3 
 4X [164] 4.7 ± 1.3 33.5 ± 4.5 41.8 ± 4.7 20.0 ± 2.1 
 1X [25] 1.3 ± 0.2 50.2 ± 2.1 33.5 ± 2.0 15.1 ± 1.5 
EtOAc 2X [50] 2.6 ± 0.6 56.0 ± 3.2 27.6 ± 1.9 13.9 ± 1.3 
 4X [100] 3.5 ± 0.3 48.4 ± 3.9 30.7 ± 4.1 17.5 ± 1.4 
 1X [200] 1.5 ± 0.5 51.7 ± 2.9 34.3 ± 2.0 12.6 ± 1.3 
HEX 2X [400] 1.2 ± 0.3 58.0 ± 4.2 28.1 ± 3.5 12.6 ± 3.0 
 4X [800] 1.8 ± 0.4 64.7 ± 4.9 24.7 ± 3.5 8.8 ± 1.7 
Mean HCT116 cell population (%) in each cell cycle phase (± SEM) obtained 
from DNA content histograms analysis generated by flow cytometry. Control 
(DMSO treated) samples were compared with extract-treated groups using 
'XQQHWW¶VPXOWLSOHFRPSDULVRQ2QH-way ANOVA) analysis. Any statistically 
significant values (p < 0.05) are highlighted bold. 
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Figure 3-5: HCT116 cell cycle distributions after 48-hour exposure to D. 
grandiflora extracts. Bars (error bar = SEM) denote the mean cell population 
(%) in each cell cycle phase after exposure to Water, EtOH, EtOAc and HEX  
H[WUDFWV IURP   (n = 2) individual experiments. 'XQQHWW¶V PXOWLSOH
comparison (One-way ANOVA) analysis was used to compare each extract-
treated group to the control group. Any statistically significant values are 
denoted: * = statistically significant (p < 0.05). 
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Figure 3-6: Detection of PI staining of HCT116 cellular DNA content after 
exposure to D. grandiflora extracts at 4X GI50 concentration for 48 hour.  
Data is represented as histogram of cellular DNA content revealing % events in 
each cell cycle phase; images from a single representative experiment are 
shown.  The samples were kept chilled overnight in a solution containing 
buffer, detergent and ribonuclease A prior to analysis.  The results were 
HVWDEOLVKHGIURPWKUHH 15,000 cells per sample and processed using EXPO32 
software.  Image is representative of cell cycle distribution of one sample 
following treatment with UNMC extract as described above. 
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3.1.4 Pseuduvaria macrophylla extracts¶ effects on HCT116 cell 
cycle distribution 
The change in HCT116 cell distribution after exposure to P. macrophylla 
extracts is illustrated in Table 3-4.  Flow cytometric analysis of HCT116 cells 
treated with P. macrophylla extracts revealed a significant rise in sub-G1 
populations of ~ 1% - 8 % compared to control population (0.9 %), shown in 
Figure 3-7.  In general, cells exposed to low concentrations of EtOH, EtOAc 
and HEX extracts displayed increased G2/M cell populations accompanied by 
a decreasing G1/0 cell population.  Moreover, the level of sub-G1 events is 
significantly higher than the control when exposed to higher extract 
concentrations (p < 0.05).  Overall, similar cell cycle distribution patterns were 
observed across P. macrophylla extract-treated HCT116 cells (Figure 3-8).   
 
Table 3-4: Cell cycle distribution of HCT116 cells after exposure to P. 
macrophylla extracts 
P.  macrophylla 
extract concentration 
GI50 YDOXH>ȝJPO@ 
HCT116 cell cycle phase 
Sub-G1 G1/0 S G2/M 
DMSO 
control [0] 0.9 ± 0.1 37.6 ± 1.7 39.5 ± 0.7 22.1 ± 0.9 
EtOH 
1X [5] 2.2 ± 0.3 44.9 ± 3.7 35.0 ± 1.35 17.9 ± 2.1 
2X [10] 9.0 ± 0.0 29.2 ± 0.9 33.0 ± 0.6 28.8 ± 0.4 
4X [20] 8.4 ± 0.2 25.7 ± 0.9 42.2 ± 1.3 23.7 ± 0.1 
DMSO 
control [0] 2.1 ± 0.6 41.1 ± 2.5 38.4 ± 1.4 18.4 ± 2.2 
EtOAc 
1X [2] 3.4 ± 0.9 25.3 ± 4.0 44.7 ± 3.5 26.6 ± 2.7 
2X [4] 5.5 ± 1.0 22.4 ± 2.1 37.7 ± 3.8 34.4 ± 5.2 
4X [8] 7.4 ± 0.9 25.8 ± 3.0 41.1 ± 2.6 25.7 ± 3.0 
DMSO 
control [0] 2.1 ± 0.6 41.1 ± 2.5 38.4 ± 1.2 18.4 ± 2.2 
HEX 
1X [5] 3.2 ± 0.5 35.7 ± 3.0 36.2 ± 1.6 24.9 ± 2.3 
2X [10] 4.7 ± 0.9 34.9 ± 2.0 39.8 ± 2.1 20.6 ± 2.1 
4X [20] 6.2 ± 1.0 33.4 ± 2.9 38.1 ± 3.3 22.6 ± 2.5 
Mean HCT116 cell population (%) in each cell cycle phase (± SEM) obtained 
from DNA content histograms analysis generated by flow cytometry.  Control 
(DMSO treated) samples were compared with extract-treated groups using 
'XQQHWW¶VPXOWLSOHFRPSDULVRQ2QH-way ANOVA) analysis. Any statistically 
significant values (p < 0.05) are highlighted bold.  
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Figure 3-7: HCT116 cell cycle distributions after 48-hour exposure to P. 
macrophylla extracts. Bars (error bar = SEM) denote the mean cell population 
(%) in each cell cycle phase after exposure to EtOH, EtOAc and HEX extracts 
IURPQ LQGLYLGXDOH[SHULPHQWV'XQQHWW¶VPXOWLSOHFRPparison (One-
way ANOVA) analysis was used to compare each extract-treated group to the 
control group.  Any statistically significant values are denoted: * = statistically 
significant (p < 0.05). 
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Figure 3-8: Detection of PI staining of HCT116 cellular DNA content after 
exposure to P. macrophylla extracts at 4X GI50 concentration for 48 hour.  
Data is represented as histogram of cellular DNA content representation of cell 
population % in each cell cycle phase; images from a single representative 
experiment are shown.  The samples were kept chilled overnight in a solution 
containing buffer, detergent and ribonuclease A prior to analysis.  Results were 
established from three experiments  15,000 cells per sample (n = 2) and 
processed using EXPO32 software.  Image is representative of cell cycle 
distribution of one sample following treatment with UNMC extract as 
described above. 
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3.1.5 Summary of cell cycle analysis after exposure to UNMC 
extracts 
The measurement of DNA content (hypodiploid, diploid and hyperdiploid) 
after exposure of cells to UNMC extracts revealed disturbances in specific cell 
cycle phases i.e. sub-G1, G1/0, S and G2/M.  
 
Acalypha wilkesiana: Inhibition of HCT116 cell growth and clonogenicity was 
observed following exposure to EtOH extract, this could be associated to an 
increase in sub-G1 (apoptotic) cell population at higher treatment 
concentrations, hence inability to proliferate and form colonies.  Overall, 2X 
and 4X GI50 EtOH and HEX treatment were more active in increasing cell 
numbers in sub-G1 and G1/0 phases and less active in causing G2/M arrest.  
This could be that compounds in EtOH extract are DNA damaging agents 
hence cell cycle halted at G1 phase to allow repair of DNA damaged cells 
before proceeding in the rest of the cell cycle.  Since no significant differences 
were observed between DNA histograms of extract-treated cells and DMSO 
control cells, which can suggest DNA repair mechanisms are in place or that 
extracts might be eliciting a cytostatic effect.  Neutral and alkaline comet 
assays have previously shown that U87MG and A549 cells following 72 h 
exposure to EtOAc and HEX extracts contain single and double DNA strand 
breaks resulting in apoptosis at concentratioQVDVORZDVȝJPOLQDGRVH-
dependent manner.234  Bussing et al. (1999) have shown induction of apoptosis 
in Ficoll-isolated lymphocytes following treatment with A. wilkesiana seeds 
extract (1 - ȝJPO) as a possible consequent of granulocytes recruitment 
leading to excess ROI production hence cell death.175   
 
Archidendron ellipticum: MDA-MB-468 cells treated with EtOH extracts 
revealed greatest levels of G2/M cell population accompanied by a decreased 
G1/0 cell population, which suggests that cells in G1/0 phase could not proceed 
past mitosis, i.e. G2 block.  Compounds which enhance the G2 block and 
pushing the cell to override G2/M block (e.g. disruption in mitosis) can 
enhance cytotoxicity of DNA damaging agents hence leading to the observed 
apoptotic sub-G1 cell population (treated cells in sub-G1 phase (%) is 4 - 8 % 
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greater than control).  Interestingly, EtOH leaf and bark extracts displayed 
similar cell cycle effects, and is suggestive of similar phytochemicals are 
present in the extracts to arrest cells in the G2/M phase.  There was not enough 
evidence to suggest EtOAc and HEX leaf extracts are affecting the cell cycle 
distribution. 
 
Duabanga grandiflora: Growth inhibitory effects of bark extracts complement 
effects seen in cell cycle profiles where a similar trend of potency was 
observed EtOAc > HEX > EtOH > Water.  Cell cycle analysis revealed 
increased sub-G1 populations in all D. grandiflora extracts treated cells, 
however no significant differences was detected between cell cycle 
perturbation measured in D. grandiflora leaf extracts and control population.  
Increased sub-G1 and G1/0 populations in the presence of bark extracts is 
accompanied by decrease S and G2/M phases, which is indicative of cell death 
hence cells not proceeding pass G1/0 phase i.e. G1/0 block.  Together with 
clonogenicity results revealing HCT116 cells were able to overcome the G1/0 
block when extracts were removed from the cells; this may suggest DNA 
damage in cells are reversible and upon DNA repair, cells could proceed in the 
cell cycle. 
 
Pseuduvaria macrophylla: An emergence of HCT116 cells in the sub-G1 and 
G1/0 phase was observed in association with decreased S and G2/M cell 
populations after exposure to P. macrophylla extracts.  Results imply cell death 
was induced by the extracts, and as sub-G1 cells increased, fewer cells were 
able to enter and progress past G1/0 phase.  Generally extract-treated cells 
displayed increased G2/M cell populations accompanied by decreasing G1/0 
cell populations, which is evidence of a G2/M block preceding cell death; as 
well as significantly higher levels of sub-G1 events (> 5-fold) when compared 
to than the control.  The high potency and lack of clonogenicity suggests 
compounds may induce permanent cellular damage. 
 
In summary, UNMC extracts contributed to increasing sub-G1 (hypodiploid) 
cell population, however further analysis was required to confirm if the sub-G1 
populations were apoptotic cells induced by UNMC plant extracts since it is 
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unclear whether DNA fragmentation was a result of apoptotic enzyme cleavage 
or DNA damaging agents.  Apoptosis serves several purposes throughout 
development in life e.g. when in response to pathological and physiological 
stimuli, cells respond by triggering signaling cascades ultimately resulting in 
caspase activation.250  Characteristics of apoptosis include morphological 
changes (cell shrinkage) and biochemical features such as the degradation of 
DNA into oligomers (180 bp) by endonuclease; this could be measured and 
determined as hypodiploid (sub-G1) cells.91  
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3.2 Detection of apoptotic cells after exposure to UNMC plant 
extracts 
Dysfunction of the apoptosis mechanism is often associated with cancers.120  
One of the hallmarks of early apoptosis involves the translocation of 
phosphatidylserine (PS) from the inner to the intact outer plasma membrane.  
The membrane integrity of an apoptotic cell diminishes when progressing into 
late apoptosis/necrosis.  A calcium ion (Ca2+) dependent phospholipid-binding 
protein, annexin V, possesses high PS binding affinity.251  Dual staining with 
annexin V (conjugated to FITC, a green fluorescent dye) and PI was employed 
to detect and distinguish early apoptotic (FITC+/PI-) and late apoptotic/necrotic 
(FITC+/PI+) cell populations using flow cytometric techniques.  Hence, 
detection of PS is one method of confirming apoptosis in cells treated with 
UNMC plant extracts.94 The cell lines and treatment concentrations chosen to 
examine the ability of UNMC extracts to induce apoptosis were guided by 
results from the selection assays, 1X, 2X and 4X GI50 concentrations. 
'XQQHWW¶V PXOWLSOH FRPSDULVRQ 2QH-way ANOVA) analysis was used to 
compare each extract-treated group to the control group.  Any statistically 
significant values are denoted: * = 0.01< p < 0.05.  Regrettably, due to the 
unavailability of A. wilkesiana extracts it could not be determined whether the 
significant increase in sub-G1 cell population caused by EtOH extracts was a 
consequence of cells undergoing apoptosis.  
 
3.2.1 Time-dependent apoptosis induction in MDA-MB-468 
cells after exposure to Archidendron ellipticum extracts 
The increase in healthy cells (FITC-/PI-) entering apoptosis and progressing to 
late apoptosis/necrosis during exposure to A. ellipticum extracts is shown in 
Figure 3-9.  At 24 h, the levels of apoptosis in EtOH, EtOAc and HEX bark 
extract-treated cells were greater than that seen in the control population by 
36.1%, 26.5% and 35.6%, respectively (p < 0.05).  Between 24 h to 48 h, 
EtOAc bark extract caused an overall 1.6% increase in early apoptotic MDA-
MB-468 cells progressing to late apoptosis/necrosis.  Conversely, a longer 
exposure period to EtOH and HEX bark extracts revealed that there were fewer 
     
102 
apoptotic cells measured than at 24 h (-2.4% and -5.0%, respectively; shown in 
Figure 3-10).  Likewise a longer exposure period to EtOH and HEX leaf 
extracts displayed fewer apoptotic cells than at 24 h (-16.1% and -3.3%, 
respectively; shown in Figure 3-10).  In addition, the decrease in healthy cell 
populations treated with EtOH, EtOAc and HEX leaf extracts was 
accompanied by increased apoptotic cell populations: 48.3%, 26.5% and 37.4%, 
respectively.  Between 24 h and 48 h, HEX leaf extract caused an overall 3.3% 
increase of early apoptotic MDA-MB-468 cells progressing to late 
apoptosis/necrosis.  
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Figure 3-9: Phosphatidylserine detection in MDA-MB-468 cells after exposure to A. ellipticum bark (top) and leaf (bottom) extracts at 4X 
GI50 concentration after 24 and 48 hour exposure.  Dot plots of annexin V-FITC (green dye) and PI (red dye) analysis from a single 
representative experiment is shown. Dual staining of FITC and PI were used to determine the number of cells (%) that are healthy (FITC-/PI-; 
lower left quadrant), undergoing early apoptosis, (FITC+/PI-; lower right quadrant) and late apoptosis/necrosis (FITC+/PI+ top right quadrant). 
     
104 
 
 
Figure 3-10 Apoptosis induced in HCT116 cells by A. ellipticum extracts 
after 24 and 48 hour exposure. Cells were exposed to 4X GI50 concentrations 
of bark and leaf extracts and stained with annexin V-FITC and PI. Bars denote 
the mean % cell population (± SEM) in early apoptosis (annexin V-FITC+ /PI-) 
(top). Bars denotes the mean % cell population (± SEM) in early apoptosis, late 
apoptosis/necrosis (annexin V-FITC+ /PI+) and healthy (annexin V-FITC- /PI-) 
(bottom).  4 LQGHSHQGHQW H[SHULPHQWV  15,000 cells/sample; n  3) were 
performed. 'XQQHWW¶V PXOWLSOH FRPSDULVRQ 2QH-way ANOVA) analysis was 
used to compare each extract-treated group to the control group.  Any 
statistically significant values are denoted: * = statistically significant (p  
0.05). 
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3.2.2 Time-dependent apoptosis induction in HCT116 cells 
after exposure to Duabanga grandiflora extracts 
There was a gradual progression of early apoptotic cells (lower right quadrant) 
to late apoptotic/necrotic cells (top right quadrant) as exposure period to D. 
grandiflora extracts increased (Figure 3-11).  Following 24 h exposure to bark 
extracts, approximately 33% to 49 % of HCT116 cells underwent early 
apoptosis (FITC+/PI-) as illustrated in Figure 3-12.  Early apoptotic HCT116 
cells were detected: 33.8%, 39.7%, 41.3%, and 48.5% of total population when 
exposed to Water, EtOH, EtOAc and HEX bark extracts, respectively; this is at 
least twice as many than that of early apoptotic control cell population (16.8%).  
Between 24 h and 48 h, in the presence of Water, EtOH and EtOAc and bark 
no considerable increase in levels of early apoptotic to late apoptotic/necrotic 
HCT116 cells (< 7%) was observed.  
 
A gradual progression of early apoptotic cells to late apoptotic/necrotic cells as 
the cellular exposure period to D. grandiflora leaf extracts was observed 
(Figure 3-11).  At 48 h, the percentage of early to late apoptotic cells increased 
significantly by 24.1%, and 38.1% in the presence of EtOH extract and Water 
leaf extracts, respectively, when compared to the control population (p < 0.05).  
The apoptotic/necrotic cells induced by Water leaf extracts at 48 h is 
significantly higher by 50.3% than the control population and comparable to 
the level of apoptotic cells following treatment with Water bark extract 
(49.9%).  Overall, the concentrations used and cytotoxic effects of EtOH and 
Water extracts were comparable with only minor differences in apoptotic 
populations of 5.76% (24 h) and 5.23% (48 h), respectively.  There was no 
considerable increase in the level of early apoptotic to late apoptotic/necrotic 
HCT116 cells treated with EtOAc leaf extract between 24 h and 48 h (6.7%); 
this is comparable to activity seen in EtOAc bark extract (Figure 3-12).  The 
percentage of early to late apoptotic cells increased significantly by 31.9% in 
the presence of HEX leaf extracts (p < 0.05).  HEX leaf extract at the highest 
FRQFHQWUDWLRQȝJPODSSHDUHGWREHOHVVDFWLYHWKDQ lower concentrations 
of HEX EDUNH[WUDFWȝJPO   
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Figure 3-11: Detection of apoptotic populations of HCT116 cells after exposure to D. grandiflora bark (top) and leaf (bottom) extracts at 
4X GI50 concentration after 24 and 48 hour exposure.  Dot plots of annexin V-FITC (green dye) and PI (red dye) analysis from a single 
representative experiment is shown. Dual staining of FITC and PI were used to determine the number of cells (%) that are healthy (FITC-/PI-; 
lower left quadrant), undergoing early apoptosis, (FITC+/PI-; lower right quadrant) and late apoptosis/necrosis (FITC+/PI+ top right quadrant). 
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Figure 3-12: Apoptosis induced in HCT116 cells by D. grandiflora extracts 
after 24 and 48 hour exposure. Cells were exposed to 4X GI50 concentrations 
of bark and leaf extracts and stained with annexin V-FITC and PI.  Bars denote 
the mean % cell population (± SEM) in early apoptosis (annexin V-FITC+ /PI-) 
(top). Bars denote the mean % cell population (± SEM) in early apoptosis, late 
apoptosis/necrosis (annexin V-FITC+ /PI+) and healthy (annexin V-FITC- /PI-) 
(bottom).   LQGHSHQGHQW H[SHULPHQWV   FHOOVVDPSOH Q   ZHUH
performed.  'XQQHWW¶VPXOWLSOHFRPSDULVRQ2QH-way ANOVA) analysis was 
used to compare each extract-treated group to the control group.  Any 
statistically significant values are denoted: * = statistically significant (p  
0.05). 
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3.2.3 Time-dependent apoptosis induction in HCT116 cells 
after exposure to Pseuduvaria macrophylla extract 
The numbers of healthy cells (FITC-/PI-) entering apoptosis and progressing to 
late apoptosis/necrosis as the exposure period to P. macrophylla extracts 
increases is illustrated in Figure 3-13. 
 
 
Figure 3-13: Phosphatidylserine detection in HCT116 cells after exposure 
to P. macrophylla extracts at 4X GI50 concentration after 24 and 48 hour 
exposure.  Dot plots of annexin V-FITC (green dye) and PI (red dye) analysis 
from a single representative experiment is shown. Dual staining of FITC and PI 
were used to determine the number of cells (%) that are healthy (FITC-/PI-; 
lower left quadrant), undergoing early apoptosis, (FITC+/PI-; lower right 
quadrant) and late apoptosis/necrosis (FITC+/PI+ top right quadrant). 
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Following 48 h exposure, cell populations undergoing late apoptosis were 
evident, < 20% viable cells (FITC-/ PI-) were detected in cells exposed to 
EtOH extracts and < 40% viable cells following exposure to EtOAc and HEX 
extracts (Figure 3-14).  During 24 h and 48 h, the decrease in healthy cell 
population was accompanied by an increase in apoptotic cell populations: 
33.6%, 13.5% and 15.4% for EtOH, EtOAc and HEX extracts, respectively.  
At both time points, all P. macrophylla extracts caused significantly increased 
levels of early apoptotic HCT116 populations (p < 0.05). 
 
 
Figure 3-14: Apoptosis induced in HCT116 cells by P. macrophylla 
extracts after 24 and 48 hour exposure. Cells were exposed to 4X GI50 
concentrations of extracts and stained with annexin V-FITC and PI. Bars 
denote the mean % cell population (± SEM) in early apoptosis (annexin V-
FITC+ /PI-) (top). Bars denotes the mean % cell population (± SEM) in early 
apoptosis, late apoptosis/necrosis (annexin V-FITC+ /PI+) and healthy (annexin 
V-FITC- /PI-) (bottom).  4 independent experiPHQWV000 cells/sample; n 
 ) were performed.  'XQQHWW¶V PXOWLSOH FRPSDULVRQ 2QH-way ANOVA) 
analysis was used to compare each extract-treated group to the control group.  
Any statistically significant values are denoted: * = statistically significant (p  
0.05). 
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3.3 Identification of caspase 3 and Mcl-1 protein expressions 
Detection of changes in protein expression in cells following their treatment 
with UNMC extracts could provide information on possible mechanism(s) of 
action.  As mentioned in section 1.3.2, cancer cells gain the ability to evade 
apoptosis therefore disrupting homeostasis.  Apoptosis is co-ordinated by 
initiator and executioner proteins involved in two main apoptotic pathways, 
known as the intrinsic (mitochondrial) and extrinsic (death receptor) pathways.  
Both pathways eventually converge on the same execution pathway, which is 
irreversibly initiated by executioner caspase 3.  Caspase 3 is activated by 
cleavage commonly by multiple death signals and this activation is essential 
for apoptosis-associated DNA fragmentation.260   
The overexpression of anti-apoptotic (pre-survival) proteins of the Bcl-2 family 
e.g. Bcl-2, Bcl-XL and Mcl-1 can inhibit apoptosis and enable deregulated 
oncogene expression.  Apoptosis failure is a major contributor to 
tumourigenesis; therefore induction of cancer cell apoptosis by 
inhibition/downregulation of survival proteins is an important goal of 
experimental cancer therapies.  
 
Western blot analysis was employed to detect presence of proteins within 
cellular extracts.  Proteins could be extracted from samples, denatured and 
separated according to molecular weight by gel electrophoresis.  Analysis of 
band densities as relative density to control was carried out using Image J 
software.  
 
3.3.1 Effect of Duabanga grandiflora and Pseuduvaria 
macrophylla extracts on protein expression  
The in vitro anticancer properties of P. macrophylla EtOH and EtOAc extracts 
and D. grandiflora EtOH and HEX extracts were examined.  Water and EtOAc 
extracts induced anti-proliferative effects, which would be worthy of 
investigation, however stocks remaining were insufficient for repeating 
independent experiments.  HCT116 cells were exposed to control treatments 
(DMSO and camptothecin) and available UNMC extracts.  Whole cell lysates 
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were prepared 48 h later and SDS-PAGE/Western blot analysis was performed 
to examine Mcl-1 and caspase 3 expressions (Figure 3-16 and Figure 3-15).   
 
Caspase 3 expression was examined in UNMC extracts treated HCT116 cell 
lysates after 48 h exposure.  Distinct full length and cleaved forms of caspase 3 
were expressed in P. macrophylla EtOAc and D. grandiflora EtOH and HEX 
extract-treated HCT116 cells (Figure 3-15).  Caspase 3 expression was not 
detected in DMSO treated cells, however expression of full-length caspase 3 
protein was detected in camptothecin-treated cells. 
 
 
Figure 3-15 Caspase 3 protein expressions after 48-hour exposure to D. 
grandiflora and P. macrophylla extracts.  HCT116 cells were treated with P. 
macrophylla EtOAc extract and D. grandiflora EtOH and HEX extracts for 48 
h.  Western blots of whole cell lysates representative of two independent 
experiments are presented.  DMSO (-) and camptothecin (+) were used as 
control. 
 
Noticeably, relative density of bands illustrating cleaved caspase 3 in cell  
lysates treated with 1X GI50 of D. grandiflora EtOH and HEX extracts 
increased as concentration increased to 5X GI50 and was accompanied by 
decreased relative density of full-length caspase 3 protein expression, therefore 
suggesting dose-dependent cleavage and expression of caspase 3.  A similar 
trend was observed with P. macrophylla EtOAc extracts, higher relative 
densities of cleaved caspase 3 bands were noticed accompanied by lower 
relative density of full-length caspase 3 band (relative band density of 1X GI50: 
1.08 and 5X GI50: 0.96).  Expression of Mcl-1 in negative control cells was 
illustrated as a band that is ~6-fold higher in relative density than positive 
control cells.  D. grandiflora EtOH and HEX (1X GI50) treated cell lysates 
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illustrated Mcl-1 expression similar to relative band density of negative control 
(1.0).  Whereas at HEX 5X GI50 treatment resulted in Mcl-1 expression that 
was less than half of the relative band density (0.3) than that detected in lysates 
of negative control.   
 
In lysates of P. macrophylla EtOH extract-treated cells, Mcl-1 expression was 
comparable to that in control lysates (relative band density1.1 and 1.0, 
respectively), whereas lysates prepared from cells exposed to EtOAc extracts 
revealed bands of lower relative density (0.7).  
 
 
Figure 3-16: Mcl-1 protein expressions after 48-hour exposure to D. 
grandiflora and P. macrophylla extracts.  HCT116 cells were treated with P. 
macrophylla EtOH and EtOAc extracts and D. grandiflora EtOH and HEX 
extracts for 48 h.  Western blots of whole cell lysates representative of two 
independent experiments are presented.  DMSO (-) and camptothecin (+) were 
used as control. 
 
3.4 Summary of studies to investigate UNMC extract-induced 
apoptosis 
Morphological changes in cancer cells were apparent under a phase-contrast 
microscope after 24 h and 48 h exposure to UNMC extracts.  A proportion of 
FHOOV DSSHDUHG VPDOOHU FLUFXODU DQG µEOHEEOLQJ¶ RI WKH FHOO PHPEUDQH ZDV
evident.  Morphological observations accompanied by dual staining of cells 
with annexin V-FITC and PI confirmed the induction of apoptosis.  The 
apoptosis-inducing capacity of UNMC extracts was highlighted by increased 
numbers of cells displaying FITC+/PI- fluorescence compared with the DMSO-
treated control cells after 24 h and 48 h exposures (Figure 3-14).   Furthermore, 
Caspase-3 is susceptible to activation by any of the initiator caspases (caspase -
8, -9 or -10).  Detection of caspase 3 fragments suggests the execution pathway 
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has been initiated, however it is not certain whether initiation of caspase 3 was 
a consequence of the extrinsic or the intrinsic pathway activation.  Activation 
of caspase 3 would lead to DNA fragmentation and these results are agreement 
with the sub-G1 cell population (lower DNA content) detected in the cell cycle 
distribution with apparent morphological changes.  Quantifying expression of 
caspase 3 initiators e.g. caspase 8 or caspase 9 could reveal information on 
possible pathways employed by compounds in the extracts.  Whereas, 
detection of anti-apoptotic Mcl-1 protein in D. grandiflora or P. macrophylla 
treated cells may suggest that Mcl-1 is not an influential factor in induction of 
apoptosis and that compounds embedded do not inhibit cdk-9.  
It is noted that Mcl-1 and caspase 3 proteins expression were detected in D. 
grandiflora- and P. macrophylla-treated HCT116 cell lysates.  
  
Archidendron ellipticum: Time-dependent induction of apoptosis by A. 
ellipticum extracts in MDA-MB-468 cells (increased sub-G1 cell populations) 
was confirmed by Annexin-V FITC/PI staining.  At 48 h, significantly higher 
levels of early and late apoptotic HCT116 cells were detected than in control 
cells.  Previously observed enhanced levels of EtOH extract-treated G2/M cell 
populations at 48 h suggested inhibition of or interference with mitosis; 
however, cellular/DNA repair mechanisms may be operating to overcome 
damage leading to the observation of slightly fewer apoptotic cells or cells may 
remain viable but unable to proceed to G2/M phase.  Familiar examples of 
marketed anticancer drugs, which demonstrated similar effects on cells include 
WD[RODQLQKLELWRURIȕ-subunit of tubulin, which binds to the inner surfaces of 
microtubule leading to inhibition of microtubule depolymerisation and disrupts 
the normal dynamic reorganisation of the microtubule network causing G2/M 
cell cycle arrest and consequently interference with mitotic spindles resulting 
in cell death.141  Additionally, effects of docetaxel are prominently observed in 
G2/M phase of the cell cycle and have minimal toxicity against cells in G1 
phase.  Contrastingly, vinca alkaloids can affect cells by inhibiting mitotic 
spindle assembly and reducing tension at the kinetochores of the chromosomes, 
also resulting in G2/M block.  It has been reported that taxanes can cause cell 
arrest in G2/M phase (by inhibiting of depolymerisation) and phosphorylate 
Bcl-2 proteins and this provides additional basis to investigate possible pro-
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apoptotic activity induced by UNMC extracts as cell cycle data of A. ellipticum 
revealed G2/M block and increased sub-G1 population.  Kuntiz inhibitor found 
in A. ellipticum is able to activate caspase 3 and 8, which is suggestive of 
extrinsic pathway activation.  Acacia genus of the Fabaceae family, which is 
also rich in saponins, has demonstrated apoptosis-inducing abilities in Jurkat 
cells via permeablisation of mitochondrial membrane (time-dependent 
cytochrome C release) and caspase 3 activation. 
 
Duabanga grandiflora: The presence of sub-G1 HCT116 cell populations 
were observed following exposure of cells to D. grandiflora extracts and the 
Annexin-V FITC assay confirmed the sub-G1 cell population to be apoptotic 
cells.  The observed G1/0 block is indicative of possible DNA damage 
resulting in inability to progress past G1/0 and apoptosis.  Significant levels of 
early apoptotic HCT116 cells were measured in all D. grandiflora treated cells, 
in particular, following polar Water and EtOH extracts treatments.  The level 
of apoptotic/necrotic cells emerging following exposure of cells to Water and 
HEX bark, Water and EtOH leaf extracts were time-dependent and significant 
compared to untreated control populations (p < 0.05).  This is supported by the 
detection of cleaved caspase 3 proteins. 
 
Pseuduvaria macrophylla: The ability of P. macrophylla extracts to induce 
apoptosis in HCT116 cells was evident in this series of in vitro assays 
(potency: EtOH > EtOAc > HEX).  Initially, early apoptosis was detected in all 
P. macrophylla extracts treated cells at significant levels (39 % to 48 %).  As 
exposure time increased, a distinct progression of early apoptotic cells into late 
apoptosis was noticed hence appearance of apoptotic/necrotic cells was time-
dependent (62% to 86 %; 24 h ± 48 h).  An aporphinoid, liriodenine (8H-
benzo[g]-1,3-benzodioxolo[6,5,4-de]-quinolin-8-one), similar to that isolated 
from P. macrophylla revealed cytotoxicity against A549 lung cancer cells 
EHWZHHQDQGȝ0RI liriodenine causing G2/M cell cycle arrest, together 
with 67% and 80% early apoptosis (Annexin-V FITC+/PI- cells), 
respectively.252  As previously mentioned, liriodenine, similar to 38 isolated 
from P. macrophylla has revealed the ability to cleave PARP in A459 cells, 
which is suggestive of caspase 3 activation.252  Both aporphinoids could be 
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exerting their cytotoxicity via  similar mechanisms since similar trends of cell 
cycle perturbations were also observed.   
 
Cell cycle perturbations and appearance of apoptotic cells have been detected, 
which suggest involvement of proteins such as cysteine-dependent aspartate-
directed proteases caspases (executors of apoptosis).  It has been reported that 
Fas, caspase -3 and -8 are involved in PS externalisation facilitating non-
inflammatory phagocytic recognition hence uptake of apoptotic cells.250  
Overall, detection of cleaved (activated) caspase 3 by Western blot and 
Annexin V positive, PI negative cells by flow cytometry provide robust 
evidence of cells undergoing early apoptosis.  Both sets of data together with 
evidence of morphological changes can confirm caspase-dependent apoptosis; 
these preliminary results illustrating execution of apoptosis provide support for 
further investigation of constituents in UNMC plants as potential anti-tumour 
agents. 
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4  
Effects of UNMC plant extracts on cell migration  
The ability of malignant cells to migrate and invade surrounding tissue, 
vascular beds, ECM is crucial to cancer metastasis.  Invasion and metastasis 
represent one of the hallmarks of cancer.  It is interestiQJWKDWWKHFDQFHUFHOOV¶
acquired resistance mechanism to VEGF inhibitors leads to enhanced 
migratory capacity.124 
 
4.1 Effects of UNMC plant extracts on cell migration  
A simple in vitro assay was used to mimic in vivo cell migration during wound 
KHDOLQJ  $ µZRXQG¶ LV FUHDWHG LQD FHOO PRQROD\HUDQGREVHUYDWLRQV LPDJHV
captured) at timed intervals will enable analysis of the migration rate of the 
cells.253  Wound images (n = 2) of the marked section were analysed using 
ImageJ and the wound area was measured as area covered (%).  At 0 h, the 
wound is considered as 100% and over time, the area of the wound can 
decrease (as cells migrate), increase (cell death; floating cells) and/or remain 
the same (migration inhibition); if necessary, medium was replenished to 
remove floating cells for clearer images of the wound.  The end point was 
considered when wound size of the control cells is 0% regardless of the wound 
size of treated cells.  'XQQHWW¶V PXOWLSOH FRPSDULVRQ 2QH-way ANOVA) 
analysis was used to compare each extract-treated group to the control group.  
Any statistically significant values are denoted: * = 0.01< p < 0.05.  Certain 
extracts were selected for anti-migration activities based on the acquired 
growth inhibitory/cytotoxicity data and extract availability.   
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4.1.1 Effect of Archidendron ellipticum extracts on HCT116 cell 
migration 
The investigation of in vitro anticancer properties of HEX bark extract was 
terminated due to the lack of supply.   
At 24 h treatment period, significant differences in wound area (%) were 
observed between bark extract-treated and control cells (Figure 4-1).  A 
comparable migration rate in EtOAc bark and EtOH leaf extract-treated cells 
was observed after 24 h treatment, however EtOH bark and EtOAc leaf extract 
treatment led to emergence of a larger wound area observed as a consequence 
of detached cells (p < 0.05) .  This result supports the observation seen in the 
MTT assay that EtOH bark and EtOAc leaf extracts were the most active 
against MDA-MB-468 cells.  At 56 h, remaining wound area of MDA-MB-468 
cells at 62.2% and 87.9% after exposure to low concentrations EtOH bark 
extracts (2 and 8 ȝJPO) revealed strong anti-migration properties.   
The remaining wound sizes of 42.1% and 43.5% after treatment of cells with 
1X and 4X GI50 EtOAc bark extract, respectively, were significant compared to 
control cells; statistical analyses have shown significant differences in wound 
size (p = 0.005 and 0.020, respectively).  To a lesser extent, a steady cell 
migration rate was observed following EtOH leaf extract treatment than 
compared to control cells until 64 h where a significant wound area was 
observed, ~ 30%, with both concentrations of EtOH extract.  Whereas 
following 24 h treatment, similar effects of EtOAc leaf extract at 1X GI50 
illustrate a steady migration rate comparable to the control cells.  Only at 4X 
GI50 treatment, were cells unable to migrate completely due to cytotoxicity of 
EtOAc extracts; the cell monolayer was lost due to cell death.  Anti-migration 
effects of HEX leaf extracts were only observed at very high concentrations 
(772 ȝJPO) in MDA-MB-468 cells.  It is interesting to note that between 0 h 
and 48 h, the healing (migration) rate of MDA-MB-468 cells supersedes the 
control cells under the influence of HEX extract (p < 0.05). 
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Figure 4-1: Inhibitory effect of A. ellipticum bark and leaf extracts on 
MDA-MB-468 wound healing (%) over a 64 h period.  Cells were exposed 
to 1X and 4X GI50 concentrations of EtOH (A), EtOAc (B) and HEX (C) 
extracts measured at specific sections every 24 h (monitored closely when 
wound is ~ 10%).  Mean measurements are from 3 independent experiments (n 
= 2).  'XQQHWW¶VPXOWLSOHFRPSDULVRQ2QH-way ANOVA) analysis was used to 
compare each extract-treated group to the control group.  Any statistically 
significant values are denoted: * = statistically significant (p  0.05). 
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4.1.2 Effect of Duabanga grandiflora extracts on cell migration 
The investigation of in vitro anticancer properties of EtOH and HEX bark 
extracts was carried out.  Water and EtOAc extracts induced anti-proliferative 
effects, which would be worthy of investigation, however supply was 
insufficient to allow for repeated independent experiments.   
A positive correlation was observed between extracts¶ concentration and 
potency against HCT116 cell migration inhibition as prominent effects were 
observed (Figure 4-2).  At 56 h, EtOH extractVDWDQGȝJPO were able 
to significantly inhibit HCT116 cell migration as wound area remained at 
38.6% and 53.6%, respectively (p = 0.005).  A steady inhibition of HCT116 
cell migration under the influence of EtOH bark extract was revealed; wound 
areas of > 50% remained without the loss of cell monolayer, suggesting that 
cells are viable but reluctant to migrate.  Inhibitory effects on cell migration 
were observed when HCT116 cells were treated with 1X GI50 HEX extract, as 
wound sizes remained constant at 81.4% to 75.0%.  While, detached dead cells 
were noticed with HEX extract treatment at 4X GI50, resulting in a significantly 
greater wound area (> 100%); HEX extracts appeared to be cytotoxic to 
HCT116 cells as the cell monolayer was lost during longer treatment times (> 
48 h; represented by a wound area of > 100%.   
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Figure 4-2: Inhibitory effect of D. grandiflora bark extracts on HCT116 
wound healing (%) over a 56 h period.  Cells were exposed to 1X and 4X 
GI50 concentrations of EtOH (A) and HEX (B) extracts and measured at 
specific sections every 24 h (monitored closely when wound is ~ 10%).  Mean 
measurements are from 3 independent experiments (n = 2).  'XQQHWW¶VPXOWLSOH
comparison (One-way ANOVA) analysis was used to compare each extract-
treated group to the control group.  Any statistically significant values are 
denoted: * = statistically significant (p  0.05). 
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4.1.3 Effect of Pseuduvaria macrophylla extracts on HCT116 
cell migration 
The rate of wound healing decreased when HCT116 cells were treated with 
EtOH and EtOAc extracts, when compared to control cells at 56 h; hence 
results suggest the anti-migration effects were induced by P. macrophylla 
extracts.  There was no significant difference in wound area between EtOH 
extract-treated and control cells (p < 0.05) between 0 h and 48 h (Figure 4-3).  
 
 
Figure 4-3: Inhibitory effect of P. macrophylla extracts on HCT116 wound 
healing (%) over a 56 hour period.  Cells were exposed to 1X and 4X GI50 
concentrations of EtOH (A) and EtOAc (B) extracts and measured at specific 
sections every 24 h (monitored closely when wound is ~ 10%).  Mean 
measurements are from 3 independent experiments (n = 2).  'XQQHWW¶VPXOWLSOH
comparison (One-way ANOVA) analysis was used to compare each extract-
treated group to the control group.  Any statistically significant values are 
denoted: * = statistically significant (p  0.05). 
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At 56 h, the remaining wound area in cells exposed to 5 and ȝJPl EtOH 
were 33.7% and 42.5%, respectively and cell migration was significantly 
inhibited by 2 and 8 ȝJPl EtOAc extract with remaining wound size of 42.1% 
and 43.5%, respectively compared to control cells.  Statistical analyses have 
shown significant differences in wound size after 40 h of exposure (p = 0.005 
and 0.020, respectively).  
 
4.1.4 Summary of migration inhibition properties of UNMC 
extracts 
A wound-healing assay was performed to assess the UNMC extracts¶ ability to 
inhibit cell migration as this could have potential therapeutic uses specifically 
for cancer metastasis inhibition and also to overcome acquired resistance to 
VEGF inhibitors.   
 
Archidendron ellipticum:  Comparable migration rates to the control cells 
were observed in MDA-MB-468 cells following 0 h to 48 h exposure to EtOAc 
bark and EtOH leaf.  To a greater extent, this trend was also observed with 
EtOAc leaf extracts with remaining wound size of 43.0%.  However, cell 
migration could no longer be observed due to loss of cell monolayer (> 100%, 
hence cell death) at higher concentrations of EtOAc leaf extract.  EtOH bark 
induced greatest significant anti-migration effects at lowest concentrations 
used compared with wound area of control cells; the wound area of cells 
IROORZLQJ (W2+ EDUN WUHDWPHQW  DQG  ȝJP) remained at 46.1% and 
46.5%, respectively.  It is interesting to note the enhanced migration rate of 
MDA-MB-468 cells under the influence of HEX extract, suggesting embedded 
compounds could encourage cell migration prior to inhibitory effects at longer 
exposure time.  It is anticipated that HEX bark extract would have comparable 
low anti-migration effects as to HEX leaf extract based on previous in vitro 
assays results of HEX extracts on HCT116 cells e.g. MTT, cell cycle and 
annexin-V FITC.   
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Duabanga grandiflora:  Inhibition of HCT116 cell migration was observed 
following treatment with EtOH and HEX bark extracts.  A steady decrease in 
wound area was observed with EtOH-treated HCT116 cells.  From 12 h 
onwards, inhibition of HCT116 cell migration following HEX extract 
treatment was evident as the remaining wound areas were preserved at 75% to 
82%.  Following 24 h, detachment of cells was clearly observed following 
replenishment of medium containing extracts, suggesting cytotoxicity with 
high concentrations of HEX extract where wound area (%) was measured at > 
100%, which indicated cell death.  It may be expected that EtOAc bark and 
leaf extracts would induce greater inhibitory effects on HCT116 migration, 
based on previous in vitro assays results of EtOAc extracts on HCT116 cells 
from e.g. MTT, cell cycle and annexin-V FITC assays.  
 
Pseuduvaria macrophylla:  Extracts exhibited a gradual inhibition of cell 
migration with slightly greater effects seen with EtOAc extract than EtOH 
extract: larger wound areas were observed at lower concentrations of EtOAc 
applied.  It is expected that HEX extract may induce similar inhibitory effects 
on HCT116 migration, based on previous in vitro assay results of HEX extracts 
on HCT116 cells (e.g. MTT, cell cycle and annexin-V FITC) which yielded 
comparable results to EtOH and EtOAc extracts. 
 
Overall, inhibition of cell migration was observed in several of the UNMC 
extracts.  It is speculated that compounds present in the extracts could be 
influencing the TNF-Į pathway resulting in lack of survival and inflammation 
signals via  inactivation of NF-ț% signaling and induction of apoptosis by 
caspase 3 activation.254  TNF-Į FDQ LQGXFH F\WRNLQHV DQJLRJHQLF IDFWRUV DQG
metalloproteinases (MMPs).  Polyphenols such as (-)-epigallocatechin-3-
gallate (EGCG) can modulate MMP-2 and MMP-9, which affect the basement 
membrane turnover and tissue remodeling that are associated in tumour 
invasion and metastasis, which requires changing the dynamics of extra 
cellular matrix (ECM) to gain motility.255, 256  
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4.2 Effect of UNMC plant extracts on cellular senescence  
Cellular senescence describes the irreversible growth arrest, which is the 
underlying mechanistic cause of aging in normal somatic cells upon reaching 
their Hayflick replicative limit; hence senescence is also a tumour suppression 
mechanism.  Many tumours possessing unlimited and/or extended replicative 
potential, hence escaping mortality, can progress to malignant transformation; 
however several chemotherapeutic agents can induce senescence in tumours.257 
The biomarker, ȕ-galactosidase, present in the lysosomes of senescent cells has 
been measured to determine the effects of UNMC plant extracts on senescence 
and, indirectly, cancer cell immortality.  Increased detection of blue-green-
stained ȕ-galactosidase within the cytosol of cells undergoing senescence 
following incubation of cells with X-gal has been used to determine senescent 
cells. The level of ȕ-galactosidase in cells treated with UNMC plant extracts at 
1X and 2X GI50 was determined by counting the number of blue/green cells 
under the microscope as a result of the binding of X-JDO WRȕ-galactosidase in 
senescent cells.  DMSO and RHPS4 were used as negative and positive control 
treatments for the detection of senescence in HCT116 cells (Figure 4-4).  
Pentacyclic acridine RHPS4 is a telomere-targeted agent that stabilises G-
quadruplex structures within telomeric DNA, hence preventing telomere-
telomere interaction.258  'XQQHWW¶V PXOWLSOH FRPSDULVRQ 2QH-way ANOVA) 
analysis was used to compare each extract-treated group to the control group.  
Any statistically significant values are denoted: * = 0.01< p < 0.05.   
 
   
Figure 4-4: ,PDJHV RI ȕ-galactosidase positive (senescent) HCT116 cells. 
Senescence of HCT116 cells treated with DMSO as negative control (left) and 
RHPS4 as positive control (right) were assessed using X-gal staining.  Cells 
were exposed to DMSO and RHPS4 (1 µM) for 8 days; ȕ-galactosidase+ cells 
appearing blue/green in colour.  Images shown were captured by Nikon 
Coolpix camera (100X magnification). 
RHP
 
Control 
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4.2.1 Effect of Archidendron ellipticum extracts on cellular 
senescence  
EtOH bark and all leaf extracts were investigated for senescence-inducing 
activity.  The level of senescence in MDA-MB-468 cells induced by A. 
ellipticum extracts is illustrated in Figure 4-5 and Figure 4-6.  All extract-
treated cells have significantly higher numbers of ȕ-galactosidase positive cells 
than the DMSO control population (1.9%) by 10- to 23-fold.  The percentage 
of senescent cells was significantly higher than control cells by 21.7% and 
25.3% when exposed to 1X and 2X GI50 of EtOH bark extract (2 and 4 ȝJPO.  
 
 
Figure 4-5: MDA-MB-468 cells undergoing senescence after exposure to A. 
ellipticum extracts. Cells were exposed to 1X and 2X GI50 concentrations of 
bark and leaf extracts for 7 days then stained with X-gal followed by 24 h 
incubation at 37 °C in the dark. %OXHJUHHQȕ-galactosidase+ cells were counted 
under a light microscope. Bars represent mean measurements are from 3 
independent experiments (n = 2).  'XQQHWW¶V PXOWLSOH FRPSDULVRQ 2QH-way 
ANOVA) analysis was used to compare each extract-treated group to the 
control group.  Any statistically significant values are denoted: * = statistically 
significant (p  0.05). 
 
Levels of senescent cells were more significant following treatment with 
extract at high concentrations of EtOH and EtOAc leaf extracts (p  0.05).  The 
difference in the levels of senescent cells after exposure to 1X GI50 (26.5%) 
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and 2X GI50 (34.1%) EtOH leaf extracts was 7.7%.  A larger 14.5% difference 
in the level of senescence cells between 1X GI50 (28.8%) and 2X GI50 (43.3%) 
between EtOAc leaf extracts was observed.  Significant numbers of senescent 
cells were induced at very high concentrations of HEX leaf extracts (p < 0.05). 
 
Images of MDA-MB-468 cells were captured to illustrate the appearance of 
senescent cells (Figure 4-6); cells exposed to A. ellipticum EtOH bark extracts 
appeared to have swelled up and are more circular whereas smaller circular 
shapes were seen with the EtOAc-treated MDA-MB-468 cells, which is 
suggestive of apoptotic bodies.  Following statistical analysis, significant 
differences in the level of senescence observed between extract treated cells 
and control was measured.  
         127 
 
Figure 4-6: ,PDJHVRIȕ-galactosidase positive (senescent) MDA-MB-468 cells. Senescence was assessed using X-gal staining.  Cells were 
exposed to 1X and 2X GI50 A. ellipticum extracts concentrations DQG ȕ-galactosidase+ cells appearing blue/green in colour (highlighted by 
arrows) were counted under a light microscope.  Images shown were captured by Nikon Coolpix camera (100X magnification) and are from a 
single representative experiment (n = 2).  
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4.2.2 Effect of Duabanga grandiflora extracts on cellular 
senescence  
The investigation of in vitro anticancer properties of Water and EtOAc bark 
and leaf extracts was terminated due to the lack of supply.  EtOH and HEX 
bark extracts were investigated for senescence-inducing activity. 
The level of senescence in HCT116 cells induced by D. grandiflora extracts is 
illustrated in Figure 4-7.  All extract-treated cells appeared to have a higher 
level of senescence than those measured in the DMSO control population 
(1.5%) by 2- to 5- fold.  Levels of senescent HCT116 cells following exposure 
to (W2+ EDUN H[WUDFWV  DQG  ȝJPO ZHUH PHDVXUHG at 5.8% and 6.0%, 
respectively.  The % of senescent HCT116 cells treated with 1X GI50 HEX 
EDUN H[WUDFWV  ȝJPO ZDV  KLJKHU WKDQ WKH FRQWURO SRSXODWLRQ DQG
greater effects were seen at 2X GI50 of HEX H[WUDFW  ȝJPO treatment 
yielding a significant senescent population of 5.6% compared with control cells.  
Images of HCT116 cells were captured to illustrate the appearance of senescent 
cells (Figure 4-8).  Observation of single cells individually enabled careful 
examination of each cell to determine not only ȕ-galactosidase status but also 
morphological changes.  HCT116 cells became longer and fibroblast-like with 
long spindle-like protrusions.  Following statistical analysis, significant 
differences were noticed between control and HEX bark extract-treated cells, 
however there was no significant difference in the level of senescence observed 
between the EtOH and low concentrations of HEX extract treated cells (p > 
0.5).   
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Figure 4-7: HCT116 cells (%) undergoing senescence after exposure to D. 
grandiflora extracts.  Cells were exposed to 1X and 4X GI50 concentrations of 
extracts for 7 days then stained with X-gal followed by 24 h incubation at 
&LQWKHGDUN%OXHJUHHQȕ-galactosidase+ cells were counted under a light 
microscope.  Bars represent mean measurements are from 3 independent 
experiments (n = 2).  'XQQHWW¶V PXOWLSOH FRPSDULVRQ 2QH-way ANOVA) 
analysis was used to compare each extract-treated group to the control group.  
Any statistically significant values are denoted: * = statistically significant (p  
0.05). 
 
 
Figure 4-8: ,PDJHV RI ȕ-galactosidase positive (senescent) HCT116 cells. 
Senescence was assessed using X-gal staining.  Cells were exposed to 1X and 
2X GI50 concentrations of D. grandiflora bark H[WUDFWV DQG ȕ-galactosidase+ 
cells appearing blue/green in colour (highlighted by arrows) were counted 
under a light microscope.  Images shown were captured by Nikon Coolpix 
camera (100X magnification) and are from a single representative experiment 
(n = 2).  
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4.2.3 Effect of Pseuduvaria macrophylla extracts on cellular 
senescence  
EtOH and EtOAc extracts were investigated for senescence-inducing activity.  
The level of senescence induced in HCT116 cells by P. macrophylla extracts is 
illustrated in Figure 4-9.  All extract-treated cells had greater levels of X-gal 
(ȕ-galactosidase) staining than the DMSO control population (1.5%) by 2- to 
5- fold.  The percentage of senescent cells was greater by 2.0% and 5.9% when 
exposed to 1X and 2X GI50 of EtOH extract (5 and 2 ȝJPO WKDQ control 
population.  Similarly, EtOAc extracts induced greater levels of senescent cells 
compared to control cells by 3.2% and 7.0% at 2 and ȝJPOUHVSHFWLYHO\  
The difference in the level of senescent cells after exposure to 1X GI50 (3.5%) 
and 2X GI50 (7.4%) EtOH extracts was 3.9%.  A larger difference in the level 
of senescence cells between 1X GI50 (4.7%) and 2X GI50 (8.5%) EtOH leaf 
extracts was 3.8%.  There was not enough evidence to conclude P. 
macrophylla extracts induced significant levels of senescence in sensitive 
HCT116 cells (Figure 4-9).   
Images of HCT116 cells were captured to illustrate the appearance of senescent 
cells (Figure 4-6).  IQFUHDVHG QXPEHU RI µEOXHJUHHQ¶ FHOOV FRYHULQJ D ZLGer 
area can be observed in extract-treated HCT116 cells (Figure 4-10) and extract-
treated cells appeared small and circular which could be indicative of apoptotic 
bodies.  A low level of naturally occurring senescent cells was detected in the 
control population, which may be due to high cell density in certain sections.  
Statistical analysis revealed significant difference in the level of senescence 
observed between extract treated cells at 2X GI50 and the control (p < 0.5).  
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Figure 4-9: HCT116 cells undergoing senescence after exposure to P. 
macrophylla extracts. Cells were exposed to 1X and 2X GI50 extract 
concentrations for 7 days then stained with X-gal followed by 24 h incubation 
at 37 °C in the darN ȕ-galactosidase+ cells appear blue/green in colour and 
ZHUHFRXQWHGXQGHUDOLJKWPLFURVFRSH%OXHJUHHQȕ-galactosidase+ cells were 
counted under a light microscope.  Bars represent mean measurements are 
from 3 independent experiments (n = 2).  DunneWW¶VPXOWLSOHFRPSDULVRQ2QH-
way ANOVA) analysis was used to compare each extract-treated group to the 
control group.  Any statistically significant values are denoted: * = statistically 
significant (p  0.05). 
 
 
Figure 4-10: ,PDJHVRIȕ-galactosidase positive (senescent) HCT116 cells. 
Senescence was assessed using X-gal staining.  Cells were exposed to 1X and 
2X GI50 concentrations of P. macrophylla H[WUDFWVDQGȕ-galactosidase+ cells 
appearing blue/green in colour (highlighted by arrows) were counted under a 
light microscope.  Images shown were captured by Nikon Coolpix camera 
(100X magnification) and are from a single representative experiment (n = 2).  
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4.2.4 Summary of migration inhibition properties of UNMC 
extracts 
The detection of ȕ-galactosidase in senescence cell populations after exposure 
to UNMC plant extracts at 1X and 4X GI50 was determined by counting the 
numbers of blue/green (senescent) cells.  Low levels of naturally occurring 
senescent cells seen in the control population could due to high cell density in 
certain areas.   
 
Archidendron ellipticum: All extracts examined were capable of inducing 
senescence in the cells at a significantly higher level than control cells.  
Considering the concentrations of A. ellipticum extracts and corresponding 
senescence, (W2+EDUNH[WUDFWDQGȝJPODSSHDUHGWREHWKHPRVWSRWHQW  
since higher concentrations (of ~ 1.5 to > 22 ±fold) of EtOH (9 and 18 ȝJPO), 
EtOAc DQGȝJPO and HEX (200 and 400 ȝJPO leaf extracts induced 
only slightly greater levels of cellular senescence.   
 
Duabanga grandiflora:  The ability of extracts to induce senescence in 
HCT116 cells was observed and in particular HEX EDUN H[WUDFW  ȝJPO; 
7.1%) causing significant senescence compared to the DMSO control sample 
(1.5%).  Slight increase in senescence was observed with higher concentrations 
of (W2+EDUNH[WUDFWȝJPO. 
 
Pseuduvaria macrophylla:  EtOAc extract was slightly more effective at 
inducing cellular senescence than EtOH extract even at lower concentrations. 
The level of senescent cells measured after exposure to P. macrophylla extracts 
was similar to cells exposed to D. grandiflora extracts, however A. ellipticum 
extracts were most active at inducing cellular senescence in cells. 
 
Certain compounds present in UNMC extract cells may induce low levels of 
DNA damage in cells which activate DNA repair mechanisms resulting in a 
slower transition through the S and G2/M phase, maintaining G1 phase 
senescence equilibrium, as shown by some sesquiterpene lactone 
dehydroleucodine.259  Previous results also suggest accumulated damage will 
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stimulate the activation of apoptosis and impair cell proliferation.  A 
telomerase inhibitor, telomestatin, isolated from Streptomyces anultus can bind 
to the terminal G-quatert of a DNA quadruplex thus affecting the binding of 
protective capping proteins with telomerase; this may induce a DNA damage 
response leading to cell growth arrest, senescence or death by inhibiting 
telomerase activities (e.g. elongation of telomeres).260, 261 
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5  
Chemical content and fractionation of Pseuduvaria macrophylla, 
Archidendron ellipticum and Duabanga grandiflora crude 
extracts 
5.1 Chemical content and free radical scavenging ability of 
UNMC crude extracts 
Plants live in a conspecific and heterospecific environment.  This can depend 
on complex phytochemical interactions to increase survival chances for 
themselves and surrounding plants.  Plants are able to produce and emit 
phytochemicals to fend off harmful or unfavourable conditions.  Recent reports 
explain that some plants are also able to emit semi-volatile compounds to 
µFRPPXQLFDWH¶ WR QHLJKERXULQJ SODQWV in order to reduce harm caused by 
herbivores.262  For many years, these phytochemicals have been exploited by 
mankind to treat many adverse biological conditions e.g. use as chemical 
structures templates to synthesise and develop therapeutic compounds.  Plant 
extracts were subjected to analysis for their flavonoid and phenolic contents 
using the aluminium trichloride and Folin-Ciocalteau (FC) colorimetric 
methods.  Subsequently, their corresponding antioxidant activity was measured 
using the DPPH assay. 
 
The aluminium trichloride (AlCl3) colorimetric method was adapted from 
Meda et al. (2005)263 and Chang et al. (2002).264  AlCl3 can form acid-stable 
complexes with reactive groups of flavones and flavonols and form acid-labile 
complexes with the flavonoids.  Quercetin is a widely distributed flavonoid 
found in nature hence was employed as a standard to measure against the 
UNMC extracts for total flavonoid content determination.  Secondly, an FC 
colorimetric method was adapted from Singleton et al. (1999) and Meda et al. 
(2005).263  FC reagent contains phosphomolybdate and phosphotungstate, 
which reacts with reducing substances such as polyphenolic compounds.  
Gallic acid (GA) is a widely distributed phenolic compound found in nature 
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and is the chosen standard used to measure against the UNMC extracts for total 
phenolic content determination.  3HDUVRQ¶V FRUUHODWLRQ DQDO\VLV ZDV XVHG WR
calculate the coefficient (r) to determine the strength of the association of the 
quercetin and gallic acid standard curves; a strong association is considered if r  
=  (-) 1.   
 
Phenolic compounds also act as antioxidants and scavenge free radicals, hence 
the 2,2-diphenyl-1-picrylhydrazyl radical (DPPH.) assay was employed to 
determine antioxidant capacity of UNMC extracts.  Antioxidant activity is 
correlated to phenolic content.  In brief, DPPH. is a stable free radical, which 
can be used to indirectly assess the radical scavenging activity of plant extracts. 
On reaction with an antioxidant such as polyphenol compounds, DPPH - is 
reduced to the molecular form (DPPHH) resulting in a colour change from 
yellow to purple.  This change in absorbance can be used to measure the 
radical scavenging power of the plant extracts.  The following method was 
adapted from the method described by Amic et al. (2003)265 and Nara et al. 
(2006).266  Antioxidants play a crucial role in the prevention of chronic 
GLVHDVHV VXFK DV KHDUW GLVHDVH FDQFHU DQG $O]KHLPHU¶V GLVHDVH E\ UHGXcing 
oxidative stress.267   
 
Extracts of UNMC plants A. ellipticum, D. grandiflora and P. macrophylla 
were tested for their chemical contents and free radical scavenging activity. 
There was insufficient A. wilkesiana extracts for testing and the latest batch of 
A. wilkesiana specimen have been collected from a different location and was 
not subjected to analytical tests to determine its chemical profile and the 
variability between batches.  
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5.1.1 Flavonoid and Phenolic content and free radical 
scavenging activity of Archidendron ellipticum extracts 
Flavonoid and phenolic content was determined using 1 mg of A. ellipticum 
extracts.  There were comparable quantities of flavonoids detected in the leaf 
and bark extracts, shown in Table 5-1.  The total flavonoids in bark extracts 
(EtOH, EtOAc and HEX) were estimated to be 2.65, 2.87 and 2.44 mg 
quercetin equivalent/g, respectively, which is slightly lower than the total 
flavonoids detected in leaf extracts: 3.57, 3.56 and 2.65 mg quercetin 
equivalent/g, respectively  3HDUVRQ¶V FRUUHODWLRQ DQDO\VLV VXJJHVWV D VWURQJ
association of the quercetin standard curve, r  =  0.84.  Ranked in the order of 
highest flavonoids present in bark extracts: EtOAc > EtOH > HEX and in leaf 
extracts: EtOH > EtOAc > HEX. 
 
Table 5-1: Flavonoid content in Archidendron ellipticum extracts 
A. ellipticum extract 
Total flavonoids as 
quercetin equivalent 
mg/ 1g extract (QE) 
Total phenolics as gallic 
acid equivalent mg / 1 g 
of extract (GAE) 
Ba
rk
 
EtOH 2.65 ± 0.00 1.03  ± 0.01 
EtOAc 2.87 ± 0.00 4.23 ± 0.02 
HEX 2.44 ± 0.00 3.09 ± 0.04 
Le
a
f 
EtOH 3.57 ± 0.00 2.44 ± 0.02 
EtOAc 3.56 ± 0.00 0.69 ± 0.00 
HEX 2.65 ± 0.00 0.69 ± 0.01 
Flavonoid and Phenolic contents from 1 mg of A. ellipticum extracts are 
presented as quercetin equivalents (QE), mg/ gram of extract and gallic acid 
equivalents (GAE), mg, /gram of extract (n = 3). Pearson product-moment 
correlation coefficients were 0.84 and 0.83 for flavonoids and phenolic 
standard curves, respectively. 
 
Phenolic compounds were detected in the leaf and bark extracts, shown in 
Table 5-1.  The levels of phenolic compounds varied between bark and leaf 
extracts.  The total phenolic compounds in A. ellipticum bark extracts (EtOH, 
EtOAc and HEX) were estimated to be 1.03, 4.23 and 3.09 mg GAE/g, 
respectively; this is considerably less than the total phenolic compounds 
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GHWHFWHGLQOHDIH[WUDFWVDQGPJ*$(J3HDUVRQ¶VFRUUHODWLRQ
analysis suggests a strong association of the gallic acid standard curve, r  =  0.83.   
Ranked in the order of highest phenolic content in bark extracts: EtOAc > HEX 
> EtOH and in leaf extracts: EtOH > EtOAc = HEX.  Previously, Beutler et al. 
(1997) reported detection of a series of new saponins in A. ellipticum 
Ch2Cl2:MeOH extracts; plants of  this genus have been found to contain sterols, 
triterpenes and coumarins, which may contribute to phenolic content.235  
A. ellipticum extracts displayed modest direct antioxidant behavior (Table 5-2); 
EtOH extracts emerged as the most active and HEX bark extracts were least 
active compared with the other extracts.  Ranked in the order of highest free 
radical scavenging ability (%) in bark and leaf extracts, respectively: EtOH 
(43.8, 66.7) > EtOAc (24.1, 41.8) > HEX (3.9, 24.1).  Overall, a corresponding 
order of extract potency and % of radical scavenging ability was observed in 
leaf extracts.  No particular trend was noted between antioxidant activity and 
the amount of phenolics present in the bark extracts and the amount of 
flavonoids present in the bark and leaf extracts. 
 
Table 5-2: Free radical scavenging ability of Archidendron ellipticum extracts. 
A. ellipticum extract Free radical scavenging (%) 
Ba
rk
 
EtOH 43.8 ± 0.5 
EtOAc 24.1 ± 0.6 
HEX 3.9 ± 2.6 
Le
a
f 
EtOH 66.7 ± 0.5 
EtOAc 41.8 ± 0.6 
HEX 24.1 ± 2.6 
Average % free radical scavenging ability of extracts ± SEM are shown; the 
antioxidant content was determined using a standard curve of quercetin (0 ± 1.2 
mg/ml). Pearson product-moment correlation coefficient was used to measure 
correlations of free radical scavenging (%) between extracts; three independent 
experiments were performed (n = 4). 
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5.1.2 Flavonoid and Phenolic content and free radical 
scavenging activity of Duabanga grandiflora extracts 
Flavonoid and phenolic content were determined using 1 mg of D. grandiflora 
extracts.  There were considerably greater amounts of flavonoids detected in 
the leaf extracts compared to bark extracts, shown in (Table 5-3).  The total 
flavonoids in D. grandiflora bark extracts (Water, EtOH, EtOAc and HEX) 
were estimated to be 3.01, 0.08, 0.97 and 0.08 mg quercetin equivalent/g, 
respectively.  This was considerably less than the total flavonoids detected in 
leaf extracts: 2.39, 3.17, 3.20 and 2.35 mg quercetin equivalent/g, respectively.  
Ranked in the order of highest flavonoids present in bark extracts: Water > 
EtOAc > EtOH = HEX and in leaf extracts: EtOAc > EtOH > Water > HEX. 
Phenolic agents were detected in the leaf and bark extracts.  The total phenolic 
compounds in D. grandiflora bark extracts (Water, EtOH, EtOAc and HEX) 
were estimated to be 12.73, 34.87, 9.57 and 2.20 mg gallic acid equivalent 
(GAE)/g, respectively.  This is less than the total phenolic compounds detected 
in leaf extracts: 12.60, 27.81, 17.92 and 0.37 mg GAE/g, respectively.  Ranked 
in the order of highest phenolics present in bark extracts: EtOH > Water > 
EtOAc > HEX and in leaf extracts: EtOH > EtOAc > Water > HEX.  The 
levels of phenolic compounds varied; however, the ranking order of phenolics 
present was comparable between corresponding extracts in bark and leaf.  
Overall, HEX extracts contained the least flavonoid and phenolic content.  
Othman et al (2011) found appreciable amounts of phenolic agents in EtOH 
bark and leaf extracts whilst moderate amounts were detected in EtOAc bark 
and leaf extracts.  There were appreciable amounts of flavonoids in EtOAc 
bark and EtOH leaf extracts whereas trace amounts were noticed in EtOH bark 
extract.205  Additionally, Othman et al (2011) investigated the presence of 
alkaloids, tannins, saponins, steroids and triterpenes in D. grandiflora extracts; 
the aforementioned chemicals were detected in D. grandiflora EtOH bark and 
leaf extracts excluding alkaloids and triterpenes.  Whereas, trace amounts of 
saponins and triterpenes and steroids and triterpenes were found in EtOAc bark 
and leaf extracts, respectively.205  
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Table 5-3: Flavonoid and Phenolic contents in Duabanga grandiflora extracts 
D. grandiflora 
extract 
Total flavonoids as 
quercetin equivalent 
mg/ 1g extract (QE) 
Total phenolics as gallic 
acid equivalent mg / 1 g 
of extract (GAE) 
Ba
rk
 
Water 3.01 ± 0.00 12.73 ± 0.23 
EtOH 0.08 ± 0.00 34.87 ± 0.03 
EtOAc 0.97 ± 0.00 9.57 ± 0.01 
HEX 0.08 ± 0.00 2.20 ± 0.01 
Le
a
f 
Water 2.39 ± 0.00 12.60 ± 0.05 
EtOH 3.17 ± 0.00 27.81 ± 0.01 
EtOAc 3.20 ± 0.00 17.92 ± 0.01 
HEX 2.35 ± 0.00 0.37 ± 0.00 
Flavonoid and Phenolic contents from 1 mg of D. grandiflora extracts are 
presented as quercetin equivalents (QE), mg/ gram of extract and gallic acid 
equivalents (GAE), mg, /gram of extract (n= 3). Pearson product-moment 
correlation coefficients were 0.84 and 0.83 for flavonoids and phenolic 
standard curves, respectively. 
 
Table 5-4: Free radical scavenging ability of Duabanga grandiflora extracts 
D. grandiflora extract Free radical scavenging (%) 
Ba
rk
 
Water 94.4 ± 0.4 
EtOH 38.3 ± 0.5 
EtOAc 86.3 ± 0.6 
HEX 28.7 ± 2.6 
Le
a
f 
Water 95.3 ± 0.1 
EtOH 96.3 ± 0.1 
EtOAc 95.7 ± 1.1 
HEX 9.4 ± 1.0 
Average % of free radical scavenging abilities of extracts ± SEM are shown; 
the antioxidant content was determined using a standard curve of quercetin (0 ± 
1.2 mg/ml). Pearson product-moment correlation coefficient was used to 
measure correlations of free radical scavenging (%) between extracts; three 
independent experiments were performed (n = 4). 
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D. grandiflora extracts displayed direct antioxidant behavior in the DPPH 
radical scavenging assay (Table 5-4), with Water and EtOAc extracts emerging 
as the most active (> 85%) and leaf extracts with greater free radical 
scavenging ability in general.  Ranked in the order of highest free radicals 
scavenging ability (%) in bark extracts: Water (94.4)> EtOAc (86.3)> EtOH 
(38.3)> HEX (28.7) and in leaf extracts: EtOH (96.3)> EtOAc (95.7)> Water 
(95.3)> HEX (9.4).   
The results suggest that flavonoid levels in bark extracts correlated to their 
ability in free radical scavenging ability, which was also observed with Water, 
EtOH and EtOAc extracts possessing high levels of flavonoids.  However it 
was interesting to observe that HEX leaf extract contained similar levels of 
flavonoids to Water leaf extract, and did not yield comparable antioxidant 
activity as expected; this maybe due to the difference in different flavonoids, 
hence difference in activity.  There was a general positive correlation between 
antioxidant activity and phenolic compounds in the extracts; the amount of 
phenolics detected in leaf extracts corresponded to level of free radical 
scavenging activity.  Whereas no obvious correlation was observed between 
phenolics level in bark extract and the level of free radical scavenging activity.  
In general, the extracts (Water, EtOH and EtOAc) with higher quantities of 
phenolic agents displayed greater levels of DPPH scavenging ability.   
 
5.1.3 Chemical content and free radical scavenging ability of 
Pseuduvaria macrophylla extracts 
Flavonoid and phenolic contents were determined using 1 mg of P. 
macrophylla extracts.  Flavonoid contents in the leaf and bark extracts is 
shown in Table 5-5.  The total flavonoids in whole extract (EtOH, EtOAc and 
HEX) were estimated to be 2.39, 2.39 and 1.71 mg QE/g, respectively.  
3HDUVRQ¶V FRUUHODWLRQ DQDO\VLV VXJJHVWV D VWURQJ DVVRFLDWLRQ RI WKH TXHUFHWLQ
standard curve, r =  0.84.  Ranked in the order of highest flavonoids present in 
whole extract: EtOAc = EtOH > HEX. 
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Table 5-5: Flavonoid content in Pseuduvaria macrophylla extracts 
P. macrophylla 
extract 
Total flavonoids as 
quercetin equivalent 
mg/ 1g extract (QE) 
Total phenolics as gallic 
acid equivalent mg / 1 g 
of extract (GAE) 
EtOH 2.39 ± 0.00 7.09 ± 0.07 
EtOAc 2.39 ± 0.01 5.72 ± 0.02 
HEX 1.71 ± 0.00 4.06 ± 0.02 
Flavonoid and Phenolic contents from 1 mg of P. macrophylla extracts are 
presented as quercetin equivalents (QE), mg/ gram of extract and gallic acid 
equivalents (GAE), mg, /gram of extract (n= 3). Pearson product-moment 
correlation coefficients were 0.84 and 0.83 for flavonoids and phenolic 
standard curves, respectively. 
 
Phenolic compounds were detected in whole extract, shown in Table 5-5.  The 
total phenolic compounds in P. macrophylla extracts (EtOH, EtOAc and HEX) 
ZHUHHVWLPDWHGWREHDQGPJ*$(JUHVSHFWLYHO\ 3HDUVRQ¶V
correlation analysis suggests a strong association of the gallic acid standard 
curve, r =  0.83.  Ranked in the order of highest phenolics present in extracts: 
EtOH > EtOAc > HEX.  Othman et al. (2011) reported phytochemical tests for 
alkaloids, tannins, phenolics, saponins, flavonoids, steroids and triterpenes 
were performed revealing moderate amount of alkaloids and phenolics, trace 
amount of saponins and appreciable amount of steroids within EtOH extracts.  
In addition, moderate quantities of alkaloids, tannins and steroid, trace amount 
of triterpenes were present in EtOAc extracts.205 Several of these 
phytochemicals were found in bark and leaf P. macrophylla EtOH and EtOAc 
extracts.  
 
P. macrophylla extracts varied in their direct antioxidant ability summarised in 
Table 5-2, with EtOH extracts emerging as the most active.  Highest DPPH 
radical scavenging ability was observed in the EtOH extract (58.9%), whereas 
the EtOAc and HEX extracts shared similar antioxidant activity (9.8% and 
8.9% respectively).  A positive correlation was noted between antioxidant 
activity and phenolic content.   
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Table 5-6: Free radical scavenging ability of Pseuduvaria macrophylla 
extracts 
P. macrophylla extract Free radical scavenging (%) 
EtOH 58.9 ± 15.9 
EtOAc 9.8 ± 2.9 
HEX 8.9 ± 3.0 
Average % of free radical scavenging ability of extracts ± SEM are shown; the 
antioxidant content was determined using a standard curve of quercetin (0 ± 1.2 
mg/ml). Pearson product-moment correlation coefficient was used to measure 
correlations of free radical scavenging (%) between extracts; three independent 
experiments were performed (n = 4). 
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5.1.4 Summary of chemical contents and free radical 
scavenging activity in UNMC extracts 
In general, UNMC extracts do possess moderate amounts of phenolic and 
flavonoid compounds and displayed potent antioxidant activity.  As previously 
mentioned, many of the already known plant-derived drugs are naturally 
occurring phytochemicals e.g. flavonoids and phenolics and it is known that 
compounds with antioxidant activity can be used in chemoprevention.255  
 
Archidendron ellipticum:  Similar quantities of flavonoids were detected 
across the bark (~ 2.5 mg QE) and leaf (~ 3.5 mg GAE) extracts.  The level of 
phenolic compounds varied across the extracts and bark extracts contained 
greater amounts than leaf extracts.  Leaf EtOH extract contained good levels of 
flavonoids and phenolics and demonstrated greatest DDPH scavenging activity 
(66.7%).  EtOH and EtOAc bark and EtOAc and HEX leaf extracts 
demonstrated modest antioxidant activity (24.1% to 43.8%).  HEX bark extract 
was the least active in free radical scavenging (3.9%).  It was interesting to 
observe that HEX leaf extract demonstrated greater antioxidant activity 
(24.1%) to HEX bark extract that are of similar levels of the aforementioned 
extracts. 
 
Duabanga grandiflora: In general, Water bark extract and Water, EtOH and 
(W2$FOHDIH[WUDFWVFRQWDLQHGaPJRIIODYRQRLGVDV4(DQGa
PJRISKHQROLFVDV*$(DQG\LHOGHGIUHHUDGLFDOVFDYHQJLQJDFWLYLW\
Interestingly, EtOH bark extract contained the greatest amount of phenolics 
and the least amount of flavonoids, however the antioxidant activity was only 
38.3%.  Whereas, EtOAc bark extract contained modest amounts of flavonoids 
(0.97 mg) and phenolics (9.57 mg) yet the antioxidant activity was 86.3% as 
compared 94.4% Water bark extract (flavonoids: 3.01 mg and phenolics: 
12.73).  Both HEX extracts contained the least amount of flavonoid and 
phenolic compounds accompanied by lowest % of DPPH scavenging.   
 
Pseuduvaria macrophylla: EtOH and EtOAc extracts contained the same 
flavonoid content (2.39 mg, GE) and in comparison, HEX extract contained ~ 
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2-fold less flavonoid compounds; and modest levels of phenolic compounds 
were present in all extracts.  The highest antioxidant activity was seen in EtOH 
(58.9%) whereas EtOAc (9.8%) and HEX (8.9%) displayed similar levels of 
antioxidant activity.  Previously, Mahmood et al. (1986) isolated an 
aporphinoid from P. macrophylla extracts.   
 
Collectively the ranking of highest level of flavonoid compounds present in 
extracts is: A. ellipticum extracts leaf > D. grandiflora leaf > A. ellipticum 
extracts bark > P. macrophylla whole > D. grandiflora bark extracts.  The 
ranking of highest level of phenolic compounds present in extracts is: D. 
grandiflora bark > D. grandiflora leaf > P. macrophylla whole > A. ellipticum 
extracts bark > A. ellipticum extracts leaf extracts.  The ranking of highest level 
of free radical scavenging activity seen in extracts is: D. grandiflora leaf > D. 
grandiflora bark > A. ellipticum extracts leaf > A. ellipticum extracts bark > P. 
macrophylla whole extracts. 
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5.2 Chromotography of UNMC crude extracts and effects of 
fractions on cell growth 
Compound mixtures can be separated using a mobile and a stationary phase in 
chromatography.  Reverse column chromatography solid-phase extraction 
(SPE) can separate crude extracts using different eluents (of varying polarity) 
and a non-polar stationary phase into phytochemicals groups with similar 
physicochemical characteristics such as solubility, size, shape and electrical 
charge.18, 193  Subsequent analysis using hyphenated techniques such as HPLC 
and MS can produce a unique spectrum for each extract.  Each compound has a 
unique profile, which can be matched against in a database.  UNMC crude 
extracts were separated using a C-18 extraction cartridge and solvents of 
varying polarity; subsequently the fractions were analysed using LC-MS (see 
Appendix 2 for the fraction yields (%)).  Fractions were examined for their 
bioactivity by MTT assay to determine whether concentrating the active 
component(s) and/or reducing putative antagonistic or synergistic interactions 
with other phytochemicals in the complex mixture could achieve greater or the 
same activity (active fraction) or lower activity (inactive fraction).  The results 
could provide fraction leads for further bio-guided sub-fractionation and lead 
to possible study into synergistic or antagonistic activities and isolation of 
active component(s).  
 
5.2.1 Chromotography of Archidendron ellipticum crude 
extracts and in vitro growth inhibitory properties of 
fractions in MDA-MB-468 cells 
HPLC spectra of A. ellipticum bark and leaf extracts measured at 220 and 254 
nm, are shown in Figure 5-1 and the main dominant peaks are represented in 
Table 5-7.  Due to insufficient HEX bark extracts, fractionation could not be 
performed on this extract.  A solvent peak is illustrated in the spectra at tR 
~0.32 min.  There was no dominant peak present in EtOH crude bark extracts, 
which suggest glycoside compounds are unlikely to be present.  The most 
abundant peak detected in the EtOAc bark spectrum was at tR 3.10 min 
amongst several peaks between tR 2.10 to 3.00 min.  This implies that alkaloids, 
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aglycones and glycosides could be present in these crude extracts.  Similarly, 
the spectrum of crude HEX bark extract revealed various minor peaks detected 
and a major peak at tR 3.09 min at 220 nm (Figure 5-1; C); the compounds 
embedded in HEX crude extract are likely to be waxes, fats and oils.  Both 
spectra of EtOAc and HEX bark extracts reveal a peak detected at tR ~3.10 min. 
The appearance of a major peak tR ~2.10 min in EtOH and EtOAc could be 
indicative of similar components present in leaf extracts and not found in bark 
extracts.  Whereas, the appearance of tR ~ 3.11 min in HEX leaf crude extract 
suggests that some of the components are also present in the HEX bark crude 
extract; a dominate peak at tR ~ 4.97 min was also observed in HEX leaf crude 
extract.   
 
Table 5-7: Retention time and colour of Archidendron ellipticum extracts 
dominant peaks using reversed phase chromatography.  
A. ellipticum 
extracts 
Retention time (tR, min) an colour of A. ellipticum extracts 
Crude F1 F2 F3 F4 F5 F6 
Ba
rk
 
EtOH 
2.08 2.41 4.24 2.15 2.34 3.75 4.24 
 Golden 
brown Clear 
Pale 
yellow Golden Yellow 
Green 
tint Clear 
EtOAc 
3.10 - - 2.21 3.12 3.11 4.15 
 Dark green/ 
brown tint 
Yellow 
tint Clear 
Yellow 
tint 
Pale 
yellow 
Pale 
yellow 
Pale 
yellow 
HEX 
4.09 
Light green 
- - - - - - 
Le
a
f 
EtOH 
2.10 2.63 4.21 2.27 2.47 2.70 4.14 
Dark green Yellow 
tint Clear 
Yellow
/brown 
hint 
Yellow 
Yellow
/green 
tint 
Pale 
yellow 
EtOAc 
2.12 4.27 2.64 2.11 3.19 4.05 3.65 
Very dark 
green Clear Clear Clear 
Yellow 
tint 
Dark 
green Green 
HEX 
4.97 2.91 4.23 5.09 2.89 3.12 3.16 
Dark green Clear Clear Clear Yellow 
tint Yellow 
Pale 
yellow 
Extracts (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were analysed 
using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, (Phenomenex 
C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent compounds were 
detected at a wavelength of 220 nm.  Data of active fractions are highlighted in 
bold, data of inactive fractions are displayed in grey DQG µ-µ GHQRWHV QRW
available data. 
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Following chromatography of A. ellipticum crude extracts of varying polarity 
into six fractions; in vitro growth inhibitory properties of these fractions in 
MDA-MB-468 cells were examined (Table 5-8).  HPLC spectra of the active 
fractions are shown Figure 5-3 to Figure 5-6 and spectra of inactive fractions 
are shown in Appendix 3, Figure 8-15 to 8-21.  Interestingly, fractionation of 
crude EtOH bark extract revealed that F4 was the only active fraction with a 
very low GI50 YDOXH  ȝJPO almost identical to that of whole extract, 
hence it is very likely that the active component is present in this fraction and 
is worthy of sub-fractionation.  There appears to be a mixture of components in 
EtOAc bark F4 and F5 as represented by various peaks in the HPLC spectra; 
F4 and F5 exhibited greater in vitro growth inhibition in MDA-MB-468 cells 
compared to crude EtOAc extract.   
 
Table 5-8: In vitro growth inhibition effect of Archidendron ellipticum extracts 
fractions in MDA-MB-468 cells. 
A. ellipticum crude 
extract 
GI50 value >ȝJPO] 
GI50 values of A. ellipticum IUDFWLRQVȝJPO 
F1 F2 F3 F4 F5 F6 
Ba
rk
 
EtOH 
[1.73] > 50 > 50 > 50 1.75 > 50 > 50 
EtOAc 
[40.44] > 50 > 50 > 50 26.35 32.13 > 50 
HEX 
[>200] - - - - - - 
Le
a
f 
EtOH 
[40.92] > 50 > 50 > 50 2.00 7.66 > 50 
EtOAc 
[24.73] > 50 > 50 > 50 14.26 5.63 7.61 
HEX 
[>200] > 50 > 50 > 50 4.10 6.02 12.64 
([WUDFW FRQFHQWUDWLRQȝJPODWZKLFKFHOOJURZWK LVLQKLELWHGE\*,50) 
after 72 h. The mean GI50 YDOXHVȝJPO6(0ZHUHREWDLQHGIURPQ 
4) individual experiments. Fractions exhibiting GI50 values less than GI50 
parent crude extract are considered active and highlighted in bold, fractions 
with GI50 values > 5 ȝJPO DUH FRQVLGHUHG DV LQDFWLYH DQG µ-µ GHQRWHV
unavailable extracts. 
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Figure 5-1: HPLC traces of A. ellipticum crude bark extracts using 
Reversed Phase chromatography. EtOH (A), EtOAc (B) and HEX (C) 
extract eluents  (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were 
analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Figure 5-2: HPLC traces of A. ellipticum crude leaf extracts using 
Reversed Phase chromatography. EtOH (A), EtOAc (B) and HEX (C) 
extract eluents  (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were 
analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm.
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Figure 5-3: HPLC traces of A. ellipticum bark extract µDFWLYH¶ fractions 
using Reversed Phase chromatography. EtOH: F4 (A) and EtOAc: F4 (B) 
and F5 (C) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were 
analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Figure 5-4: HPLC traces of A. ellipticum leaf extract µDFWLYH¶ fractions 
using Reversed Phase chromatography. EtOH: F4 (D) and F5 (E) (1 mg/ml 
in DMSO) in 1:1 distilled water and MeOH were analysed using 10% B for 1 
min, 10-98% B over 2 min, at 98% for 2 min, (Phenomenex C18 Gemini-NX 
ȝ-110A 50x2 mm column). The eluent compounds were detected at a 
wavelength of 220 nm (i) and 254 (ii) nm. 
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Figure 5-5: HPLC traces of A. ellipticum OHDI H[WUDFW µDFWLYH¶ IUDFWLRQV
using Reversed Phase chromatography. EtOAc: F4 (F), F5 (G) and F6 (H) 
(1 mg/ml in DMSO) in 1:1 distilled water and MeOH were analysed using 10% 
B for 1 min, 10-98% B over 2 min, at 98% for 2 min, (Phenomenex C18 
Gemini-1;ȝ-110A 50x2 mm column). The eluent compounds were detected 
at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Figure 5-6: HPLC traces of A. ellipticum leaf extract µDFWLYH¶ fractions 
using Reversed Phase chromatography. HEX: F4 (I), F5 (J) and F6 (K) (1 
mg/ml in DMSO) in 1:1 distilled water and MeOH were analysed using 10% B 
for 1 min, 10-98% B over 2 min, at 98% for 2 min, (Phenomenex C18 Gemini-
1; ȝ-110A 50x2 mm column). The eluent compounds were detected at a 
wavelength of 220 nm (i) and 254 (ii) nm. 
     
154 
EtOH leaf F4 and F5 displayed by 20.5- and 5.3- fold greater activity, 
respectively against MDA-MB-468 cells compared to the crude extract; 
whereas all the other fractions induced no growth inhibition DW   ȝJPO
hence F4 and F5 should be further fractionated and apoptotic and anticancer 
properties of sub-fractions examined.  The spectra of EtOH leaf F4 revealed an 
abundance of peaks between tR ~ 2.10 to 3.16 min at 220 nm.  Major peaks at 
tR 1.98, 2.23, 2.54 and 2.70 were detected in EtOH leaf F5 at both wavelengths 
(220 and 254 nm), which could be indicative of amino acids with aromatic 
groups.  Likewise, EtOAc leaf F4, F5 and F6 exerted in vitro cytotoxic effects 
greater than previously observed in the crude extract by 1.7-, 4.4 and 3.2- fold, 
respectively; the spectra of F4, F5 and F6 reveal that several components 
eluted in these fractions share similar retention time.  Astoundingly, fractions 
IURP ³LQDFWLYH´ FUXGH HEX leaf extracts (GI50 >  ȝJPO displayed very 
potent in vitro activity revealing GI50 value  < ȝJPOwhere previously no 
activity was seen in MDA-MB-FHOOVDWȝJPO HEX crude leaf extract 
(Table 5-8).  Two dominant peaks at tR ~ 2.89 and 3.14 min were detected in 
HEX leaf F4as well as in F5 and F6 at a lower concentration.  The peaks which 
appeared in all three spectra were measured at tR ~2.89, 4.05, 4.20, 4.79 and 
4.98 min.  Overall, fractionation of A. ellipticum extract yielded fractions with 
greater in vitro activity than the crude extract.  Interestingly, EtOH bark F4 was 
the only active fraction with an almost identical activity to that seen in the 
crude extract; HEX leaf extract fractions F4, F5 and F6 displayed intriguing 
activity suggesting that in the whole extract components interact 
antagonistically or the activity of the active component(s) was µPDVNHG¶by all 
the other components and needs to be concentrated for its activity to be 
detected.  
 
Previous NCI 60 screening in the 60 cell line panel conducted by Beutler et al. 
(1997) illustrated in vitro cytotoxicity of an elliptoside isolated from A. 
ellipticum DCM:MeOH (1:1 v/v) leaf extract with mean panel GI50 of ȝJPO
This biologically active elliptoside possesses a novel structure yet shares 
similarities to saponins reported from other leguminosae.235  The NCI-60 mean 
fingerprint graph for saponin of Acer negundo and 8 unrelated cytotoxic 
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saponins was reported to have a similar cytotoxicity profile to that of the 
elliptoside (40) (Figure 5-8).235   
 
40 
 
Figure 5-7: The chemical structure of elliptoside (40) isolated from 
Archidendron ellipticum. 
 
However, in vivo screening results with a human melanoma (LOX) xenograft 
model in athymic mice and elliptoside (40) administered by intravenous and 
intraperitoneal methods only hinted at modest activity, which was expected as 
the fingerprint graph reveals that most melanoma cell lines including 
LOX1MV1, are insensitive to compound 40.235  The fingerprint graphs of 
elliptoside (40) and A. ellipticum bark extracts reveal similar sensitivity 
patterns of the cell lines hence compound 40 could reside in bark sections of A. 
ellipticum plant.  
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Figure 5-8: NCI-60 mean fingerprint graphs for an elliptoside extracted 
from A. ellipticum (synonym Archidendron ellipticum) leaf extracts 
adapted from GI50 values (log10) published by Beutler et al. (1997).235 Bars 
represent the individual mean GI50 value to the function of log10 of the cell 
line.  The overall mean GI50 value of all the cell lines was set to the center (0.0).  
Bars to the left indicate cell lines that are less sensitive than the mean whereas 
bars to the right indicate cell lines that are more sensitive than the mean to the 
extract. 
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5.2.2 Chromotography of Duabanga grandiflora crude extracts 
and in vitro growth inhibitory properties of fractions in 
HCT116 cells 
There was insufficient Water extract stock to perform analysis.  HPLC spectra 
of D. grandiflora bark and leaf extracts were measured at 220 and 254 nm 
(Figure 5-9 and Figure 5-10, respectively) and dominant peaks recorded 
(Figure 5-2).  A solvent peak is illustrated in all spectra at retention time (tR) 
~0.32 min.  The major peaks in bark extracts were revealed at tR 1.97 min 
(Water) and 1.96 min (EtOH) and minor peaks at tR 2.10 min (Water) and 2.11 
min (EtOH); similarly, the major and minor peaks in leaf extract were revealed 
at tR 1.96 (Water) min and 1.98 min (EtOH).  This suggests compounds 
(represented by the peaks) present in the crude extracts eluted are likely to be 
of the same class such as sugars, amino acids and glycosides.  A major peak at 
tR 1.99 min and a minor peak at tR 2.10 from EtOAc bark and leaf analyses also 
implies that sugars, amino acids and glycosides could be present in these crude 
extracts.  Nevertheless, the spectra of crude HEX bark extract revealed various 
minor peaks detected at 220 nm and several major peaks at tR 4.09, 4.18, 4.95 
and 5.28 min; significant peaks were not detected in HEX leaf extract (Figure 
5-11; D) at 220 nm.  Due to the non-polar nature of HEX, the compounds 
embedded in the crude extract are likely to be waxes, fats and oils.   
Chromatography of D. grandiflora crude extracts into six fractions, the sub-
fractions obtained were examined for their in vitro growth inhibitory properties 
using the MTT assay.  HPLC spectra of the active fractions are shown in 
Figure 5-11 to Figure 5-13.  Fractions from leaf extracts did not demonstrate 
any in vitro growth inhibition DW FRQFHQWUDWLRQVȝJPO (HPLC spectra of 
inactive fractions are presented in Appendix III-I to M).  Several fractions from 
bark extracts displayed growth inhibitory HIIHFWV DW   ȝJPO LQ +&7
cells (Figure 5-11 to Figure 5-13).  A major peak at tR ~1.97 min and minor 
peaks were revealed in F3, F4 and F5 from EtOH active fractions, which 
suggest this peak area contains some of the active components.  Although 
EtOH bark F2 contained the same major peak, the concentrations detected 
were much less (2-fold).  The presence of tR ~1.97 major peak in inactive F2 
and F3 EtOAc was found at a level similar to F1, F4, F5 and F6 of EtOAc 
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extracts in which activity was observed, however the spectra identifies several 
minor peaks suggesting minor components could be responsible for the activity 
or other components in F2 and F3 could cause antagonistic effects. 
 
Table 5-9: Retention time and the colour of Duabanga grandiflora extracts 
dominant peaks using reversed phase chromatography.  
D. 
grandiflora 
extract 
Retention time (tR, min) and colour of D. grandiflora 
extracts  
Crude F1 F2 F3 F4 F5 F6 
Ba
rk
 
Water 1.97 - - - - - - Dark brown 
EtOH 
1.96 4.25 2.24 1.98 1.97 1.98 2.90 
Tan brown Tan brown 
Darker 
tan 
brown 
Light 
brown Clear Clear Clear 
EtOAc 
1.99 1.99 2.51 2.74 2.00 1.97 2.70 
/LJKWµSLQH¶
brown 
Light 
brown 
Pale 
brown Golden  Golden Golden 
Yellow 
hint 
HEX 
4.09 4.22 4.22 2.64 3.09 4.12 4.11 
Dark 
yellow/ 
green hint 
Clear Clear Clear Clear Pale yellow 
Pale 
yellow 
Le
a
f 
Water 1.96 - - - - - - Dark brown 
EtOH 
1.98 2.12 2.24 4.22 2.83 4.13 4.22 
Medium 
brown 
Golden 
brown 
Golden 
brown 
Pale 
yellow/ 
brown 
hint 
Clear Yellow hint Clear 
EtOAc 
1.99 2.08 2.06 2.54 2.91 3.72 3.64 
 Dark 
green/ 
brown hint 
Pale 
yellow 
Pale 
yellow 
Pale 
yellow 
Pale 
yellow Yellow Yellow 
HEX 
4.96 4.21 4.21 4.22 4.22 3.74 4.21 
Green/ 
brown hint Clear Clear Clear Clear Clear Clear 
Extracts (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were analysed 
using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, (Phenomenex 
C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent compounds were 
detected at a wavelength of 220 nm. Data of active fractions are highlighted in 
bold, inactive fractions are displayed in grey DQGµ-µGHQRWHVQRWDYDLODEOHGDWD 
 
Interestingly, active F5 and F6 of HEX bark fractions revealed a different set 
of minor and major peaks (tR = 4.12 min; 2.75, 3.00 and 3.11 min, 
respectively); these peaks were absent from corresponding leaf fractions.  A 
major peak at tR ~1.98 min was detected in HEX bark fractions at low 
concentrations in F2, F3 and F4 amongst several minor peaks at 220 and 254 
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nm.  Noticeably, D. grandiflora EtOAc bark F1 displayed a conjoined major 
peak at tR ~1.99 min and a single major peak at tR ~1.99 in all the other 
fractions.  This major peak was the only peak detected in HEX F3 at 220 nm.  
Comparable spectra of EtOAc fractions containing a conjoined major peak in 
EtOAc leaf F1, which is similar to that seen in EtOH; the major peak at tR 
~1.99 was detected at 220 nm in all fractions.  There were few significant 
peaks detected in HEX bark fractions at 220 and 254 nm suggesting that there 
is a lack of aromatic groups, amide bonds (proteins or amino acids) present. 
 
Table 5-10: In vitro growth inhibitory effects of Duabanga grandiflora extract 
fractions in a HCT116 cells revealed by the MTT assay. 
D. grandiflora 
crude extract 
GI50 value >ȝJPO] 
GI50 values of D. grandiflora IUDFWLRQVȝJPO 
F1 F2 F3 F4 F5 F6 
Ba
rk
 
EtOH 
[37.54] > 50 > 50 30.01 27.41 15.90 > 50 
EtOAc 
[21.69] 38.76 > 50 > 50 39.30 28.99 27.09 
HEX  
[28.88] > 50 > 50 > 50 > 50 29.62 41.60 
Le
a
f 
EtOH 
[40.92] > 50 > 50 > 50 > 50 > 50 > 50 
EtOAc 
[24.73] > 50 > 50 > 50 > 50 > 50 > 50 
HEX 
[>200] > 50 > 50 > 50 > 50 > 50 > 50 
Extract concentrations ȝJPODWZKLFKFHOOJURZWKLVLQKLELWHGE\*,50) 
after 72 h treatment. Mean GI50 YDOXHVȝJPO6(0ZHUHREWDLQHGIURP
(n = 4) individual experiments. Fractions exhibiting GI50 values less than GI50 
parent crude extract are considered active and highlighted in bold, fractions 
with GI50 values > 1 ȝJPO DUH FRQVLGHUHG DV LQDFWLYH DQG µ-µ GHQRWHV
unavailable extracts. 
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Overall, only F4 and F5 of EtOH bark fractions revealed greater growth 
inhibitory activity than that of the crude extract by 1.4- and 2.4- fold, 
respectively, therefore these two fractions should be subjected to further bio-
guided fractionation in order to isolate and identify the active components.  
The decrease in activity of EtOAc bark F2 suggests that the embedded 
phytochemicals interact synergistically.  Furthermore, HEX bark F5 displayed 
a similar GI50 value to that of the crude suggesting that the active component(s) 
is embedded in this fraction and is worthy of further investigation.  Since 
eugeniin has been isolated from D. grandiflora, the presence of aromatic 
groups should be expected.  Cytotoxic effects of compounds extracted from D. 
grandiflora on HuCCA-1, A549, HeLa, HepG2 and MDA-MB-231 have been 
demonstrated by Kaweetripob (2012) et al.193 
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Figure 5-9: HPLC traces of D. grandiflora crude bark extracts using 
Reversed Phase chromatography. Water (A), EtOH (B), EtOAc (C) and 
HEX (D) extract eluents (1 mg/ml in DMSO) in 1:1 distilled water and MeOH 
were analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
FRPSRXQGVZHUHGHWHFWHGZLWKD89OLJKWDWȜ 220 (i) and 254 (ii) nm.  
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Figure 5-10: HPLC traces of D. grandiflora crude leaf extracts using 
Reversed Phase chromatography. Water (A), EtOH (B), EtOAc (C) and 
HEX (D) extract eluents (1 mg/ml in DMSO) in 1:1 distilled water and MeOH 
were analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50 x 2 mm column).  The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm.  
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Figure 5-11: HPLC traces of D. grandiflora bark extract µDFWLYH¶IUDFWLRQV
using Reversed Phase chromatography. EtOH: F3 (A), F4 (B), F5 (C) and 
F6 (D) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were analysed 
using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, (Phenomenex 
C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent compounds were 
detected at a wavelength of 220 nm (i) and 254 (ii) nm.  
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Figure 5-12: HPLC traces of D. grandiflora bark extract µDFWLYH¶IUDFWLRQV
using Reversed Phase chromatography. EtOAc: F1 (E), F4 (F), F5 (G) and 
F6 (H) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were analysed 
using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, (Phenomenex 
C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent compounds were 
detected at a wavelength of 220 nm (i) and 254 (ii) nm.  
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Figure 5-13: HPLC traces of D. grandiflora bark extract µDFWLYH¶IUDFWLRQV
using Reversed Phase chromatography. HEX: F5 (I) and F6 (J) (1 mg/ml in 
DMSO) in 1:1 distilled water and MeOH were analysed using 10% B for 1 min, 
10-98% B over 2 min, at 98% for 2 min, (Phenomenex C18 Gemini-1;ȝ-
110A 50x2 mm column). The eluent compounds were detected at a wavelength 
of 220 nm (i) and 254 (ii) nm.  
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5.2.3 Chromotography of Pseuduvaria macrophylla crude 
extracts and in vitro growth inhibitory properties of 
fractions in HCT116 cells 
HPLC spectra of available P. macrophylla crude extracts measured at 220 and 
254 nm are shown in Figure 5-14 and a summary of the main dominant peak is 
represented in Table 5-11.  A solvent peak is illustrated in all spectra at tR 
~0.31 min.  The major peak present in EtOH, EtOAc and HEX crude extracts 
was detected at tR ~2.18 min. Compounds present in EtOH and EtOAc could 
be in the class of alkaloid, aglycone and glycoside compounds. Figure 5-14 
displayed spectra, which revealed other peaks in both extracts were at tR ~2.40 
min and 2.74 min amongst several minor peaks. 
 
Table 5-11: Retention time of Pseuduvaria macrophylla extracts dominant 
peaks using reversed phase chromatography.  
P. 
macrophylla 
extracts 
Retention time (tR, min) and colour of P. macrophylla 
extracts  
Crude F1 F2 F3 F4 F5 F6 
EtOH 
2.40 4.24 1.11 2.18 2.76 3.58 2.71 
Dark brown/ 
green hint 
Yellow 
tint 
Yellow 
tint 
Light 
brown Tan brown 
Light 
brown 
Light 
brown 
EtOAc 
2.16 2.43 1.11 2.18 2.73 3.58 4.25 
Dark brown/ 
green hint 
Yellow 
tint 
Yellow 
tint 
Yellow 
tint 
Yellow/ 
green hint Yellow 
Yellow 
tint 
HEX 
- 
- - - - - - 
 Green 
Extracts (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were analysed 
using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, (Phenomenex 
C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent compounds were 
detected at a wavelength of 220 nm.  Data of active fractions are highlighted in 
bold, data of inactive fractions are displayed in grey DQG µ-µ GHQRWHV QRW
available data. 
 
Comparable peaks were observed in HPLC spectra of EtOH crude extract 
analysed at 220 and 254 nm suggesting aromatic compounds and amide bonds 
are present in the fraction; the same observation was noticed for EtOAc crude 
extract.  Following chromatography of P. macrophylla crude extracts of 
varying polarity were separated into six fractions.  Following freeze-drying and 
reconstitution (100 mg/ml DMSO) growth inhibitory properties of fractions 
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were examined in HCT116 cells using the MTT assay.  HPLC spectra of the 
active fractions are shown in Figure 5-16 to Figure 5-17 and spectra of inactive 
fractions are shown in Appendix 3, Figure 8-22 and 8-23.  P. macrophylla 
EtOH and EtOAc F3 displayed potent growth inhibitory effects in HCT116 
cells yielding GI50 concentrations lower than the crude extracts by 2.1-fold ( 
Table 5-12).  Results from the MTT assay revealed that the most active 
components in EtOH and EtOAc is embedded in F3; spectra of F3 illustrated a 
major peak at tR ~2.18 min (254 nm) as well as several minor peaks.  There 
were many minor peaks detected in EtOH F4 and F6, which suggest the 
presence of aromatic groups; however this fraction was less active than the 
crude extract.  The detection of EtOAc F4 at both wavelengths suggests that 
components with aromatic rings and amide bonds were present in the fraction; 
however F4 is less active than the crude extract.  Mahmood et al (1986) 
elucidated aporphinoid (1,2,3-trimethoxy-4,5-dioxo-6a,7-dehydroaporphine) in 
P. macrophylla and Wirasathien et al. (2006) reported the same alkaloid in 
Pseuduvaria setosa, described as a yellow amorphous  powder, which may 
possibly be present in EtOH F1 and F2 and/or EtOAc F2 to F6 in varying 
quantities.213 
 
Table 5-12: In vitro growth inhibition effects of Pseuduvaria macrophylla 
extract fractions in HCT116 cells. 
P. macrophylla 
crude extract 
GI50 value 
>ȝJPO] 
GI50 values of P. macrophylla IUDFWLRQVȝJPO 
F1 F2 F3 F4 F5 F6 
EtOH 
[5.16] > 10 > 10 
2.50 ± 
0.74 
6.48 ± 
1.27 > 10 
8.06 ± 
1.17 
EtOAc 
[1.61] > 10 > 10 
0.75 ± 
0.13 
3.33 ± 
0.61 > 10 > 10 
HEX 
[5.41] - - - - - - - 
([WUDFW FRQFHQWUDWLRQȝJPODWZKLFKFHOOJURZWK LVLQKLELWHGE\*,50) 
after 72 h. The mean GI50 YDOXHVȝJPO6(0ZHUHREWDLQHGIURPQ 
4) individual experiments.  Fractions exhibiting GI50 values less than GI50 
parent crude extract are considered active and highlighted in bold, fractions 
with GI50 values > 1 ȝJPO are considered as inactive DQG µ-µ GHQRWHV
unavailable extracts.  
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Figure 5-14: HPLC traces of P. macrophylla extracts using Reversed Phase 
chromatography. EtOH (A) and EtOAc (B) extract eluents (1 mg/ml in 
DMSO) in 1:1 distilled water and MeOH were analysed using 10% B for 1 min, 
10-98% B over 2 min, at 98% for 2 min, (Phenomenex C18 Gemini-1;ȝ-
110A 50x2 mm column).  The eluent compounds were detected at a 
wavelength of 220 nm (i) and 254 (ii) nm. 
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Figure 5-15: HPLC traces of P. macrophylla extract fractions using Reversed 
Phase chromatography. EtOH: F3 (A), F4 (B) and F6 (C) (1 mg/ml in DMSO) in 
1:1 distilled water and MeOH were analysed using 10% B for 1 min, 10-98% B over 
2 min, at 98% for 2 min, (Phenomenex C18 Gemini-1;ȝ-110A 50x2 mm column). 
The eluent compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Figure 5-16: HPLC traces of P. macrophylla extract fractions using Reversed 
Phase chromatography. EtOAc: F3 (A) and F4 (B) (1 mg/ml in DMSO) in 1:1 
distilled water and MeOH were analysed using 10% B for 1 min, 10-98% B over 2 
min, at 98% for 2 min, (Phenomenex C18 Gemini-1;ȝ-110A 50x2 mm column). 
The eluent compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Figure 5-17: HPLC traces of P. macrophylla extract fractions using 
Reversed Phase chromatography. EtOAc: F3 (D) and F4 (E) (1 mg/ml in 
DMSO) in 1:1 distilled water and MeOH were analysed using 10% B for 1 min, 
10-98% B over 2 min, at 98% for 2 min, (Phenomenex C18 Gemini-1;ȝ-
110A 50x2 mm column). The eluent compounds were detected at a wavelength 
of 220 nm (i) and 254 (ii) nm. 
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6  
Conclusion and future direction 
Selection of UNMC plants Acalypha wilkesiana, Duabanga grandiflora, 
Archidendron ellipticum and Pseuduvaria macrophylla, for investigation was 
based on different approaches e.g. random screening of plants with unknown 
biological activity or selection on the basis of traditional use reported in 
literature.  A range of bioassays and a panel of cancer cell lines were employed 
in systematic examination of UNMC plants¶H[WUDFWV, starting with examination 
of any untoward activity (cytotoxicity, cytostasis) against cancer cells.  Data 
from initial stages of this project provided direction to explore extracts¶-
induced growth inhibition observed and the induction of apoptosis to provide 
information on the mechanism of action of UNMC extracts.  Simultaneously, 
extracts were also tested for activities against cell migration (important in 
invasion and metastasis), colony formation ability (responsiveness to cell death 
signals) and induction of senescence (limiting replicative potential). 
Furthermore, preliminary fractionation of UNMC crude extracts was 
performed alongside in vitro examination of crude extracts to further explore 
anticancer activities of extract fractions and to provide guidance on selection of 
isolation of compounds in active sub-fractions in earlier stages.  Malaysian 
rainforest plants selected for this project have revealed interesting and valuable 
information from a series of assays and are worthy of further investigation as 
summarised overleaf. 
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Table 6-1: Summary table outlining each activity performed 
Assay 
(indication) Description 
Most active 
plant(s) 
MTT 
(viability) 
>ȝJPO- ȝJPO@A. 
wilkesiana, A. ellipticum, D. 
grandiflora 
>ȝJPO- ȝJPO@P. 
macrophylla 
Exposure: 72 h 
P. 
macrophylla 
Clonogenic 
(survival) 
GI50: [0X, 0.5X, 1X and 2X]  
Exposure: 24 h 
D. 
grandiflora 
PI staining 
(cell cycle distribution) GI50: [0X, 1X, 2X and 4X] 
Exposure: 48 h 
D. 
grandiflora 
and P. 
macrophylla 
Annexin V-FITC/PI 
staining 
Western blot 
(Apoptosis) 
GI50: [0X, 1X, 2X and 4X] 
GI50: [0X, 1X and 5X] 
Exposure: 24 h and 48 h 
D. 
grandiflora 
and P. 
macrophylla 
Scratch 
(Migration) 
GI50: [0X, 1X and 4X] 
([SRVXUHKDQGK 
P. 
macrophylla 
Ǻ-galactodase detection 
(Senescence) 
GI50: [0X, 1X and 2X] 
Exposure: 7 to 12 days A. ellipticum 
Aluminium trichloride 
Folin-Ciolteau 
(Chemical content) 
Extract concentration [1 mg/ml], 
total flavonoid content as quercetin 
equivalent.  
Extract concentration [1 mg/ml], 
total phenolic content as gallic acid 
equivalent.  
D. 
grandiflora 
DPPH 
(Free radical scavenging) 
Extract concentration [1 mg/ml]. D. 
grandiflora 
HPLC 
(Fractionation) 
Fractionation using solvent 
gradients consisting of Water, 
MeOH and MeCN, a total of 6 
fractions of decreasing polarity  
Detection wavelengths: 220 and 
254 
A. ellipticum 
Broth dilution assay 
(Antimicrobial activity) 
[1 ± 128 µg/ml]: D. grandiflora, P. 
macrophylla 
Exposure: 24 h and 48 h 
D. 
grandiflora 
and P. 
macrophylla 
Summary table listing the assays performed and the respective UNMC plant(s) 
that contributed towards the most favourable result for that assay.  
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Acalypha wilkesiana (Euphorbiaceae) 
Polar (EtOH and EtOAc) extracts of A. wilkesiana were able to cause growth 
inhibitory effects across the cell line panel (cell line panel mean GI50 (ȝJPO): 
EtOH = 51.79; EtOAc = 55.99; HEX = > 200).  Breast cancer MDA-MB-468 
cells without ER, PR and Her-2 expressions revealed the greatest sensitivity 
towards compounds present in EtOH and EtOAc extracts (GI50: 22.67 and 
15.88, respectively) and some selectivity was observed as GI50 values against 
MRC-5 fibroblasts (GI50: 46.60 ȝJPO and 53.26 ȝJPO, respectively) was 
observed.  Inhibition of colony formation induced by EtOH extracts (at 36 
ȝJPO and 72 ȝJPO) was observed in approximately 70% of MDA-MB-468 
cells within 24 h.  A similar effect was observed with HEX extracts, however 
the concentrations used were too high to be considered as µactive¶ according to 
WKH 1&,¶V DFWLYH FUXGH H[WUDFW FULWHULD.  Detection of increased sub-G1 cell 
population suggests EtOH extract was able to cause cellular damage leading to 
cell death; however this effect was not deemed as significant in MDA-MB-468 
cell cycle distribution.  A. wilkesiana illustrated significant growth inhibitory 
effects in triple-negative MDA-MB-468 cells, therefore, the presence of HER, 
ER and PR receptors may not be a factor determining sensitivity of cells to 
these plant extracts suggesting the active constituents may or may not be in the 
phytochemical class of isoflavonoids or flavonoids.   
Collectively, results may suggest impaired proliferation and colony formation 
inhibition were due to DNA damage leading to cell cycle arrest (for repair) or 
cell death (irreparable damage); such findings are in agreement with data 
previously reported of double-strand break (DSB) and single-strand break 
(SSB) accumulation and execution of apoptosis by A. wilkesiana.234  The 
effects observed could be due to cytotoxic constituents previously identified in 
A. wilkisiana extracts that have the ability to induce apoptosis such as 
anthraquinone (via caspase 8), corilagin (via G2/M arrest), gallic acid (via 
G0/G1 arrest), geraniin (by up-regulation of Fas ligand), kaempferol (by p53 
activation).175  Since cytotoxic compounds have been previously found in this 
plant, continuing with detailed in vitro investigations may not serve much 
purpose (response will be observed due to known cytotoxic compounds), 
whereas fractionating extracts from this plant would be of greater interest to 
isolate potential new compounds and investigate any potential novel effects. 
 175 
Archidendron ellipticum (Leguminosae) 
Polar (EtOH and EtOAc) extracts of A. ellipticum contain compounds causing 
most potent growth inhibition in MDA-MB-468 cells (Bark GI50 (ȝJPO): 
EtOH = 1.7; EtOAc = 40.9; HEX = > 200; Leaf GI50 (ȝJPO): EtOH = 9.3; 
EtOAc = 9.3; HEX = > 200).  On the whole, bark extracts were more active 
than leaf extracts against the cell line panel, however only leaf EtOAc extract 
demonstrated selectivity between MDA-MB-468 cells and MRC5 fibroblasts 
(GI50 = 69.7 ȝJPO).  Separation of bark EtOH extract revealed a single active 
fraction (F4; GI50: ~1.75 ȝJPO) causing growth inhibition at the same 
concentration of the crude extract (GI50: ~1.73 ȝJPO), further fraction 
separation is justified, towards isolation of single active compounds.   
Although, crude HEX extracts failed to inhibit growth at concentrations as 
JUHDWDVȝJPO, it is intriguing that extract separation yielded fractions with 
significantly enhanced (> 50-fold) growth inhibitory activity in the fractions 
(GI50 (ȝJPO): F4 = 10.0; F5 = 6.0; F6 = 12.6), which strongly suggests 
antagonism and/or masking of hydrophobic compounds present in the crude 
extracts.  A. ellipticum fractions illustrated comparable or greater activity than 
their crude extracts, which suggests DQWDJRQLVP RU µPDVNLQJ¶ RI DFWLYLW\.  
Further fractionation may reveal compounds of greater activity in sensitive cell 
lines worthy of isolation and testing.  A. ellipticum illustrated greatest growth 
inhibition in triple-negative MDA-MB-468 cells, therefore the active 
constituents may not be in the phytochemical class of isoflavonoids or 
flavonoids.  Polar extracts of bark and leaf were most active against MDA-
MB-468 colony formation with  40% of cells unable to proliferate and form 
colonies.  This could be as a result of apoptosis initiation by compounds 
present in the extracts, as shown by increased sub-G1 populations and 
detection of PS on the outer membrane in  40% of the cells after 48 h 
treatment.  Induction of apoptosis will lead to the inability of cells to 
proliferate and inhibit colony growth.  Bark and leaf HEX extracts were able to 
induce highest numbers of senescent cells detected in comparison to other 
extracts examined.  Other compounds in the crude mixture, possibly sterols, 
triterpenes, coumarins and saponins can scavenge free radicals and it appears 
WKDWH[WUDFWV¶DELOLW\WRLQGXFHVHQHVFHQFHLVLQYHUVHO\UHODWHGWRWKHLUDELOLW\WR
scavenge free radicals.235   
 176 
Duabanga grandiflora (Lythracae) 
Sensitivity of cancer cells varied towards D. grandiflora extracts. Modest 
growth inhibitory activity and selectivity between MRC5 fibroblasts and CRC 
HCT116 cells were seen with polar (Water and EtOH) extracts.  Moreover, 
EtOAc extracts were the most active against the panel of cell lines tested (mean 
GI50 ȝJPO bark EtOAc = 31.58 and leaf EtOAc = 43.78).  Interestingly, 
non-polar bark HEX extract also demonstrated good growth inhibitory effects 
against the cell line panel (GI50 = 36.36 ȝJPO), which is in contrast to leaf 
HEX extract (GI50 = > 200 ȝJPO).  However, lack of selectivity between 
cancer cell lines and MRC5 fibroblast was observed with less polar extracts.  
Separation of crude bark extracts has revealed antagonistic interaction or 
masking of activity in the crude mixture.  It will be of interest to priortise 
additional fractionation of EtOH and HEX bark fractions in an attempt to 
identify sub-fractions with greater growth inhibitory activity in HCT116 cells 
than seen with the crude extracts.  While loss of activity seen in all leaf extracts 
following fractionation suggests separated compounds contained in different 
fractions may have been interacting in a synergistic manner previously.    
Unexpectedly, 6L+D FHOOV¶ JURZWK ZDV QRWDIIHFWHGE\ low concentrations D. 
grandiflora polar extracts although studies revealed eugeniin activity against 
:DONHU FDUFLQRVDUFRPD  LQ UDWV ZKLFK PD\ EH GXH WR µPDVNLQJ¶ RU
antagonism of (a) particular compound(s) activity by other compounds which 
comprise the chemical mixtures of crude extracts.  It would be of interest to 
investigate the expression levels of viral proteins in light of reports of 
HXJHQLLQ¶VDFWLYLW\KLQGHULQJ+6951$DQG'1$UHSOLFDWLRQ Accumulation 
of sub-G1 and G1/0 cell populations accompanied by decreased events in S 
and G2/M suggest cells were unable to progress through G1 phase and as 
apoptosis was triggered (positive Annexin V+/PI- binding and activated caspase 
3 protein).  These observations imply that damage induced by compounds 
present in D. grandiflora polar extracts were sufficient to affect cell survival 
and prevent subsequent colony formation; this effect was seen to a lesser extent 
in less polar extracts.   
Previously, a range of compounds has been isolated from D. grandiflora 
extracts and some constituents can induce apoptosis such as ellagic acid (by G1 
phase arrest), hentriacontane, hentriacontanol, b-sitosterol, a-amyrin, 
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epifriedelinol, betulinic acid, acacetin and tetramethylellagic acid.  Similarly, D. 
grandiflora EtOH bark fractions and all leaf extract fractions possessed greater 
activity than the crude extract suggesting antagonistic or masking activity of 
compounds in crude mixtures.   
Furthermore, D. grandiflora crude EtOH and HEX bark extracts appear to 
contain compounds that may inhibit cell migration, possibly via TNF-Į 
pathway, which may be due to the detected caspase 3 activation (Figure 6-1).  
A low level of senescence (< 10%) was present in EtOH treated cells but was 
comparable to the control. Greatest free radical scavenging (FRS) activity was 
seen in D. grandiflora in comparison to all of the UNMC plants tested.  Free 
radical scavenging activity decreased with extract polarity; highest levels of 
free radical scavenging (~ 95%) was seen with polar extracts since significant 
quantities of phenolics and flavonoids were detected.  Extraction of plants 
using polar solvents (Water, EtOH and EtOAc) yielded extracts with good to 
moderate activity implying compounds such as sugars, amino acids, glycosides, 
alkaloids, aglycones, glycosides could be present in the crude extracts.  D. 
grandiflora bark HEX extracts revealed growth inhibitory effects in HCT116 
cells.  Compounds of chemical class of waxes, fats and oils could be extracted 
in non-polar hexane solvent, hence may be responsible for the activity.  It is 
also interesting to note that in agreement with recent studies, D. grandiflora 
extracts were able to inhibit both Gram ±ve and Gram +ve bacteria (8 ± 32 
mg/L), which may be due to ellagic acid and betulinic acid.189 
  
Pseuduvaria macrophylla (Annonaceae) 
P. macrophylla extracts demonstrated the greatest growth inhibitory and anti-
clonogenic effects across the cell line panel (mean GI50: EtOH: 5.05, EtOAc: 
2.02 and HEX: 11.99 ȝJPO) in the MTT and clonogenic assays.   
P. macrophylla HEX extract-treated cells were able to form colonies following 
extract removal suggesting cellular damage was reversible, therefore different 
compounds influencing different mechanisms may be responsible for the 
effects observed or longer exposure time might be required for accumulation of 
damage that is beyond  repair.  Collectively, P. macrophylla crude extracts 
may contain compounds that can inhibit cell growth and colony formation by 
inducing DNA damage.  This may result in cell cycle arrest to allow for DNA 
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repair, activation of apoptosis due to irreparable DNA damage or induction of 
cellular senescence or LPSDLULQJ FHOOV¶ SUROLIHUDWLYH SRWHQWLDO Alkaloids 
contained in P. macrophylla (Annonaceae) are very likely to be accountable 
for the observed effects such as increased G2/M cell population preceding cell 
death.209  In comparison, it is known that vinca alkaloids isolated from C. 
roseus (Apocynaceae) possess anti-microtubule, anti-mitotic activity leading to 
G2/M block.10  Subsequently, flow cytometric and Western blotting techniques 
have confirmed apoptotic cell populations and caspase-3 (cleavage) activation.  
P. macrophylla HEX extracts revealed selective growth inhibitory effects in 
HCT116 cells, compounds classes comprising of chemical class of waxes, fats 
and oils could be extracted in non-polar hexane solvent, hence the above 
mentioned chemicals could be responsible for the observed activity.  
Compound 38 previously isolated from P. macrophylla may also be 
responsible for the observed effects since similar activity was observed in NCI-
H187 cells (3.0 ȝJPO).214  However compounds (possibly compound 38) in F3 
yielded greater effects in HCT116 cells (0.75 ȝJPO).  Similarly low levels (< 
10%) of senescent cells were observed following EtOH and EtOAc treatments 
and were similar to levels observed in control cells.  Remarkably, P. 
macrophylla extracts were able to inhibit both Gram ±ve and Gram +ve 
bacteria at very low concentrations (8 ± 32 mg/). 
In comparison, there is also limited information on the biological activity of a 
related species Uvaria Macrophylla due to its decline in recent years.  
Nevertheless, U. macrophylla bark and leaf (EtOH, CHL and HEX) extracts 
appeared to be potent against MCF-7 and HCT116 cells (see appendix 4).  
CHL and HEX extracts were able to inhibit growth of both cell lines by 50% at 
low concentrations (3.25 to 27.03 ȝJPO).  These GI50 values are comparable to 
that observed in HCT116 cells exposed to P. macrophylla EtOH, EtOAc and 
HEX extracts (GI50: 5.16, 1.61 and 5.41 ȝJPO, respectively).  In general, 
similar inhibition of colony formation was observed with U. macrophylla 
extracts, however EtOH concentrations used were  -fold greater than P. 
macrophylla EtOH extract.  Preliminary cell cycle distribution data suggest 
that no changes were induced by U. macrophylla EtOH and HEX extracts 
(Appendix 4, Figure 10-24), whereas increased sub-G1 HCT116 cell 
population with CHL extracts is indicative of apoptotic cells and should be 
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confirmed by the Annexin V-FITC assay.  Other studies in China revealed 
EtOH root extract from U. macrophylla and isolated a new dihydroflavone, 
macrophyllol as well as uvamalols and uvarimacrophin, dihydroflavones, 
acetogenins, polyoxgenated cyclohexenes and (benzylisoquinoline) 
alkaloids.268, 269  Since the Annonaceae family is known for possessing 
alkaloids and both Uvaria and Pseuduvaria genus have been previously 
identified to possess new compounds, these two plants are worthy of further 
investigation such as bio-guided fractionation leading to isolation and structure 
elucidation of the active compound(s).  
 
Overall, all of the UNMC plants selected for this investigation revealed 
intriguing anticancer properties worthy for further examination.  It is important 
to continue fractionation of these crude extracts in order to isolate and 
elucidate structures of active compounds.  This could be achieved by using 
hyphenated methods consisting of e.g. HPLC, MS, NMR, technologies that 
would provide information of chemical composition of pure active compounds 
for identification on natural compound databases (de-replication).  Analytical 
results obtained would offer a deeper insight into the class of chemical group 
present; hence enabling estimation of activity (reaction groups) and hypotheses 
of mechanism(s) of action(s).  It may be considered inefficient to only 
performing bioassays on crude extracts containing a mixture of compounds; 
likewise, it maybe inefficient to spend significant time conducting only 
separation and isolation procedures to identify various compounds present in 
the crude extracts since there may be no suitable (inactive or already known) 
compounds present.  A selection of in vitro tests should be performed in 
parallel with analytical assays, the efficiency of two processes may be 
improved and decisions regarding pursuit of investigation could be facilitated 
based on the preliminary biological and analytical data obtained.  This is also 
of importance for sub-fractions, which demonstrate activity where the whole 
crude extract failed to show activity.  
On isolation of the active compound, detection of pro-apoptotic members of 
Bcl-2 family expression e.g. BAX, and BAK and regulators of the anti-
apoptotic Bcl-2 proteins to promote apoptosis e.g. BAD, NOXA and PUMA, 
could provide insight into the possible involvement of proteins from the 
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extrinsic or intrinsic apoptotic pathways e.g. FasL, TNF and TRAIL or 
mitochondria-caspase interaction leading to apoptosis, respectively.270  Bid is 
the common modulator between the intrinsic and extrinsic pathways; cleavage 
of Bid by caspase 8 (extrinsic pathway) enables communication with the 
intrinsic pathway by activating Bax/Bak protein leading to cytochrome c 
release and mitochondrial fragmentation.270  Hence it is important to consider 
the detection of caspase 8 and cleaved Bid (tBid) protein expression in UNMC 
extract-treated cells to distinguish between intrinsic or extrinsic pathway that 
has led to activation of caspase 3.  In addition, expression of other proteins of 
interest may also provide further mechanistic insight including Ȗ+$; D
marker of DNA double-strand breaks KLVWRQH Ȗ+$; LV SKRVSKRU\ODWHG RQ
serine 139 by PI3-family) H2AX protein is also involved in DNA repair and 
regulation cell cycle division hence possesses a role in genomic stability.88  
Cytosolic cytochrome C levels would distinguish intrinsic apoptotic pathway; 
cleaved PARP protein could confirm subsequent activation of caspase 3.271  
Inhibition of cell migration following treatment of UNMC extracts may be due 
to involvement of the TNF-Į pathway and subsequently activating caspase 3 
activation and inhibition of NF-kB inhibition hence preventing signals to EMT 
induction (Figure 6-1).272  
 
 
Figure 6-1: The downstream signaling pathways of TNF-Į as illustrated by 
Wu and Zhou (2010). TNF-Į can activate two types of TNF receptors (TNFR 1 
and 2).  TNFR1 can induce apoptosis by binding caspase 8 to Fas-Associated 
protein with Death Domain (FADD).  TNFR2 can promote inflammation and 
cell survival via activation of NF-kB and Akt signaling pathways, which can 
give rise to EMT and invasion in tumour cells.272 
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Furthermore, another interesting assay to investigate possible targets of active 
compounds would be using micro-array techniques to enable a range of protein 
targets to be identified thus generating a fingerprint profile for the plants.  
Similarly, metabolite profiling could SURYLGHLQIRUPDWLRQRQH[WUDFWV¶influence 
on metabolism pathways in a biological system.273  Any similarity with 
existing profiles could provide suggestions of possible mechanism of action or 
reveal any unique patterns.   
Determination of the type of DNA damage induced by different compounds 
present in UNMC extracts could provide additional insight into possible 
mechanisms.  For example COMET assay would be able to detect whether 
single strand breaks or double strand breaks have occurred within the DNA, 
however there will be a need to distinguish between the causes of DNA strand 
breaks i.e. a consequence of caspase cleavage (during apoptosis) or extracts per 
se.  Subsequently, it would be of interest WR H[DPLQH LVRODWHG FRPSRXQGV¶
abilities to inhibit invasion, angiogenesis and metastasis by growing cells on 
wells with a matrigel and measure if cells are able to migrate through this 
barrier.  $GGLWLRQDOµQRUPDO¶FHOOOLQHVVKRXOGEHXVHGWRGHWHUPLQHtherapeutic 
window and any active compounds could be used as a template for structural 
modification in order to achieve selectivity between cancer cells and normal 
cells.   
There is such a huge variety of assays that are available, however it is 
important to consider the nature of compound(s) isolated from these plants in 
order to select purposeful assays to yield more significant results.  In addition, 
compounds testing negative for anticancer properties does not mean they are 
unsuccessful candidates for other disease areas and it is important to document 
both positive and negative findings to avoid replication of work and for use by 
other researchers.   
 
From this body of work, it is concluded that there are several general yet 
critical points to be made when investigating natural products for therapeutic 
use, in particularly as anticancer agents.     
These points could be broadly categorised into non-practical and practical 
concerns.  
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Firstly, one of the main concerns in natural product research surrounds the 
processes of collection (e.g. random versus literature/ethnopharmacological 
systems, correct verification of specimens and sustainability of the source) and 
standardisation of raw material (e.g. location and the environment, 
developmental stage of the plant, storage conditions of collected material, 
techniques) as well as the subsequent extraction process used.   In addition, 
publication of results is necessary for de-replication and further information on 
the plant profile.  The lack of supply of A. wilkesiana and P. macrophylla from 
their primary collection location has highlighted a non-practical concern 
experienced in this project as it could mean that the interesting results obtained 
so are in vain if endangered P. macrophylla became extinct; whereas an A. 
wilkesiana specimen was found and collected from a secondary location and it 
LVYHU\OLNHO\WKDWYDULDELOLW\LQFRPSRXQGVRIWKHVHFRQGEDWFKZLOODIIHFWFHOOV¶
response and produce different in vitro results.  Therefore the importance of 
standardization is raised; use of analytical equipment to determine the variation 
between batches is essential, and decisions made as to acceptance of identical 
compound profiles or compromise for the most abundant compounds.  This 
may be overcome by ensuring enough supply prior to selection.  Once in vitro 
experiments have verified activity, enough specimens should be collected to 
perform separation and analytical analyses.  Alternatively, if the active 
compound(s) is identified then analysis of analytical data could be focused on 
the detection of the active compound(s).  
It is important to not cease testing of crude extracts prematurely and give more 
attention to bio-guided fractionation activity of these extracts; this has been 
supported by the differences observed in growth inhibition of cancer cells 
when exposed to crude (inactive) and fractionated A. ellipticum HEX extracts 
µDFWLYH¶  Collectively, the results revealed that selection of cell lines are 
dependent on the in vitro experiments being performed due to the characteristic 
variability of cell types, hence their different level of sensitivity towards 
different compounds, and the indication of the assay.  However, it is 
unnecessary to continuously test crude extracts against different cell lines in 
the early stages of in vitro testing as long as the mixture still proves to be 
µDFWLYH¶ ZLWK UHIHUHQFH WR WKH 1&,¶V JXLGDQFH DJDLQVW WKH FHOO OLQHV EHLQJ
tested.  It is important to employ analytical equipment for bio-guided 
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fractionation process, to separate and elucidate the structure(s) of active 
compound(s).  Natural product research should aim to obtain pure active 
compounds so that investigation into mechanism of action (defined targets) can 
be conducted, which would be favourable in obtaining a investigation license 
approved by regulatory bodies for clinical development in a defined population 
and indication(s), and subsequently a marketing license.  On the contrary, it is 
difficult to predict the interaction (in vivo) for a mixture of compounds (shot-
gun effect) and adverse events that may arise - hence inadequate safety profile 
and poor benefit-risk assessment of the compound.  Therefore, the UNMC 
extracts examined in this project should be subjected to further bio-guided 
fractionation and reconcile on verified databases (de-replication).  If UNMC 
extracts contain active compound(s), which are subsequently verified to be a 
novel compounds (or compounds lacking biological data) then it will be 
interesting to initiate in vivo studies.  
In general, identification and structure elucidation of active compounds and 
mechanisms of action are considerably long processes without evening 
considering antagonistic, masking or synergistic activities of crude extracts, so 
supply of material is a critical factor.  Furthermore it is also important to 
DFNQRZOHGJHWKDWWKHµLQDFWLYH¶IUDFWLRQVPD\VWLOOKDYHDUROHWRSOD\LQRWKHU
therapeutic areas, therefore it is important to analyse the results, which may 
reveal alternative uses and may be followed.  Above all, this work requires the 
experience and expertise of botanists to correctly verify specimens and vigilant 
record-keeping as well as international efforts to communicate and maintain an 
authenticate database.    
 
For potential therapeutic compounds to be identified from the diverse botanic 
systems, pharmaceutical companies will need to invest significantly into 
natural product drug discovery programs or find the balance with their 
investment into high-throughput screening technologies and compound 
libraries.  Therefore there is still a prominent role for natural compounds in 
drug discovery.  
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7  
Materials and Methods 
7.1 Materials 
7.1.1 Plant collection and identification 
Malaysian rainforest flora Acalypha wilkesiana Müll Arg., Duabanga 
grandiflora Walp, Archidendron ellipticum (Blume) Hassk and Pseuduvaria 
macrophylla (Oliv.) Merr were collected in Malaysian rainforests and 
authenticated by Dr. Christophe Wiart (Table 7-1).  The extraction of collected 
plant specimens was conducted by colleagues of the UNMC School of 
Biosciences and School of Pharmacy (chapter 4.2.1).  The UNMC plant 
extracts were delivered to the University of Nottingham, UK, and kept at ±
20 °C until use. 
 
7.1.2 Mammalian cell lines 
Human±derived cancer cell lines MCF7, MDA-MB-468, SK-OV-3, Caki-1, 
HCT116 and non-transformed cell line MRC-5 fibroblasts were purchased 
from the American Type Cell Culture (ATCC), Rockville, U.S.A.  Human 
cancer cell lines IGROV 1, TK10 and HCC 2998 and were purchased from the 
National Cancer Institute (NCI), Bethesda, U.S.A (Table 7-2). 
 
7.1.3 Bacterial strains 
Gram-negative bacteria (Pseudomonas aeruginosa, (P. aeruginosa) and 
Escherichia coli (E. coli)), Gram-positive (Staphylococcus aureus (S. aureas) 
and Enterococcus faecalis (E. faecalis) and yeast Candida albicans (C. 
albicans) were purchased from ATCC. 
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Table 7-1 UNMC Plant name and reference number, place of collection and UNMC plant extraction solvents.  
UNMC 
Number 
Genus Species Family 
Place of 
collection 
(Forest) 
 
Extraction solvent and Yield (%) 
C
hl
o
ro
fo
rm
 
H
ex
a
n
e 
Et
hy
l a
ce
ta
te
 
Et
ha
n
o
l 
W
at
er
 
9 Acalypha Wilkesiana  Euphorbiaceae Broga Whole - 0.32 0.18 3.29 - 
20 Pseuduvaria Macrophylla Annonaceae Sg. Congkak Whole - n/a n/a n/a - 
35 Archidendron Ellipticum Leguminosae Sg. Congkak Leaf - 1.79 1.82 2.33 - 
35 Archidendron Ellipticum Leguminosae Sg. Congkak Bark  - n/a 0.10 2.30 - 
37 Duabanga Grandiflora Lythraceae Semenyih Dam Leaf - 2.54 4.72 18.27 6.63 
37 Duabanga Grandiflora Lythraceae Semenyih Dam Bark - 1.02 0.64 4.11 2.73 
- Uvaria Macrophylla Annonaceae - Whole n/a n/a - n/a - 
Each plant was assigned a UNMC number and was subjected to extraction in solvents of varying polarity: chloroform (CHL), hexane (HEX), 
ethylacetate (EtOAc)HWKDQRO(W2+DQGZDWHU:DWHUDQGWKHFRUUHVSRQGLQJ\LHOGGLVSOD\HGVHYHUDOH[WUDFWV¶\LHOGVFRXOGQRWEH
determined and indicated as n/a (not available). 
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Table 7-2 Mammalian cell lines and maintenance conditions 
Further information on the human cell lines used can be obtained from the 
American Type Cell Culture (www.atcc.org) and the National Cancer Institute 
(http://dtp.nci.nih.gov).  
 
 
Cell 
type 
Cell line Reference Supplement 
B
re
as
t  
A
de
n
o
ca
rc
in
o
m
a 
MCF7 ATCC no. HTB-22 
Brooks et al. 1973219 
RPMI 1640 medium 
supplemented with 10% 
FBS in a humidified 
atmosphere at 37°C in 5% 
CO2. 
MDA-MB-
468 
ATCC no. HTB-132 
Cailleau et al. 1978220 
O
v
ar
ia
n
 
A
de
n
o
ca
rc
in
o
m
a 
IGROV1 Bénard et al. 1985221 
SK-OV-3 ATCC no. HTB-77 
Frogh et al. 1975222 
R
en
al
 
ce
ll 
ca
rc
in
o
m
a Caki-1 ATCC no. HTB-46 
Frogh et al. 1975222 
TK-10 Bear et al. 1987223 
Co
lo
re
ct
al
 
ca
rc
in
o
m
a 
HCT116 ATCC no. CCL-247 
Brattain et al. 1981224 
HCC2998 
Goldwasser et al. 
1995225  
Kobayashi et al. 
1999226 
N
o
n
-
tr
an
sf
or
m
ed
 
fo
et
al
 
lu
n
g 
fib
ro
bl
as
t 
MRC-5 ATCC no. CCL-171  Jacobs et al. 1970228 
MEME medium 
supplemented with 10% 
FBS, 7.5% sodium 
bicarbonate, 1% 0.1 mM 
Non essential amino acids, 
1 M HEPES, 1% 200 mM 
L-glutamine and 1% 
penicillin. Cells are kept in 
Humidified atmosphere at 
37°C in 5% CO2. 
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7.1.4 Antibodies 
Rabbit polyclonal antibodies (Ab) to histone H2A.X (phosphor S139; product 
code: ab11174) and rabbit monoclonal Ab to Į-Mcl1 (product code: Ab32087) 
were purchased from Abcam plc, Cambridge, UK.  Rabbit monoclonal Ab to 
PARP1 (46D11, site Gly 523; product code: 9532S), rabbit Ab to Bax (product 
code: 2772S) and mouse monoclonal Ab to Caspase 3 (product code: 9668S) 
were purchased from Cell Signaling Technology Inc., Hertfordshire, UK.  
Anti-rabbit IgG, peroxidase-linked species-specific whole Ab from donkey 
enhanced chemiluminescence (ECL; product code: NA934) were purchased 
from GE Healthcare, UK.  0RXVH,J*$EWRĮ%FO-2 (produce code: mAB827) 
was purchased from R & D systems.  All antibodies were stored at -20 °C in 
WKHGDUNLQDFFRUGDQFHWRWKHPDQXIDFWXUHUV¶JXLGDQFHXQOHVVRWKHUZLVHVWDWHG  
 
7.1.5 Chemicals and reagents 
2,2-Diphenyl-1-picrylhydrazyl radical (DPPH), 2-mercaptoethanol, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 5-bromo-4-
chloro-3-indolylȕ-D-galactopyranoside (X-gal), N-[2-hydroxyethyl]piperazine-
N¶-[2-ethanesulfonic acid] (HEPES),  111ƍ,Nƍ-tetramethylethylenediamine 
(TEMED), ȕ-mercaptoethanol, aluminium chloride (AlCl3) anhydrous, 
ammonium persulfate (AMPS),  bovine serum albumin (BSA), bromophenol 
blue,  calcium chloride (CaCl2), citric acid,  dimethyl sulfoxide (DMSO), foetal 
bovine serum (FBS), Folin-Ciocalteau (FC) phenol reagent, gallic acid (GA), 
glycerol, glycine, L-glutamine, Kodak® GBX fixer (for autoradiography films), 
magnesium chloride (MgCl2), methylene blue, minimum essential medium 
eagle (MEME), non-essential amino acids (NEAA) solution, 
penicillin/streptomycin, polyoxyethylenesorbitan monolaureate (Tween® 20), 
potassium ferricyanide, potassium ferrocyanide, propidium iodide (PI), 
protease inhibitor cocktail ($(%6)  P0 DSURWLQLQ  ȝ0 EHVWDWLQ 
mM: E-64: 1.4 mM, leupeptin: 2 mM, pepstatin A: 1.5mM, in DMSO; product 
code: P8340), quercetin, ribnonuclease A from bovine pancreas (RNAse A), 
Roswell Park Memorial Institute (RPMI)-1640 liquid medium (containing 0.3 
g/L L-glutamine and 2 g/L sodium bicarbonate), sodium bicarbonate, sodium 
carbonate (Na2CO3), sodium chloride (NaCl), sodium citrate, sodium dodecyl 
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sulphate (SDS), sodium deoxycholate, sodium phosphate (Na3PO4), sodium 
pyruvate, tris(hydroxymethyl) aminomethane (Trizma® base), 
tris(hydroxymethyl) aminomethane hydrochloride (Trizma® hydrochloride) 
and triton-X-100, trypsin/ethylenediamine tetra-acetic acid (EDTA) solution 
were purchased from Sigma Aldrich Ltd., Dorset UK.   
Phosphate buffered saline Dulbecco A (PBS) tablets (8.0 g sodium chloride, 
0.2 g potassium chloride, 1.15 g di-sodium hydrogen phosphate, 0.2 g 
potassium dihydrogen phosphate per litre at pH 7.1 -7.5) were purchased from 
Oxoid, Hampshire, UK.  Annexin V-FITC reagent was purchased from BD 
Biosciences, Oxford, UK. Coulter Clenz® Cleaning Agent, Flow Check® beads 
and IsoFlowTM Sheath Fluid were purchased from Beckman Coulter Ltd., 
Buckinghamshire, UK.  Formaldehyde (16%, MeOH free) solution ampoules 
were purchased from Thermo Scientific Inc, Rockford, IL, U.S.A.  30% w/v 
acrylamide-bis acrylamide stock solution was purchased from Severn Biotech 
Ltd, Worcestershire, UK.   
0DJLF0DUN;3:HVWHUQSURWHLQ VWDQGDUG Novex® ECL kit, Novex® Sharp 
pre-stained protein standard, NuPAGE® 4-12% bis tris gel 1.5 mm 15-well 
cassette, NuPAGE® antioxidant, NuPAGE® LDS sample buffer, NuPAGE® 
MOPS SDS running buffer, NuPAGE® sample reducing agent, NuPAGE® 
transfer buffer were purchased from Life Technologies-Invitrogen, Paisley, UK.  
Bio-Rad DC protein assay kit, bovine serum albumin (BSA) standard solution 
and polyvinylidene difluoride (PVDF) membrane were purchased from Bio-
Rad Laboratories, Hertfordshire, UK.  X-ray films processing solutions 
(Developer) was purchased from Champion Photochemistry International 
Limited (CPIL), Brentwood, UK.  Analytical grade acetonitrile Far UV (ACN), 
ethanol (EtOH), ethylacetate (AcOEt), hexane (HEX), industrial methylated 
spirits (IMS), methanol (MeOH) were purchased from Fisher Scientific Ltd., 
Leicestershire, UK.  All chemicals and reagents were stored according to the 
PDQXIDFWXUHUV¶JXLGDQFHXQOHVVRWKHUZLVHVWDWHG. 
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7.1.6 Equipment and Software 
Class II microbiological safety cabinet was supplied by BioMAT2 MDH.  Cell 
culture CO2 incubator Sterisonic GxP supplied by Sanyo-Panasonic.  UV/Vis 
spectrophotometer Ultraspec 2000, orbital shaker ZLE 164 was supplied by 
Amersham.  Spectrophotometer 2104 multi-label reader and Wallac Evision 
software manager was by PerkinElmer Wallac Evision.  Allegra® X-15R 
bench-top centrifuge, Epics XL-MCLTM flow cytometer and EXPO32TM 
software were purchased from Beckman Coulter.  Micro-centrifuge Heraeus 
Fresco 17 was supplied by Thermo Electron Corporation.  XCell SureLockTM 
Mini-Cell electrophoresis chamber system, PowerEase® 500 power supply, 
Novex® Semi-Dry blotter were products obtained from Invitrogen.  Nikon 
Coolpix 4500 camera was by Nikon.  UFLCXR system coupled to an Applied 
Biosystems API2000 was by Shimadzu.  Strata C18-E (55 µm, 70 Å) 1 g/ml 
tubes were purchased from Phenomenex®, Cheshire, UK.  C18 Gemini-NX 3u-
110A 50x2 mm column purchased from Phenomenex was kindly donated by 
Dr. A. Abdallah.  Cylchred program was created by Terry Hoy, University of 
Cardiff, UK.  WinMDI program was created by Joe Trotter of the Scripps 
Institute, La Jolla, U.S.A.  GraphPad Prism version 5.0d for Mac OS X was 
created by GraphPad software Inc. and Software MacKiev.  ImageJ program 
was created by the National Institute of Health (NIH).  
 
7.2 Methods  
7.2.1 Extraction of UNMC plants 
The extraction process was conducted at UNMC, Malaysia, and was previously 
described in Othman et al. (2011) and modified from Spigno and Marco 
(2007).205, 274  Collected plant materials were air dried in an enclosed room (25-
28 °C) for approximately two weeks.  Dried plant samples (1 g) were refined 
using a Waring® commercial heavy-duty grinder by macerating with organic 
solvent (1:8 ratio) at room temperature (RT) for 24 h.  Plant samples were then 
subjected to sequential extraction solvents of increasing polarity: HEX > 
AcOEt > EtOH > Water.  Ground samples were macerated with solvents for 24 
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h before being filtered. The filtrates were then concentrated by evaporation of 
the solvent in vacuum at 40 °C using a rotary evaporator (Buchi, USA).  
Concentrated crude extracts were desiccated for 1 - 2 weeks.  The dried crude 
extracts were kept at  ± 20 °C in the dark prior to freeze-drying.  The known 
percentage yields of corresponding plant extracts are shown in Table 7-1. 
 
7.2.1.1 UNMC extract stocks 
The plant samples were received as dried powder and stored at -20 °C in the 
dark.  Ailquots of UNMC extracts were prepared in DMSO as 100 mg/ml top-
stocks and kept at -20 °C, protected from light until use. 
 
7.2.2 General cell culture and maintenance  
All cell culture procedures were conducted aseptically in a Class II 
microbiological safety cabinet with a laminar flow system.  The safety cabinet 
was disinfected with 70% IMS in d.H2O prior to each use.  Cell lines were 
routinely cultured in tissue culture flasks (25 cm2 or 75 cm2) in culture media 
RPMI-1640 (supplemented with 10% heat inactivated FBS) or MEME 
(supplemented with 10% FBS, 7.5% sodium bicarbonate, 1% 0.1 mM NEAA, 
1% 1 M HEPES, 1% 200 mM L-glutamine and 1% penicillin) and grown in a 
humidified incubator containing 5% CO2 in air at 37 °C.  FBS was heat 
inactivated at 56 °C for 30 min prior to addition into culture medium to 
denature complement proteins and cell growth inhibitors.  When the observed 
cell growth exceeds approximately 80% confluence, the cells were sub-
cultured into new culture flasks with fresh culture medium to ensure 
maintenance of logarithmic growth when used in experiments.   
 
Prior to cell subculture, medium (RPMI-1640 and MEME) stored at 4 °C were 
warmed in a water bath to 37 °C.  To subculture adherent cells, medium was 
aspirated and cells were washed with 1 ml PBS.  The cells were treated with 1 
ml trypsin-EDTA solution (1X; 1 in 10 dilution in sterile PBS) and incubated 
for 2-5 min at 37 °C until the cells were visibly detached from the flask.  Cells 
were re-suspended in 5 ml fresh medium then 0.5 ml cell suspension was 
transferred to a new flask containing 7 ml of fresh culture medium.  The cells 
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were returned to the incubator until subsequent subculture or usage.  Cells were 
discarded once they reached their recommended passage number to minimise 
phenotypic drift and assay variation (usually after ~ 25 passages).   
 
7.2.2.1 Cell Preservation  
Batches of mycoplasma-free cells were stored in cryovials in the liquid 
nitrogen cell bank (-180 °C) as stock for future use.  Cells were grown in a 75 
cm2 flask until approximately 80% confluent then the medium was aspirated 
from the cells then the cells were washed with 3 ml sterile PBS, followed by 
incubation in 2 ml 1X trypsin-EDTA solution at RT for 2 min.  The trypsin-
EDTA solution was carefully removed and cells were incubated for a further 5 
minutes at 37 °C until they had detached.  The detached cells were re-
suspended in freezing medium (5% DMSO in 1:1 FBS and medium).  
Subsequently, 1 ml cell suspension was aliquoted into Nalgene cryovials.  
Cells secured in cryovials were immediately stored at -20 °C for 24 h then 
transferred to -80 °C storage overnight before permanently stored at -180 °C in 
the liquid nitrogen cell bank.  Frozen cells were retrieved by thawing rapidly in 
a water bath at 37 °C and re-suspending in 7 ml of fresh culture medium before 
incubation at 37 °C for 16 h to allow attachment.  Thereafter, liquid contents 
were aspirated from the flask and fresh nutrient medium introduced. 
 
7.2.3  MTT (in vitro cell viability) assay 
The following method has been adapted from Mosmann (1983), exploiting the 
colour change upon reduction of MTT by mitchondrial dehydrogenase in living 
cells, from a yellow tetrazole to purple formazan.229  Thus the increase in 
cellular formazan can be quantified and directly related to the activity of 
mitochondrial dehydrogenase.245  In apoptotic or necotic cells mitchondrial 
dehydrogenase activity is lost as a result of irreversible mitchondrial 
fragmentation.275  The MTT assay can therefore be used to assess cell viability 
and determine growth inhibitory or cytotoxic potential of investigative agents.  
 
Cells were harvested at 70-80% confluence and were gently syringed through a 
23-gauge needle to obtain a near-single cell suspension.  The average number 
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of cells counted on a haemocytometer was used to calculate the desired cell 
seeding density for 72 h treatment (2 - 3.5 x 103 for MCF7, IGROV1, HCT116, 
TK-10, MRC-5 cells; 4 - 6 x 103 for MDA-MB-468, SK-OV-3, Caki-1, 
HCC2998 cells).  Using a 96-well micro-titre plate, cells were seeded in 180 ȝl 
medium per well and incubated overnight at 37 °C (5% CO2).  A separate time 
zero (T0) plate was set-up to measure the initial viability of cells at the time of 
UNMC extract addition.  After 24 h, serial dilutions of UNMC extract stocks in 
culture medium (concentration at 100 mg/ml in DMSO) were prepared to 10X 
the final concentrations required.  The final treatment concentration ranges 
XVHGIRU810&>ȝJPO- ȝJPO@DQGIRU810&DQG>ȝJPO
± ȝJPO@ZHUHWHVWHGLQTXDGUXSOLFDWH7RHDFKZHOOOextract solution 
was added to achieve a final volume of 200 µl (DMSO concentration < 1%).  
To the peripheral lanes, 20 µl medium was added to control cells and cells in 
the T0 plate.  Cell viability was quantified at the time of extract addition for T0 
plate and following 72 h exposure of cells to test extract for treated plates using 
the MTT assay.  Initially, 50 µl MTT solution (2 mg/ml MTT in sterile PBS; 
stored at 4 °C in the dark) was added to each well and further incubated for 4 h 
at 37 °C in the dark.  The medium and any unconverted MTT were aspirated 
then 150 µl DMSO was added to each well and the plates were placed on a 
plate shaker for 2 min.  The optical density (OD) was read on a 
spectrophotometer at 555 nm using Wallac Envision software.   
 
The absorbance intensity is directly proportional to cell viability and there is a 
linear relationship between cell number and the amount of formazan present.  
The mean absorbance for treated and control cells at treatment concentration 
range could be used as a quantitative measure of cell viablity by constructing a 
dose-response curve using the mean absorbances to enable the estimated 
extract concentration inducing 50% growth inhibition (GI50 value) to be 
calculated (Equation 1).  Additionally, vehicle control (DMSO) was tested to 
ensure that DMSO did not compromise cell viability in extract-treated wells.  
Another set of assays using quercetin as a positive control was performed.  The 
GI50 values established from the MTT cytotoxicity assay will be used in all the 
subsequent assays. 
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Equation 1: Following MTT assay, concentration which inhibit cell growth by 
50%, GI50 value was determined from optical density readings of extract 
treated and control cells absorbancies. 
 
7.2.4 Clonogenic assay (in vitro cell sensitivity assay) 
The following method was adapted from the method described by Brown and 
Wouters (1999) and Plumb (2004) to determine cell death or recovery by 
determining subsequent proliferative and colony formation capacity of cells 
following brief exposure to investigative agents.276, 277   
 
HCT116 cells were harvested at 70-80% confluence and were gently syringed 
through a 23-gauge needle to obtain a near-single cell suspension.  Cells were 
counted on a haemocytometer and the average number of counted cells was 
used to calculate the desired cell seeding density for 24 h treatment.  HCT116 
cells were seeded in 6-well plate at a density of 250 cells per well in 2 ml 
culture medium and incubated overnight at 37 °C for cellular attachment.    
Freshly prepared dilutions of UNMC extract in medium were added to wells in 
triplicate to obtain treatment concentrations of 0.5X, 1X and 2X GI50 values.  
DMSO vehicle was added to the control wells.  After 24 h exposure to extracts, 
culture medium was aspirated from all wells and cells washed with 2 ml PBS 
to remove any remaining extract in the well; 2 ml fresh culture medium was 
then introduced to each well.  The cells were kept in the incubator at 37 °C to 
allow recovery and the end-point was considered when control cell colonies 
size reached   FHOOV usually 8 to 11 days.  To quantify the number of 
colonies formed, each well was rinsed in 1 ml chilled PBS and fixed with 1 ml 
chilled MeOH at RT for 10 min.  The solvent was removed and the colonies 
were stained with 500 µl methylene blue solution (0.5% methylene blue in 1:1 
MeOH and d.H20 (v/v); stored at 4 °C) for 10 min.  The plates were washed 
gently with d.H2O, air-dried and cell colonies were counted.  The plating 
efficiency for each well was > 90% (Equation 2). 
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ࡺ࢛࢓࢈ࢋ࢘࢕ࢌࢉ࢕࢒࢕࢔࢏ࢋ࢙ࢉ࢕࢛࢔࢚ࢋࢊࡺ࢛࢓࢈ࢋ࢘࢕ࢌࢉࢋ࢒࢒࢙࢙ࢋࢋࢊࢋࢊ ࢞૚૙૙ ൌ ࡼ࢒ࢇ࢚࢏࢔ࢍࢋࢌࢌ࢏ࢉ࢏ࢋ࢔ࢉ࢟ሺ ?ሻ  
Equation 2: % of plating efficiency determined by the number of colony (ies) 
counted in comparison to the total number of cells seeded in clonogenic assay. 
 
 
7.2.5 Flow cytometric techniques 
 
7.2.5.1 Cell cycle analysis  
Analyses of cell cycle distributions were performed by flow cytometric  
measurement of cellular DNA content using fluorescent dyes such as 
propidium iodide (PI), which intercalates DNA bases stoichiometrically.  Any 
disruption in the DNA histogram, which is representative of the cell cycle, 
could indicate a DNA damaging or cytotoxic effect on the cell cycle induced 
by investigative agents.  The following method was adapted from the method 
described by Nicoletti et al. (1991).249  
 
MDA-MB-468 and HCT116 cells were harvested at 70-80% confluence and 
counted on a haemocytometer.  The average number of counted cells was used 
to calculate the desired cell seeding density for 48 h treatment.  The cells were 
seeded in 6-well plates in duplicate at a density of 1.5 x 105 in 2 ml of culture 
medium.  The cells were allowed 24 h at 37 ºC to adhere and commence cell 
division.  Freshly prepared dilutions of UNMC extract stock solution in 
medium were introduced to MDA-MB-468 cells (treated with UNMC 35) and 
HCT116 cells (treated with UNMC 20 or UNMC 37) at final concentrations 
1X, 2X and 4X GI50 values.  The cells were treated for 48 h at 37 ºC.  DMSO 
vehicle was added to the control cells.  Cell cycle analysis preparation was 
conducted at 4 ºC.  Floating and trypsinised cells were pooled and pelleted by 
centrifugation (306 x g, 5 min at 4 ºC), washed with 2 ml chilled PBS.  Cells 
were pelleted again and the supernatant was discarded.  Cells were incubated in 
400 µl fluorochrome solution (0.1% sodium citrate, 0.1% triton-X-100, 50 
µg/ml PI, 0.1 mg/ml Ribonuclease A in d. H20; stored at 4 ºC in the dark) 
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overnight at 4 ºC protected from light.  Samples remained protected from light 
on ice and gently syringed prior to cell cycle distribution analysis.  Cell cycle 
distribution analysis was performed on a Beckman Coulter EPICS-XL 
MCLTM flow cytometer.  The FL3 channel was used to detect propidium 
iodide (PI) and at least 15,000 events were recorded for each sample.  Data 
were further analysed using WinMDI and Cylchred softwares. 
 
7.2.5.2 Apoptosis detection  
One of the hallmarks of early apoptosis involves the translocation of 
phosphatidylserine (PS) from the inner to the intact outer plasma membrane (as 
membrane asymmetry is lost).  The membrane integrity of an apoptotic cell 
diminishes when progressing into late apoptosis/necrosis.  A calcium ion 
(Ca2+) dependent phospholipid-binding protein, annexin V, possesses high PS 
binding affinity.  Analyses of apoptotic cell populations were performed using 
flow cytometric techniques.  Dual staining of annexin V (conjugated to FITC, a 
green fluorescent dye) and PI to detect early apoptotic (annexin V-FITC+/PI-) 
and late/necrotic cell populations (annexin V-FITC+/PI+) can be analysed using 
flow cytometric techniques.  The method was adapted from the method 
described by Vermes et al. (1995).94   
 
MDA-MB-468 and HCT116 cells were harvested at 70-80% confluence and 
counted on a haemocytometer.  The average number of counted cells was used 
to calculate the desired cell seeding density of 2 x 105 and 1.5 x 105 for 24 h 
and 48 h treatment, respectively.  MDA-MB-468 and HCT116 cells were 
seeded in 6-well plates in duplicate at the aforementioned densities in 2 ml 
culture medium and allowed 24 h to adhere at 37 ºC.  Freshly prepared 
dilutions of UNMC extract stock solution in medium were introduced to MDA-
MB-468 cells (treated with UNMC 35) and HCT116 cells (treated with UNMC 
20 or UNMC 37) at final concentrations 1X, 2X and 4X GI50 values.  DMSO 
vehicle was added to the control cells.  Preparation for apoptosis analysis was 
conducted at 4 ºC.  After 24 h and 48 h treatment, floating and trypsinised cells 
were pooled and wells were washed twice with PBS.  Cells were counted and 1 
x 105 cells were transferred to FACS polyproplene tubes on ice prior to 
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centrifugation at 306 x g for 5 min at 4 ºC.  The supernatant was discarded and 
the cell pellets were incubated in 100 µl binding buffer (10 mM HEPES/NaOH 
at pH 7.4, 0.14 M NaCl, 2.5 mM CaCl2 in d. H20; stored at 4 ºC) with 5 µl 
Annexin V-FITC (stored at 4 ºC in the dark).  Pellets were gently vortexed and 
kept in the dark for 15 min.  Subsequently, 5 µl PI solution (50 µg/ml in d.H20; 
stored at 4 ºC) and 400 µl binding buffer were added to the samples, which 
were gently vortexted and kept at 4 ºC until analysis.  Analysis of intact, early 
apoptotic and late apoptotic/necrotic cells were detected within 1 h on a flow 
cytometer. 
 
 
Figure 21: An example of flow cytometry diagram (dot plot) of double-
staining with Annexin V-FITC and Propidium iodide.  The dot plot is 
representation of annexin V-FITC log fluorescence versus PI log fluorescence.  
Cells in the top left quadrant (PI+/FITC-) represent cells with nuclear fragments, 
cells in the lower left quadrant (PI-/FITC-) represent living cells, cells in the 
lower right quadrant (PI-/FITC+) are early apoptotic cells and cells in the top 
right quadrant (PI+/FITC+) are late apoptotic/necrotic cells. 
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7.2.6 Western blot procedures 
Western blot analysis is a widely used quantitative method for investigating 
presence of proteins within cellular extracts.  Proteins extracted from samples, 
denatured and separated according to molecular weight by gel electrophoresis.  
The proteins are then electrophoretically transferred to a membrane to allow 
protein(s) of interest to be probed using specific primary antibodies, which can 
be recognised by a secondary antibody conjugated with horseradish peroxidase 
(HRP) enzyme.  The light released (from illuminating substrate 3-
aminophthalate) in chemiluminescence reaction is captured on film. Protein 
size can be determined from the bands on the film against molecular weight 
markers of proteins of known molecular weight.  Camptothecin was chosen as 
a positive control for apoptosis.  A series of procedures adapted from Towbin 
et al. (1979) were performed to obtain the protein-bound membrane for 
detection.278   
  
7.2.6.1  Cell lysis 
MDA-MB-468 and HCT116 cells were seeded in 10 cm plates at a density of 
1.5 x 106 in 5 ml of culture medium and incubated for 24 h to adhere at 37 ºC 
to allow cells to adhere and reach  ~70 % confluency.  Freshly prepared 
dilutions of UNMC extract stock solution in medium were introduced to MDA-
MB-468 cells (treated with UNMC 35) and HCT116 cells (treated with UNMC 
20 or UNMC 37) at final concentrations 1X, 2X and 4X GI50 values.  
Camptothecin (300 nM stock solution) and DMSO vehicles were added to the 
control cells.  Cell lysis preparation was conducted at 4 ºC.  At elected time 
points, 24 and 48 h, floating and scraped cells were pooled and wells were 
washed with 3 ml chilled PBS.  The procedure was repeated 4X before the cell 
suspension was transferred to FACS polypropylene tubes prior to 
centrifugation (306 x g for 5 min at 4 ºC).  Cell pellets were retained and 
incubated with 80 µl NP-40 cell lysis buffer (150 mM NaCl, 1% Triton-X-100 
and 50 mM Tris at pH 8.0) supplemented with protease inhibitor cocktail 
($(%6)  P0 DSURWLQLQ  ȝ0 EHVWDWLQ  P0 (-64: 1.4 mM, 
leupeptin: 2 mM, pepstatin A: 1.5mM, in DMSO; Sigma Aldrich product code: 
P8340).  The cell pellets in NP-40 lysis buffer were mixed gently by pipetting 
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at 4 ºC was performed to separate the cell pellet from the supernatant.  The cell 
pellet was discarded and the supernatant lysate containing protein content were 
kept in labeled eppendorfs on ice for immediate protein concentration 
determination or stored at ±20 ºC. 
 
7.2.6.2 Protein determination  
The principle of Bio-Rad DC protein assay kit is that reduction of the 
phosphomolybdic-tungstic mixed acid chromogen (present in Folin-Ciocalteau 
phenol reagent) by proteins.  The level of reduction is proportional to the 
amount of protein present in the sample, which is determined by measuring the 
absorbance on a spectrophotometer at 750 nm.  The principle of the assay is 
based on the method described in Lowry et al. 1951.279  Protein concentrations 
in the lysates were determined using the Bio-Rad DC protein assay kit in 96-
ZHOO SODWHV DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV. Briefly, 5 µl lysate 
sample, 25 µl reagentA+S and 200 µl reagentB were added into triplicate wells.  
Triplicates of BSA standards (concentration range: 0.1-10 mg/ml) were 
measured with every set of samples requiring protein determination.  The OD 
was analysed by a spectrophotometer at 750 nm using Wallac Envision 
software.  The protein content in each sample was determined using a standard 
curve using BSA standards against the lysate protein concentration.  
 
7.2.6.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) 
The separation of protein mixtures could be achieved by loading the protein 
sample in an anionic sodium dodecyl sulfate (SDS) gel and passing an electric 
current through the gel.  SDS denatures proteins into their peptide chains and 
binds to them at a constant ratio of 1.4 g of SDS per 1 g of protein, which gives 
the same charge-to-mass ratio of SDS and protein therefore the ability to 
migrate through the gel is dependent on the molecular weight of the protein.280  
Protein samples were prepared using NuPAGE® 4X LDS sample buffer (3.75 - 
7.50 µl), NuPAGE® reducing agent (1.5 ± 3.0 µl) and a calculated volume of 
cell lysate equivalent to 100 µg of protein; the total sample volume LV 30 µl.  
The samples were denatured for 5 min at 95 ºC then briefly centrifuged and 
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kept at 4 ºC.  Samples were loaded on a polyacrylamide gel (8 - 12%) 
depending on the size of the protein of interest.  Molecular weight markers 
were also loaded onto the gel before submersion in running buffer (25 mM 
Trizma base, 200 mM glycine, 1.00 g SDS, pH 8.5 HCl in 1L of d.H2O).  
Proteins were then separated by electrophoresis using 125 V on a 
polyacrylamide gel for 90 min at RT until the dye front of the loading buffer 
reached the bottom of the gel.  Pre-made NuPAGE® Bis-Tris gel (4-12%) and 
pre-made NuPAGE® MOPS SDS running buffer were used at times in place of 
WKHFRUUHVSRQGLQJPDWHULDOVDFFRUGLQJWRPDQXIDFWXUHU¶VPDQXDO.   
 
Table 7-3 Receipe for Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) gel. 
 Gel 
Material Resolving (ml) Stacking (ml) 
 8% 10% 12%  - 
10% AMPS 0.20            0.20               0.20 0.10 
10% SDS 0.20            0.20               0.20 0.10 
30% Acrylamide mix 5.30 6.70 8.00     1.70 
TEMED 0.012 0.010 0.008      0.01 
Tris 5.0  (1.5M, pH 8.8) 
1.25  
(1M, pH 6.8) 
d. H2O 9.3 7.9 6.6    6.8 
 
7.2.6.4 Western Blot 
The PDVF membrane was calibrated prior to electroblotting by being fully 
immersed in 100% MeOH for 20 min then in 10 ml of transfer buffer (25 mM 
Trizma base, 200 mM glycine, 0.375 g SDS, pH 7.6, 20% MeOH, HCl in 1L of 
d.H2O) with blotting paper for a further 10 min.  Gels were washed with 10 ml 
transfer buffer for 2 min.  Protein bands on the gels were electroblotted onto 
PDVF membranes at 100 V for 90 min at RT using Novex® Semi-Dry Blotter. 
The membranes were washed using 20 ml TBST (25 mM Tris, 113 mM NaCl, 
0.05% Tween 20 (v/v) at pH 7.4.  To reduce non-specific binding, membranes 
were kept in blocking solution (10 % fat-free milk powder in TBST) overnight 
at 4 ºC on a roller.  Subsequently, blocked membranes were washed to remove 
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excess blocking solution with TBST for 3 min, which was repeated 5 times.  
To enable any specific binding of Ab, the membranes were incubated with 10 
ml primary (1º) Ab dilution (Table 7-4) overnight at 4 ºC on a roller.   
 
Table 7-4 Primary and secondary antibodies used for western blotting. 
                
Antibody (Ab) Polyacrylamide gel (%) 
Concentration of 
Antibody 
(in 3% milk-TBST) 
Blocking 
Pr
im
ar
y Caspase 3 10 - 14 1:1000 
10% 
milk-
TBST 
Mcl-1 10 - 12 1:1000 
Se
co
n
da
ry
 
Donkey Anti rabbit 
Goat Anti mouse 
- 1:5000 
 
The membrane was washed again with 20 ml of TBST for 5 min, which was 
repeated 6 times.  After washing, the membrane was incubated with 15 ml 
secondary (2º) Ab (Table 7-4) for overnight at 4 ºC on a roller.  The membrane 
was washed with 20 ml TBST for 3 min and repeated 3 times.  Novex® ECL 
Chemiluminescent Substrate Reagent Kit was used to wash the PDVF 
membranes and developed onto x-ray film.  The reaction was stopped after 2 
min by washing the membrane with TBST and stored at 4 ºC. 
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7.2.7 6HQHVFHQFHDVVD\ȕ-galactosidase staining) 
Cellular senescence describes the irreversible growth arrest, which is the 
underlying mechanism cause of aging in normal somatic cells upon reaching 
their Hayflick replicative limit.  Hence senescence is also a tumour suppression 
mechanism.  A biomarker, ȕ-galactosidase, is present in the lysosome of 
senescent cells.  Several chemotherapeutic agents are able to induce senescence 
in tumours.257  The assay is based on detecting an increased abundance of ȕ-
galactosidase using X-gal where senescent cells are stained blue-green.  The 
following method was adapted from the method described by Dimri et al. 
(1995).257   
MDA-MB-468 cells were seeded at 1 x 104 and 5 x 104 for vehicle control and 
treatment cells, respectively, in 6-well plates in duplicates.  HCT116 cells were 
seeded at 5 x 103 and 1 x 104 for vehicle control and treatment cells, 
respectively, in 6-well plates in duplicates.  MDA-MB-468 and HCT-116 cells 
were seeded into wells containing 2 ml culture medium and allowed to attach 
overnight at 37 °C.  Freshly prepared dilutions of UNMC extract fraction stock 
solution were introduced to MDA-MB-468 cells (treated with UNMC 35) and 
HCT116 cells (treated with UNMC 20 or 37) at final concentrations of 1X and 
2X GI50 values.  DMSO vehicle was added to the control cells and 5 µM of 
RHPS4 was used as the positive control. 
 
At day 7 and 12 of treatment for HCT116 and MDA-MB-468 cells, 
respectively, culture media were aspirated from the wells and cells were 
washed twice with 2 ml PBS to remove any remaining extracts in the well.  
The cells were fixed using 1 ml fixative solution (2% formaldehyde, 0.2% 
glutaraldehyde in PBS) for 10 min then the fixative solution was removed and 
1 ml senescence buffer (5 mM potassium ferricyanide, 5 mM potassium 
ferrocyanide, 150 mM NaCl, 2 mM MgCl2, 40mM Na3PO4/citric acid buffer 
pH 6.0, 1 mg/ml X-gal in DMF in 1L of d. H20) was added to each well.  The 
plates were protected from light and incubated at 37 °C for 24 h. The number 
of senescent (blue-green stained) cells and total number of cells in the sample 
were counted (observation under phase contrast light microscope) and 
photographs of the cells were captured using a Nikon camera at 200X - 400X 
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magnification.  To quantify the proportion of senescent cell population, cells 
were scraped from the wells, syringed and counted on a haemocytometer.   
 
7.2.8 Cell migration assay (Wound healing) 
The ability of malignant cells to invade and migrate is crucial to cancer 
metastasis.  This simple in vitro assay mimics in vivo cell migration during 
ZRXQG KHDOLQJ  $ µZRXQG¶ LV FUHDWHG LQ D FHOO PRQROD\HU DQG REVHUYDWLRQV
(images captured) at timed intervals enable analysis of the migration wound-
healing capacity rate of the cells.  The following method was adapted from the 
method described by Liang et al. (2007).253   
 
The under side of 6-ZHOO FXOWXUH SODWHV ZDV PDUNHG ZLWK WZR FURVVHV µ[¶
aligned in the center.  HCT116 cells were harvested and seeded at 3 x 105 in 6-
well plate containing 2 ml culture medium with reduced 7.5% FBS.  The cells 
were incubated overnight at 37 °C to allow cellular attachment.  The scratch 
was created when cells were ~80% cellular confluent by applying a sterile 200 
µOSLSHWWHWLSWKURXJKWKHFHQWHUDOLJQHGZLWKµ[¶'LOXWLRQVRIUNMC extract 
stock solution were freshly prepared and introduced to the cells at final 
concentrations 1X and 4X GI50 values.  DMSO vehicle was added to the 
control wells.  Each extract and control sample were tested in duplicate.  The 
scratch was evaluated under phase contrast microscopy and images of the 
scratch were captured with a Nikon camera (100X magnification) at 0, 24, 48, 
DQGK  ,PDJHVRI WKH ZRXQG ZHUH WDNHQ MXVW DERYHDQGEHORZ WKH µ[¶
mark to ensure consistency.  Occassional replenishment of the medium (with 
control or extracts) is required to capture clear images of the wound.  The level 
of wound healing was analysed using ImageJ software by measuring the 
difference in total percentage wound area (%) of treated cells and untreated 
control cells.     
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7.3 Phytochemical composition of plant extracts 
UNMC plant extracts were tested for phytochemical composition using 
colorimetric assays. 
 
7.3.1 Total flavonoid content 
The aluminium trichloride (AlCl3) colorimetric method was adapted from 
Meda et al. (2005) and Chang et al. (2002).263, 264  AlCl3 could form acid stable 
complexes with reactive groups of flavones and flavonols and form acid labile 
complexes with the flavonoids.  Quercetin is a widely distributed flavonoid 
hence employed as a standard to measure against the UNMC extracts for total 
flavonoid content determination. 
UNMC extract stock solution (100 mg/ml in DMSO), quercetin stock solution 
(0.5 mg/ml in DMSO) and 2% AlCl3 working solution (20 mg/ml in MeOH 
(w/v)) were freshly prepared prior to the assay.  Due to the natural pigment of 
the extract samples, a set of UNMC control extract samples were prepared in 
glass vials to account for baseline absorbance.  Sets of control UNMC extract 
samples were prepared in triplicate in glass vials and consisted of 1998 µl 
MeOH to which 2 µl UNMC extracts stock solution was added to achieve 
concentration of 1 mg/ml in a final volume of 2 ml.  The UNMC extract test 
samples were also prepared in triplicates in glass vials, which consisted of 1.98 
ml of 2% AlCl3 working solution to which 20 µl UNMC extracts stock solution 
was added to achieve a concentration of 1 mg/ml in a total volume of 2 ml.  
Both sets of UNMC extract control and UNMC extract samples were incubated 
for 10 min at RT protected from light.   
 
Quercetin stock solution was diluted with MeOH (total volume of 2 ml) and 
prepared at a range of [0-100 µg/ml] to construct the calibration curve.  A 
µEODQN¶ FXYHWWH FRQWDLQLQJ  PO  AlCl3 and 1 ml MeOH was used for 
calibration prior to each set of readings.  The OD of quercetin standard 
solutions, UNMC extract controls and UNMC extract samples solutions were 
measured at 415 nm using UV/Vis spectrophotometer.  The mean absorbances 
of control UNMC extract control samples were determined and deducted from 
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the mean UNMC extract sample absorbances.  The total flavonoid content in 
UNMC extracts was calculated using a quercetin standard curve and expressed 
as quercetin equivalents (QE)/100 g of extract. 
 
7.3.2  Total phenolic content 
The Folin-Ciocalteau colorimetric method was adapted from Singleton et al. 
(1999) and Meda et al. (2005).263  FC reagent contains phosphomolybdate and 
phosphotungstate, which react with reducing substances such as polyphenolic 
compounds.  Gallic acid (GA) is a widely distributed phenolic compound and 
is the chosen standard used to measure against the UNMC extracts for total 
phenolic content determination.  
UNMC extract stock solution (100 mg/ml in DMSO), GA stock solution (500 
µg/ml in DMSO), 0.2 N FC working solution (0.40 ml of 20 N FC reagent in 
19.60 ml of d.H20) and sodium carbonate solution (75 mg/ml in d.H20, total 
volume of 50 ml) were freshly prepared prior to the assay.  UNMC extract 
control samples were prepared in glass vials in triplicates, of which, each vial 
consisted of 985 µl d.H2O, 500 µl NaCO3 and 15 µl UNMC extract stock 
solution in a total volume of 1.50 ml.  The UNMC extract test samples were 
prepared in triplicate in glass vials by mixing 140 µl d.H2O and 15 µl UNMC 
extract solutions then added to 845 µl 0.2 N FC reagent and incubated for 5 
min at RT protected from light.  Subsequently, 500 µl NaCO3 was added to all 
UNMC extract test samples.  Both sets of UNMC extract control and UNMC 
extract test samples were incubated for 2 h at RT in the dark.  The final extract 
concentration was 1 mg/ml in 1.50 ml final volume. 
GA stock solution was diluted with d.H20 (total volume 1.50 ml) and prepared 
at a concentration range of [0-100 µg/ml] to construct the calibration curve.  A 
µEODQN¶FXYHWWHFRQWDLQLQJ155 µl d.H2O, 845 µl 0.2N FC reagent and 500 µl 
NaCO3 was used for calibration prior to each set of reading.  The OD of GA 
standard solutions and UNMC extract sample solutions were measured at 760 
nm using UV/Vis spectrophotometer.  The mean OD of UNMC extract control 
samples was deducted from the mean UNMC extract test sample absorbances. 
The total phenolic content in UNMC extracts was calculated using a GA 
standard curve and expressed as GA equivalents (GAE)/100 g of extract. 
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7.4 In vitro free radical scavenging assay  
2,2-Diphenyl-1-picrylhydrazyl radical (DPPH.) is a stable free radical, which 
can be used to assess the radical scavenging activity of plant extracts.  In the 
presence of an antioxidant such as quercetin, DPPH- is reduced to the 
molecular form (DPPHH) resulting in a colour change from yellow to purple.  
This change in absorbance can be used to measure the radical scavenging 
potency of the plant extracts.  The following method was adapted from the 
method described by Amic et al. (2003)265 and Nara et al. (2006).266  
 
UNMC extract stock solution (100 mg/ml in DMSO), quercetin stock solution 
(500 mg/ml of quercetin in DMSO) and DPPH stock solution (1 mg/ml of 
DPPH in MeOH) were freshly prepared prior to the assay.  DPPH stock 
solution was further diluted in MeOH to a 4 % working solution.  Two 96-well 
micro-WLWUHSODWHV ZHUH ODEHOHG µVDPSOH+DPPH¶ RU µVDPSOH-DPPH¶ 7RGHWHUPLQH
810&H[WUDFWWHVWVDPSOHV¶UDGLFDOVFDYHQJLQJDFWLYLW\WKHVDPSOH+DPPH plate 
was prepared with wells containing 180 µl 4% DPPH working solution to 
which 20 µl of UNMC extract stock solution were added.  To account for the 
pigmented UNMC extract control samples, the sample
-DPPH¶SODWHZDVSUHSDUHG
with wells containing 180 µl MeOH (sample
-DPPH) to which 20 µl UNMC 
extract stock solution were added.  All tests were conducted in quadruplicate 
wells.  The baseline absorbance was considered by measuring wells containing 
solvents only (solvent0), such as MeOH, DMSO or MeOH and DMSO.  
Quercetin stock solution was diluted with MeOH in order to construct a 
calibration curve at a concentration range of [0 - 100 µg/ml] (sample+DPPH).  
Plates were wrapped in foil and incubated for 15 min at 37 °C then placed on 
an orbital plate shaker for 2 min.  Absorbances were analysed by 
spectrophotometry at 517 nm using Wallac Envision software.  The 
absorbances for plates: sample
-DPPH and solvent0, were taken into consideration 
when calculating the free radical scavenging activity of the UNMC extracts.  
The average solvent0 values were subtracted from the all UNMC extract test 
sample and quercetin measurements.  The radical scavenging activity could be 
calculated using the following equation to create a graph of radical scavenging 
(%) against UNMC concentration:  
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Equation 3: % of radical scavenging ability of extracts determined from 
optical density readings obtained from the DPPH assay. 
 ௌ௢௟௩௘௡௧బିሺௌ௔௠௣௟௘శವುುಹିௌ௔௠௣௟௘షವುುಹሻௌ௢௟௩௘௡௧బ  ? ? ?ൌ ሺ ?ሻ  
 
 
7.5 Broth microdilution method (anti-microbial assay) 
Assessment of UNMC extracts in broth microdilution method, described 
below, was performed by Dr. Jaroslav Havlík and his group from the 
Department of Microbiology, Nutrition and Dietetics, Czech Universitiy of 
Life Sciences, in Prague. 
The minimum inhibitory concentrations (MICs) were determined by the broth 
microdilution method according to the CLSI guidelines (2009) using 96-well 
microtitre plates.  Briefly, extract samples were two-fold diluted in Mueller 
Hinton broth (Oxoid, Basingstoke, UK), inoculated with bacterial suspension at 
a density of 5x107 cfu/ml (5x 104 for C. albicans) and then incubated in 
thermostat at 37° C for 24 h (48 h for C. albicans).  Growth turbidity was 
measured by Multiscan Ascent Microplate Reader (Thermo Fisher Scientific, 
Waltham, USA) at 405 nm.  Extract concentration range used was 1 ± 128 
µg/ml.  MICs were calculated based on the density of the growth control and 
were expressed as the lowest extract concentrations that resulted in 80% 
growth reduction compared to that of the extract-free growth control.  The 
bacterial strains tested were obtained from Oxoid (Basingstoke, UK) and all 
reference antibiotics used were purchased from Sigma-Aldrich (Prague, CZ).  
DMSO (Lach-Ner, Neratovice, CZ) was used as a solvent for all extracts; 
except for C. albicans, MICs of reference antibiotics used as positive controls 
were in range of acceptable limits as published by CLSI guidelines (2009).281 
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7.6 Fractionation and analysis of UNMC extract fractions 
using High Performance Liquid Chromatography (HPLC) 
The mixture of compounds embedded within UNMC extracts can be separated 
using a mobile and a stationary phase.  Reversed solid-phase extraction (SPE) 
can separate crude extracts using different eluents (of varying polarity) and a 
non-polar stationary phase into phytochemicals groups with similar 
physicochemical characteristics such as solubility, size, shape and electrical 
charge.18   
 
Crude fractionations of UNMC 20, 35 and 37 extracts were prepared in d.H2O 
and MeOH at a ratio of 50:50 in a total volume of 1 ml.  Separation was 
performed using Strata extraction cartridge.  Prior to fractionation, each 
cartridge was equilibrated using 4 ml MeOH and 4 ml d.H2O.  The crude 
UNMC extracts were weighed then loaded on a Strata C18-E extraction 
cartridge (C18-E (55 µm, 70 Å) 50 mg/ml tube).  Glass vials used to collect the 
fractions were also weighed.  Employing solvents of increasing polarity MeOH 
> MeCN > d.H20, UNMC extracts were fractionated using different solvent 
gradients.  Fractions were collected in clearly labeled glass vials.  A new 
cartridge was used for loading a different UNMC extract to prevent 
contamination.  Solvents were removed using nitrogen and d.H2O was removed 
by freeze-drying to obtain dried powder compounds (for yield (%) and 
description of compounds, see Appendix II).  The dried compounds were kept 
protected from light at ± 20 °C until further examination of the isolated 
analytes using HPLC.  Extract eluents were dissolved in DMSO (1 mg/ml) and 
1:1 d.H2O and MeOH before analysis using a Phenomenex C18 Gemini-NX 
3u-110A 50x2 mm column in a HPLC (Shimadzu UFLCXR system coupled to 
an Applied Biosystems API2000) system.  The solvents used for the gradient 
were solvents A (0.1% formic acid in d.H2O) and B (0.1% formic acid in 
MeCN).  Samples were run on a solvent gradient of 10% B for 1 min, 10-98% 
B over 2 min, isocratic elution at 98% for 2 min, re-equilibrated to 10% B over 
0.5 min (0.5 ml/min).  The samples were detected with a UV light at Ȝ 220 
and 254 nm.   
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Table 7-5 Solvent gradient used in crude extract separation. 
Fraction 
 Solvent (%)  
Water  MeOH MeCN 
1 100 0 0 
2 75 25 0 
3 50 50 0 
4 25 75 0 
5 0 100 0 
6 0 0 100 
Strata C18-E extraction cartridge was equilibrated with equal volume of d. H20 
and MeOH prior to loading the cartridge with UNMC extract.  The solvents 
were passed through the extract and collected then removed to obtain the 
extract fraction for analysis. 
 
Fractions collected required solvent evaporation via freeze-drying and/or 
nitrogen gas to separate solvents from extract fractions.  Once solvent is 
removed, the vials were weighed again to calculate the difference in weight, 
hence determine the % yield of extract fraction material collected. 
 
7.7 Statistical Analysis 
 
Data from the assays are presented as the means ± SEM.  Data analysis was 
conducted using GraphPad Prism software (Version 6.0 c, San Diego, CA, 
USA).  The differences between treatment groups and control groups were 
deteremined by one-way ANOVA for the following assays: clonogenic, cell 
cycle distribution, apoptosis detection, migration, senescence; p < 0.05 was 
considered to be statistically significant.  The correlation of chemical contents 
in the extract samples was measured against a reference compound (standard 
cruve) and analysed using the Pearson coefficient. 
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Appendices 
 
Appendix I  
The MTT assay was used to determine cell viability after exposure to UNMC 
extracts by measuring the conversion of MTT to formazan crystals in viable 
cells.  The optical density readings were used to construct dose-response curves 
KHQFHGHWHUPLQDWLRQRIWKHH[WUDFW FRQFHQWUDWLRQ ȝJPODWZKLFKFHOOJURZWK
is inhibited by 50% (GI50) after 72 h exposure.  
 
 
Appendix I-A: Dose-response curve of MDA-MB-468 cells after exposure to 
Acalypha Wilkesiana extracts for 72 hour. The optical readings (n= 4) ± SE 
obtained from a single representative experiment are shown.  The GI50 value 
ȝJPORI(W2+(W2$FDQG+(;H[WUDFWVDUHDQG!ȝJPO
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Appendix I-B: Dose-response curve of HCT116 cells after exposure to 
Duabanga grandiflora bark extracts for 72 hour. The optical readings (n= 4) ± 
SE obtained from a single representative experiment are shown.  The GI50 
YDOXHȝJPORI:DWHU(W2+(W2$FDQG+(;DQGH[WUDFWVDUH
DQG!ȝJPOUHVSHFWLYHO\ 
 
 
 
Appendix I-C: Dose-response curve of HCT116 cells after exposure to 
Duabanga grandiflora leaf extracts for 72 hour. The optical readings (n= 4) ± 
SE obtained from a single representative experiment are shown.  The GI50 
YDOXHȝJPORI:DWHU(W2+(W2$FDQG+(;DQGH[WUDFWVDUH
DQG!ȝJPOUHVSHFWLYHO\ 
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Appendix I-D: Dose-response curve of MDA-MB-468 cells after exposure to 
Archidendron ellipticum bark extracts for 72 hour. The optical readings (n= 4) 
± SE obtained from a single representative experiment are shown.  The GI50 
YDOXH ȝJPO RI (W2+ (W2$F DQG +(; H[WUDFWV DUH   DQG !
ȝJPl, respectively. 
 
 
Appendix I-E: Dose-response curve of MDA-MB-468 cells after exposure to 
Archidendron ellipticum leaf extracts for 72 hour. The optical readings (n= 4) ± 
SE obtained from a single representative experiment are shown.  The GI50 
YDOXH ȝJml) of EtOH, EtOAc, HEX and Water extracts are: 6.12, 8.06 and 
!ȝJPOUHVSHFWLYHO\ 
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Appendix I-F: Dose-response curve of HCT116 cells after exposure to 
Pseuduvaria macrophylla extracts for 72 hour. The optical readings (n= 4) ± 
SE obtained from a single representative experiment are shown.  The GI50 
YDOXH ȝJPO RI (W2+ (W2$F DQG +(; H[WUDFWV DUH   DQG 
ȝJPOUHVSHFWLYHO\ 
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Appendix I-G: Dose-response curve of MDA-MB-468 cells after exposure to 
Archidendron ellipticum EtOH bark extract fractions for 72 hour. The optical 
readings (n= 4) ± SE obtained from a single representative experiment are 
shown.  The GI50 YDOXHȝJPORIF1, F2, F3, F4, F6 and F6 extracts are: > 50, 
> 50, > 50, 1.49, > 50 and > 50 ȝJPOUHVSHFWLYHO\ 
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Appendix I-H: Dose-response curve of MDA-MB-468 cells after exposure to 
Archidendron ellipticum EtOAc bark extract fractions for 72 hour. The optical 
readings (n= 4) ± SE obtained from a single representative experiment are 
shown.  The GI50 YDOXHȝJPORIF1, F2, F3, F4, F6 and F6 extracts are: > 50, 
> 50, > 50, 19.74, 32.32 and > 50 ȝJPOUHVSHFWLYHO\ 
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Appendix I-I: Dose-response curve of MDA-MB-468 cells after exposure to 
Archidendron ellipticum EtOH leaf extract fractions for 72 hour. The optical 
readings (n= 4) ± SE obtained from a single representative experiment are 
shown.  The GI50 YDOXHȝJPORIF1, F2, F3, F4, F6 and F6 extracts are: > 50, 
> 50, > 50, 2.20, 10.11 and > 50 ȝJPOUHVSHFWLYHO\ 
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Appendix I-J: Dose-response curve of MDA-MB-468 cells after exposure to 
Archidendron ellipticum EtOAc leaf extract fractions for 72 hour. The optical 
readings (n= 4) ± SE obtained from a single representative experiment are 
shown.  The GI50 vDOXHȝJPORIF1, F2, F3, F4, F6 and F6 extracts are: > 50, 
> 50, > 50, 12.22, 4.61 and 6.08 ȝJPOUHVSHFWLYHO\ 
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Appendix I-K: Dose-response curve of MDA-MB-468 cells after exposure to 
Archidendron ellipticum HEX leaf extract fractions for 72 hour. The optical 
readings (n= 4) ± SE obtained from a single representative experiment are 
shown.  The GI50 YDOXHȝJPORIF1, F2, F3, F4, F6 and F6 extracts are: > 50, 
> 50, > 50, 2.89, 6.50 and 14.23 ȝJPOUHVSHFWLYHO\ 
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Appendix I-L: Dose-response curve of HCT116 cells after exposure to 
Duabanga grandiflora EtOH bark extract fractions for 72 hour. The optical 
readings (n= 4) ± SE obtained from a single representative experiment are 
shown.  The GI50 YDOXHȝJPORIF1, F2, F3, F4, F6 and F6 extracts are: > 50, 
> 50, 37.75, 26.31, 18.50 and > 50  ȝJPOUHVSHFWLYHO\ 
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Appendix I-M: Dose-response curve of HCT116 cells after exposure to 
Duabanga grandiflora EtOAc bark extract fractions for 72 hour. The optical 
readings (n= 4) ± SE obtained from a single representative experiment are 
shown.  The GI50 YDOXH ȝJPO RI F1, F2, F3, F4, F6 and F6 extracts are:  
41.17, > 50, > 50, 35.08, 28.78 and 28.60 ȝJPOUHVSHFWLYHO\ 
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Appendix I-N: Dose-response curve of HCT116 cells after exposure to 
Duabanga grandiflora HEX bark extract fractions for 72 hour. The optical 
readings (n= 4) ± SE obtained from a single representative experiment are 
shown.  The GI50 YDOXHȝJPORIF1, F2, F3, F4, F6 and F6 extracts are:  > 50, 
>50, >50, > 50, 31.77 and 36.18ȝJPOUHVSHFWLYHO\ 
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Appendix I-O: Dose-response curve of HCT116 cells after exposure to 
Duabanga grandiflora EtOH leaf extract fractions for 72 hour. The optical 
readings (n= 4) ± SE obtained from a single representative experiment are 
shown.  The GI50 YDOXHȝJPORIF1, F2, F3, F4, F6 and F6 extracts are:  > 50, 
>50, >50, > 50, >50 and > 50 ȝJPOUHVSHFWLYHO\ 
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Appendix I-P: Dose-response curve of HCT116 cells after exposure to 
Duabanga grandiflora EtOAc leaf extract fractions for 72 hour. The optical 
readings (n= 4) ± SE obtained from a single representative experiment are 
shown.  The GI50 YDOXHȝJPORIF1, F2, F3, F4, F6 and F6 extracts are:  > 50, 
>50, >50, > 50, >50 and > 50 ȝJPOUHVSHFWLYHO\ 
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Appendix I-P: Dose-response curve of HCT116 cells after exposure to 
Duabanga grandiflora HEX leaf extract fractions for 72 hour. The optical 
readings (n= 4) ± SE obtained from a single representative experiment are 
shown.  The GI50 YDOXHȝJPORIF1, F2, F3, F4, F6 and F6 extracts are:  > 50, 
>50, >50, > 50, >50 and > 50 ȝJPOUHVSHFWLYHO\ 
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Appendix I-P: Dose-response curve of HCT116 cells after exposure to 
Pseuduvaria macrophylla EtOH extract fractions for 72 hour. The optical 
readings (n= 4) ± SE obtained from a single representative experiment are 
shown.  The GI50 YDOXHȝJPORIF1, F2, F3, F4, F6 and F6 extracts are:  > 10, 
>10, 2.29, 8.73, > 10 and 9.67ȝJPOUHVSHFWLYHO\ 
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Appendix I-Q: Dose-response curve of HCT116 cells after exposure to 
Pseuduvaria macrophylla EtOAc extract fractions for 72 hour. The optical 
readings (n= 4) ± SE obtained from a single representative experiment are 
shown.  The GI50 YDOXHȝJPORIF1, F2, F3, F4, F6 and F6 extracts are:  > 10, 
>10, 0.61, 3.83, >10 and > 10 ȝJPOUHVSHFWLYHO\ 
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Appendix II 
Fractionation of extracts were performed using a Strata C18-E extraction 
cartridge equilibrated with equal volume of d. H20 and MeOH prior to loading 
the cartridge with UNMC extract.  The solvents were passed through the 
extract and collected in a pre-weighed glass vial followed by evaporation of 
solvent to obtain the extract fraction.  The yield was determined by the 
difference in weight of glass vial before fraction collection and after solvent 
evaporation then subjected to HPLC analysis as described in Chapter 7.5.   
 
Appendix II-A: The yield (%) of Duabanga grandiflora extract fractions.  
D. 
grandiflora 
extracts 
% Yield of D. grandiflora extract fractions 
F1 F2 F3 F4 F5 F6 Total % (mg) 
Ba
rk
 
Water - - - - - - - 
EtOH 13.0 15.5 19.3 3.4 0.5 1.9 
 
53.6 
(11.1) 
EtOAc 20.3 2.1 5.7 6.0 14.9 2.9 
 
51.8 
(19.1) 
HEX 2.3 0.9 3.5 6.0 23.4 13.9 
 
50.2 
(14.5) 
Le
a
f 
Water - - - - - - - 
EtOH 71.6 4.6 4.4 1.2 1.7 1.4 
 
84.8 
(23.5) 
EtOAc 25.6 3.8 2.4 1.2 24.4 2.3 
 
59.6 
(16.8) 
HEX 21.8 0.5 6.2 1.1 1.2 6.4 
 
47.3 
(3.12) 
Strata C18-E extraction cartridge was equilibrated with equal volume of d. H20 
and MeOH prior to loading the cartridge with D. grandiflora extracts.  The 
solvents were passed through the extract and collected then removed to obtain 
the extract fraction for analysis.  The weigh (mg) used to determine % yield of 
extracts were of the glass vial prior to collection and after solvent evaporation. 
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Appendix II-B: The yield (%) of Archidendron ellipticum extract fractions.  
A. ellipticum 
extracts 
% Yield of A. ellipticum extract fractions 
F1 F2 F3 F4 F5 F6 Total % (mg) 
Ba
rk
 
EtOH 39.1 4.4 7.8 14.9 2.6 3.2 
 
24.6  
(72.0) 
EtOAc 10.5 1.5 8.6 3.9 10.0 15.3 
 
9.9  
(49.8) 
HEX - - - - - - - 
Le
a
f 
EtOH 10.4 3.3 3.0 6.5 2.7 1.2 
 
21.7 
(27.2) 
EtOAc 0.0 0.3 2.0 2.8 7.8 6.2 
 
10.6 
(19.0) 
HEX 1.0 0.0 3.1 2.1 8.7 1.2 
 
10.72 
(16.2) 
Strata C18-E extraction cartridge was equilibrated with equal volume of d. H20 
and MeOH prior to loading the cartridge with A. ellipticum extracts.  The 
solvents were passed through the extract and collected then removed to obtain 
the extract fraction for analysis.  The weigh (mg) used to determine % yield of 
extracts were of the glass vial prior to collection and after solvent evaporation. 
 
Appendix II-C: The yield (%) of Pseuduvaria macrophylla extract fractions.  
P. 
macrophylla 
extracts 
% Yield of P. macrophylla extract fractions 
F1 F2 F3 F4 F5 F6 Total % (mg) 
W
ho
le
 
EtOH 2.8 1.1 9.1 3.8 1.7 0.4 
 
18.82 
(76.5) 
EtOAc 0.2 1.3 8.5 6.5 6.8 0.6 
 
23.8 
(27.9) 
HEX - - - - - - - 
Strata C18-E extraction cartridge was equilibrated with equal volume of d. H20 
and MeOH prior to loading the cartridge with P. macrophylla extracts.  The 
solvents were passed through the extract and collected then removed to obtain 
the extract fraction for analysis.  The weigh (mg) used to determine % yield of 
extracts were of the glass vial prior to collection and after solvent evaporation. 
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Appendix III 
 
Appendix III-A: HPLC trace of Duabanga grandiflora bark extract 
µLQDFWLYH¶IUDFWLRQVusing Reversed Phase chromatography. EtOH: F1 (A), 
and F2 (B) and EtOAc F2 (C) and F3 (D) (1 mg/ml in DMSO) in 1:1 distilled 
water and MeOH were analysed using 10% B for 1 min, 10-98% B over 2 min, 
at 98% for 2 min, (Phenomenex C18 Gemini-NX 3ȝ-110A 50x2 mm column). 
The eluent compounds were detected at a wavelength of 220 nm (i) and 254 (ii) 
nm.  
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Appendix III-B: HPLC trace of Duabanga grandiflora bark extract 
µLQDFWLYH¶ IUDFWLRQV using Reversed Phase chromatography. HEX: F1 (E), 
F2 (F), F3 (G) and F4 (H) (1 mg/ml in DMSO) in 1:1 distilled water and 
MeOH were analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% 
for 2 min, (Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The 
eluent compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm.  
 241 
 
Appendix III-C: HPLC trace of Duabanga grandiflora leaf extract 
µLQDFWLYH¶ fractions using Reversed Phase chromatography. EtOH: F1 (A), 
F2 (B) and F3 (C) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were 
analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Appendix III-D: HPLC trace of Duabanga grandiflora leaf extract 
µLQDFWLYH¶ fractions using Reversed Phase chromatography. EtOH: F4 (D), 
F5 (E) and F6 (F) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were 
analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Appendix III-E: HPLC trace of Duabanga grandiflora leaf extract 
µLQDFWLYH¶ fractions using Reversed Phase chromatography. EtOAc: F1 (G), 
F2 (H) and F3 (I) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were 
analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Appendix III-F: HPLC trace of Duabanga grandiflora leaf extract 
µLQDFWLYH¶ fractions using Reversed Phase chromatography. EtOAc: F4 (J), 
F5 (K) and F6 (L) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were 
analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Appendix III-G: HPLC trace of Duabanga grandiflora leaf extract 
µLQDFWLYH¶ fractions using Reversed Phase chromatography. HEX: F1 (M), F2 
(N) and F3 (O) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were 
analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Appendix III-H: HPLC trace of Duabanga grandiflora leaf extract 
µLQDFWLYH¶ fractions using Reversed Phase chromatography. HEX: F4 (P), F5 
(Q) and F6 (R) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were 
analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Appendix III-I: HPLC trace of Archidendron ellipticum bark extract 
µLQDFWLYH¶ fractions using Reversed Phase chromatography. EtOH: F1 (A), 
F2 (B) and F3 (C) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were 
analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Appendix III-J: HPLC trace of Archidendron ellipticum bark extract 
µLQDFWLYH¶ fractions using Reversed Phase chromatography. EtOH: F5 (D) 
and F6 (E) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were analysed 
using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, (Phenomenex 
C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent compounds were 
detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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 Appendix III-K: HPLC trace of Archidendron ellipticum bark extract 
µLQDFWLYH¶ fractions using Reversed Phase chromatography. EtOAc: F1 (F), 
F2 (G), F3 (H) and F6 (I) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH 
were analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Appendix III-xii: HPLC trace of Archidendron ellipticum leaf extract 
µLQDFWLYH¶ IUDFWLRQVXVLQJ5HYHUVHG3KDVHFKURPDWRJUDSK\ EtOH: F1 (J), 
F2 (K), F3 (L) and F6 (M) (1 mg/ml in DMSO) in 1:1 distilled water and 
MeOH were analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% 
for 2 min, (Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The 
eluent compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Appendix III-L: HPLC trace of Archidendron ellipticum leaf extract 
µLQDFWLYH¶IUDFWLRQVXVLQJ5HYHUVHG3KDVHFKURPDWRJUDSK\ EtOAc: F1 (N), 
F2 (O) and F3 (P) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were 
analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Appendix III-M: HPLC trace of Archidendron ellipticum leaf extract 
µLQDFWLYH¶ IUDFWLRQV XVLQJ5HYHUVHG3KDVHFKURPDWRJUDSK\ HEX: F1 (Q), 
F2 (R) and F3 (S) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were 
analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Appendix III-N: HPLC trace of Pseuduvaria macrophylla H[WUDFWµLQDFWLYH¶
fractions using Reversed Phase chromatography. EtOH: F1 (A), F2 (B) and 
F5 (C) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were analysed 
using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, (Phenomenex 
C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent compounds were 
detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Appendix III-O: HPLC trace of Pseuduvaria macrophylla H[WUDFWµLQDFWLYH¶
fractions using Reversed Phase chromatography. EtOAc: F1 (D), F2 (E), F5 
(F) and F6 (G) (1 mg/ml in DMSO) in 1:1 distilled water and MeOH were 
analysed using 10% B for 1 min, 10-98% B over 2 min, at 98% for 2 min, 
(Phenomenex C18 Gemini-1; ȝ-110A 50x2 mm column). The eluent 
compounds were detected at a wavelength of 220 nm (i) and 254 (ii) nm. 
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Appendix IV 
IV-1 Antimicrobial activity of UNMC crude extracts 
Rapamycin is a well-known antibiotic used in organ transplant with 
serine/threonine kinase inhibitory effects that can also affect protein 
translation, cell proliferation and transcription via inhibition of mTOR 
(mammalian target of rapamycin).78  Therefore compounds embedded in 
UNMC extracts may have multiple functions.  Aporphinoid (38) present in P. 
macrophylla has been reported to demonstrate anti-tuberculosis activity against 
Mycobacterium tuberculosis with MIC of 100 ȝJPO KRZHYHU LW LV LQDFWLYH
against Plasmodium falciparum in antimalarial assays.214  Previously, an anti-
herpesvirus compound, eugeniin, was isolated from D. grandiflora EtOAc 
extracts and has demonstrated antiviral effects on HSV strains (at 20 ȝJPO 
inhibition of viral DNA synthesis of HSV strains in Vero cells (at 20 ȝJPO 
and dose-dependent inhibition of HSV DNA and late HSV proteins.198  
Additionally, D. grandiflora extracts have been shown to inhibit accumulation 
of fat in melanoma cells and increase type II collagen production in dermal 
fibroblasts.196  Therefore, further anti-microbial properties of these species are 
justified. 
Antimicrobial properties of UNMC extracts were determined using broth 
microdilution assay performed by Dr. Jaroslav Havlík and his team from the 
Department of Microbiology, Nutrition and Dietetics, Czech Universitiy of 
Life Sciences, in Prague.  
 
The bacterial panel selected consists of both Gram-negative (S. aureus and E. 
faecalis) and Gram-positive bacteria (P. aeruginosa and E. coli), cocci and 
rods, as well as one strain of yeast (C. albicans).  Reference antibiotics were 
used as positive controls.  A. ellipticum extracts were not assessed in this assay 
due to insufficient stock.  Two-fold dilutions of each sample tested were tested 
in the concentration range of 1±128 mg/L.  Each ZHOOZDVLQRFXODWHGZLWKȝO
of microbial suspension at a density of 107 CFU/ml (108 for the yeast strain).  
The microtitre plates were incubated overnight at 37 °C.  DMSO was assayed 
as the negative control and has been shown not to affect bacterial growth.  
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Growth turbidity was measured at 405 nm and the minimum extract 
concentration required to inhibit bacterial growth (MICs) was calculated based 
on the density of the growth control and were expressed as the lowest extract 
concentrations that resulted in 80% growth reduction compared to that of 
extract-free growth control.  All samples were tested in triplicate.  
 
IV-2 Antimicrobial activity of Duabanga grandiflora crude 
extracts 
D. grandiflora bark and leaf extracts revealed comparable MIC values against 
E. faecalis (16 mg/L), P. aeruginosa (8 mg/L), E. coli (16 mg/L) and C. 
albicans (8 mg/L) in the broth microdilution assay ().  Activity against S. 
aureus varied amongst the extracts, with polar (Water and EtOH) bark extracts 
and leaf EtOH and EtOAc extracts yielding the lowest MIC (16 mg/L).  
Growth inhibition of Gram-negative bacteria possessing a good natural barrier 
suggests that these extracts contain compounds that could diffuse through the 
bacterial wall and impair its cellular function affecting its growth.   
In a recently published screening of Malaysian antimicrobial plants, both D. 
grandiflora extracts showed highest activity in an agar diffusion assay, 
revealing sensitivity of S. aureus to EtOH bark and EtOAc leaf extracts (0.094 
mg/ml) and less sensitivity to EtOAc bark and EtOH leaf extracts (0.75 and 
0.38 mg/ml, respectively).205  Higher concentrations of bark and leaf extracts 
were need to inhibit E. coli growth (0.75 ± 1.5 mg/ml).  The activity was 
among the most potent plants in the test and was non-specific against both 
Gram-negative and Gram-positive bacteria.  Recently, a time-dependent 
insecticidal study demonstrated D. grandiflora MeOH extract-treated rice was 
toxic to Sitophilus oryzae adults and toxicity increased significantly with 
increasing concentrations (0 - 32 mg/ml).206  
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Appendix IV-A: Antimicrobial activity of extracts against selected bacterial 
strains. 
D. grandiflora 
extracts/ Reference 
bacteria 
Minimum Inhibitory Concentration (mg/L) 
Gram-positive Gram-negative Yeast 
S. 
aureus 
E. 
faecalis 
P. 
aeruginosa E. coli 
C. 
albicans 
Ba
rk
 
Water 16 16 8 16 8 
EtOH 32 16 8 16 8 
EtOAc 16 16 8 16 8 
HEX 32 16 8 16 8 
Le
a
f 
Water 32 16 8 16 8 
EtOH 16 16 8 16 8 
EtOAc 16 16 8 16 8 
HEX 32 16 8 16 8 
R
ef
er
en
ce
 
a
n
tib
io
tic
 
Oxacillin 0.25 - - - - 
Vancomycin - 2 - - - 
Ciprofloxacin - - 0.25 - - 
Tetracycline - - - 1 - 
Nystatin - - - - 2 
The bacterial panel consisted of S. aureus (ATCC 29213), E. faecalis (ATCC 
29212), P. aeruginosa (ATCC 27853), E. coli (ATCC 25922) and yeast C. 
albicans (ATCC 10231).  The minimum extract concentration (mg/L; MIC) 
required to inhibit growth of selected bacteria and yeast were determined in the 
broth microdilution assay according to the CLSI guidelines (2009).281  MICs of 
reference antibiotics used as positive controls were in range of acceptable 
limits.  
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IV-C Antimicrobial activity of Pseuduvaria macrophylla crude 
extracts 
Similarly, P. macrophylla extracts possess comparable antimicrobial activity 
against E. faecalis (16 mg/L), P. aeruginosa (8 mg/L), E. coli (16 mg/L) and 
C. albicans (8 mg/L) in a broth microdilution assay ().  Activity against S. 
aureus varied amongst extracts, and the lowest MIC (16 mg/L) was seen with 
EtOH extract.  
 
 
Appendix IV-B: Antimicrobial activity of extracts against selected bacterial 
strains. 
UNMC extracts/ 
Reference bacteria 
Minimum Inhibitory Concentration (mg/L) 
Gram-positive Gram-negative Yeast 
S. 
aureus 
E. 
faecalis 
P. 
aeruginosa E. coli 
C. 
albicans 
P.
 
m
a
cr
o
ph
yl
la
 EtOH 16 16 8 16 8 
EtOAc 32 16 8 16 8 
HEX 32 16 8 16 8 
R
ef
er
en
ce
 
a
n
tib
io
tic
 
Oxacillin 0.25 - - - - 
Vancomycin - 2 - - - 
Ciprofloxacin - - 0.25 - - 
Tetracycline - - - 1 - 
Nystatin - - - - 2 
Bacterial panel consisted of S. aureus (ATCC 29213), E. faecalis (ATCC 
29212), P. aeruginosa (ATCC 27853), E. coli (ATCC 25922) and yeast C. 
albicans (ATCC 10231).  The minimum extract concentration (mg/L; MIC) 
required to inhibit growth of selected bacteria and yeast were determined in the 
broth microdilution assay according to the CLSI guidelines (2009).281  MICs of 
reference antibiotics used as positive controls were in range of acceptable 
limits.  
 
Overall, UNMC extracts were potent at very low concentrations against the 
panel of Gram-positive and Gram-negative bacteria and yeast strains.  
Antimicrobial results concurred with previously reports that very low 
concentration of D. grandiflora and P. macrophylla extracts could inhibit the 
growth of Gram-negative bacteria even though they have a good natural barrier 
against antimicrobial compounds.  
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Appendix V 
Investigating in vitro anticancer activity of Uvaria macrophylla (Annonaceace, 
related to P. macrophylla) performed by Mr Vijay Raja under my supervision.  
Extraction of U. macrophylla bark and leaf extracts using solvents (in order of 
polarity): EtOH > chloroform (CHL) > HEX was prepared by UNMC 
colleagues.  Activity of these extracts has been tested against MCF-7 and 
HCT116 cancer cells in several bioassays. 
 
V-1  In vitro growth inhibitory and cytotoxicity effects of Uvaria 
macrophylla extracts in a cell line panel  
The growth inhibitory properties of U. macrophylla extracts in MCF-7 and 
HCT116 cells were assessed using the MTT assay following 72 h exposure (as 
outlined in section 7.2.3).  Both breast and colorectal carcinoma cell lines did 
not demonstrate comparable level of sensitivity towards U. macrophylla EtOH 
extracts as observed4 with P. macrophylla extracts (Table 8-4).  
 
Appendix IV-A: In vitro growth inhibitory effects of Uvaria macrophylla 
extracts in breast and colorectal carcinoma cells revealed by the MTT assay. 
Cell line U. macrophylla 
extracts 
Mean GI50 9DOXHVȝJPO 
Bark Leaf 
MCF-7 
EtOH 79.08 ± 18.58 102.3 ± 12.88 
CHL 11.69 ± 4.45 5.89 ± 2.12 
HEX 4.72 ± 1.50 27.03 ± 7.23 
HCT116 
EtOH 68.20 ± 21.80 97.23 ± 19.97 
CHL 3.25 ± 0.66 4.55 ± 0.90 
HEX 5.59 ± 1.16 21.75 ± 8.60 
([WUDFW FRQFHQWUDWLRQȝJPODWZKLFKFHOOJURZWKLVLQKLELWHGE\*,50) 
after 72 h exposure.  Mean GI50 YDOXHVȝJPO6(0ZDVREWDLQHGIURP
(n = 4) individual experiments where active crude extracts (GI50 YDOXHV
ȝJPODUHKLJKOLghted in bold, extracts ± SEM values that could be considered 
active are highlighted in italics. 
 
HEX bark extracts demonstrated greater potency than leaf extracts by 4 to 6 
folds.  CHL bark and leaf extracts were the most active against both cell lines 
at low concentrations between (3.25 to 11.69 ȝJPO).  Extracts of CHL (used in 
U. macrophylla extraction) and EtOAc (used in P. macrophylla extraction) 
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reveal greatest activity against MCF-7 and HCT116 compared to other 
H[WUDFWLRQ VROYHQWVXVHGWKHUHIRUHLWLV OLNHO\WKDW VLPLODUµDFWLYH¶FRPSRXQGV
in this plant family are extracted by solvents this polarity range.   
On the whole, P. macrophylla extracts exerted greater growth inhibition 
activity against cancer cells than U. macrophylla extracts.  Unexpectedly, 
EtOH and HEX U. macrophylla extracts did not yield comparable GI50 values 
as that seen with P. macrophylla extracts.  
 
V-2 Influence of Uvaria macrophylla extracts on MCF-7 and 
HCT116 FHOOV¶VXUYLYDODQGFORQRJHQLFLW\ 
The clonogenic assay was employed to assess the influence of U. macrophylla 
extracts on MCF-DQG+&7FHOOV¶ VXUYLYal and colony formation ability 
(outlined in section 7.2.4).  U. macrophylla extracts inhibited colony formation 
ability of both cells at similar or lower concentrations than determined in the 
MTT assay (Table 8-5).  
  
Appendix IV-B: Effects of Uvaria macrophylla extracts to MCF-7 and 
+&7FHOOV¶VXUYLYDODQGFORQRJHQLFLW\ 
Cell line U. macrophylla 
extracts 
Mean IC50 9DOXHVȝJPO 
Bark Leaf 
MCF-7 
EtOH 19.61 ± 1.94 29.60 ± 2.81 
CHL 4.72 ± 1.77 3.44 ± 1.23 
HEX 6.60 ± 3.00 12.83 ± 4.34 
HCT116 
EtOH 42.62 ± 11.70 94.66 ± 22.41 
CHL 3.01 ± 0.67 5.17 ± 0.87 
HEX 3.68 ± 0.63 28.30 ± 7.57 
([WUDFWFRQFHQWUDWLRQȝJ/ml) at which colony formation is inhibited after 24 h 
exposure.  Mean IC50 YDOXHV ȝJPO  6(0 ZDV REWDLQHG IURP   Q   
individual experiments. 
 
It is possible that due to low seeding density, EtOH bark and leaf extracts were 
able to inhibit colony formation at lower extract concentration than expected 
than expected with the exception of leaf bark extract against HCT116 cells.  
Whereas CHL extracts were able to inhibit clonogenicity of MCF-7 and 
HCT116 cells at similar concentrations seen in the MTT assay (<11 ȝJPO
Overall, U. macrophylla bark extracts were more active against MCF-FHOOV¶
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survival and clonogenicity (Figure 8-24), even though greater GI50 results were 
seen in the MTT assay, this may suggest cells remain viable but unable to 
proliferate following exposure to U. macrophylla extracts.  Whereas similar 
GI50 and IC50 values for U. macrophylla extracts against HCT116 cells 
suggests that extracts are potent to HCT116 cells causing lost in viability and 
colony forming abilities.  
 
 
Appendix V-C: Effects of U. macrophylla extracts to HCT116 (A: bark and 
leaf) and MCF-7 (B: bark and leaf) cells¶VXUYLYDODQGFORQRJHQLFLW\.  Bars 
(error bar = SEM) denote the mean % of MCF-7/HCT116 colonies formed 
DIWHUKH[SRVXUHWRH[WUDFWVIURPQ LQGLYLGXDOH[SHULPHQWVSODWLQJ
HIILFLHQFLHVZHUHSHUH[SHULPHQWANOVA univariate analysis was used 
to compare each extract-treated group to the control group.  Any statistically 
significant values are denoted: * = 0.05< p. 
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V-3 Uvaria macrophylla extracts effects on HCT116 cell cycle 
distribution 
 Flow cytometric technique was employed to determine HCT116 cell cycle 
distribution following treatment to U. macrophylla extracts as outlined in 
section 7.2.5.1.  In general, cell cycle distribution of HCT116 cells appeared to 
be comparable to that of DMSO control cells (Figure 8-25).  Cell cycle 
histograms of cells exposed to EtOH extracts revealed subtle differences when 
compared to that of the control, such as decrease in G1/0 phase accompanied 
by increased S phase levels.  Whereas HEX bark extract treatment suggests a 
possible increase in G2/M cell population accompanied by a decrease in G1/0 
cell population.  Interestingly, CHL extract treated cells revealed increased 
sub-G1 cell population, which is indicative of apoptotic cells; CHL leaf extract 
appeared to be most active in increasing % of sub-G1 HCT116 cells.  In 
summary, preliminary data suggests low concentration of U. macrophylla CHL 
extracts could possess compounds causing cells to undergo apoptosis, however 
further analysis are required to confirm this finding and enable the use of 
statistical analysis to reveal if the cell cycle distribution of extract-treated cells 
are indeed different to the control population. 
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Appendix V-D: Detection of propidium iodide staining of HCT116 cellular DNA content after exposure to U. macrophylla extracts at 4X 
GI50 concentration for 48 hour.  Data is represented as histogram of cellular DNA content representation of cell population % in each cell cycle 
phase; images from a single representative experiment are shown.  The samples were kept chilled overnight in a solution conta ining buffer, 
detergent and ribonuclease A prior to analysis. Results were estaEOLVKHG IURP WKUHH H[SHULPHQWV RI  15,000 cells per sample (n = 2) and 
processed using EXPO32 software.    
